EX-2.1 2 ex2-1.htm EX-2.1

 

Exhibit 2.1

 

AGREEMENT AND PLAN OF MERGER

among

 

BEELINE HOLDINGS, INC.,

a Nevada corporation;

 

BLNE MERGER SUB, INC.

a Delaware corporation;

 

TYTL CORP.,

a Delaware corporation; and

 

Brendan Reilly,

 

as the Holders’ Representative

 

Dated as of November 19, 2026

 

 
 

 

TABLE OF CONTENTS

 

Section 1   DESCRIPTION OF TRANSACTION 3
       
1.1   The Merger 3
1.2   Effects of the Merger 3
1.3   Closing; Effective Time 3
1.4   Certificate of Incorporation and Bylaws; Directors and Officers 3
1.5   Conversion of Shares 4
1.6   Treatment of Options 5
1.7   Exchange and Payment 6
1.8   Dissenters Rights 8
1.10   Further Action 8
       
Section 2   REPRESENTATIONS AND WARRANTIES OF THE COMPANY 8
       
2.1   Due Organization; Subsidiaries 8
2.2   Organizational Documents 8
2.3   Authority; Binding Nature of Agreement 9
2.4   Vote Required 9
2.5   Non-Contravention; Consents 9
2.6   Capitalization 10
2.7   Financial Statements 12
2.8   Absence of Changes 13
2.9   Absence of Undisclosed Liabilities 13
2.10   Title to Assets 13
2.11   Real Property 14
2.12   Intellectual Property 14
2.13   Privacy and Data Security 16
2.14   Agreements, Contracts and Commitments 16
2.15   Compliance; Permits 17
2.16   Legal Proceedings; Orders 18
2.17   Tax Matters 18
2.18   Employee and Labor Matters; Benefit Plans 20
2.19   Environmental Matters 21
2.20   Insurance 22
2.21   No Financial Advisors 22
2.22   Transactions with Affiliates 22
2.23   Anti-Bribery 22
2.24   Disclaimer of Other Representations or Warranties 22
       
Section 3   REPRESENTATIONS AND WARRANTIES OF BLNE AND MERGER SUB 23
       
3.1   Due Organization; Subsidiaries 23
3.2   Organizational Documents 24
3.3   Authority; Binding Nature of Agreement 24
3.4   Vote Required 25
3.5   Non-Contravention; Consents 25
3.6   Capitalization 26
3.7   SEC Filings; Financial Statements 28

 

-i-
 

 

3.8   Absence of Changes 29
3.9   Absence of Undisclosed Liabilities 29
3.10   Title to Assets 29
3.11   Real Property; Leasehold 29
3.12   Intellectual Property 29
3.13   Privacy and Data Security 31
3.14   Agreements, Contracts and Commitments 31
3.15   Compliance; Permits 32
3.16   Legal Proceedings; Orders 32
3.17   Tax Reorganization 32
3.18   Employee and Labor Matters; Benefit Plans 34
3.19   Environmental Matters 35
3.20   Insurance 35
3.21   No Financial Advisors 35
3.22   Transactions with Affiliates 35
3.23   Valid Issuance 36
3.24   Anti-Bribery 36
3.25   Disclaimer of Other Representations or Warranties 36
       
Section 4   CERTAIN COVENANTS OF THE PARTIES 36
       
4.1   Operation of BLNE’s Business 36
4.2   Operation of the Company’s Business 38
4.3   Access and Investigation 40
4.4   BLNE Non-Solicitation 40
4.5   Company Non-Solicitation 41
4.6   Notification of Certain Matters 41
       
Section 5   ADDITIONAL AGREEMENTS OF THE PARTIES 42
       
5.1   Proxy Statement 42
5.2   Company Stockholder Written Consent 43
5.3   BLNE Stockholders’ Meeting 44
5.4   Regulatory Approvals 46
5.5   Indemnification of Officers and Directors 46
5.6   Additional Agreements 47
5.7   Disclosure 48
5.8   Listing 48
5.9   BLNE SEC Documents 48
5.10   Tax Matters 49
5.11   Directors and Officers 51
5.12   Section 16 Matters 52
5.13   Allocation Certificate 52
5.14   Company Financials 52
5.15   Takeover Statutes 53
5.16   Stockholder Litigation 53
5.17   Company Stockholder Agreements 53
5.18   Preferred Stock Conversion 53
5.19   Qualifying Financing 54

 

-ii-
 

 

Section 6   CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY 54
       
6.1   No Restraints 54
6.2   Stockholder Approval 54
6.3   Listing 54
6.4   Lock-Up Agreements 54
       
Section 7   ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATIONS OF BLNE AND MERGER SUB 55
       
7.1   Accuracy of Representations 55
7.2   Performance of Covenants 55
7.3   Documents 55
7.4   Tax Certificate 56
7.5   No Company Material Adverse Effect 56
7.6   Company Stockholder Written Consent 56
       
Section 8   ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATION OF THE COMPANY 56
       
8.1   Accuracy of Representations 56
8.2   Performance of Covenants 57
8.3   Documents 57
8.4   No BLNE Material Adverse Effect 57
       
Section 9   TERMINATION 57
       
9.1   Termination 57
9.2   Effect of Termination 59
       
Section 10   INDEMNIFICATION 59
       
10.1   Survival 59
10.2   Indemnification by Company Stockholders and Company Option Holders 59
10.3   Indemnification by BLNE 60
10.4   Certain Limitations 61
10.5   Indemnification Procedures 62
10.6   Effect of Investigation 63
10.8   Tax Treatment 64
10.9   Exclusive Remedies 64
       
Section 11   MISCELLANEOUS PROVISIONS 64
       
11.1   Amendment 64
11.2   Waiver 64
11.3   Entire Agreement; Counterparts; Exchanges by Electronic Transmission 65
11.4   Applicable Law; Jurisdiction 65
11.5   Assignability 65
11.6   Notices 66
11.7   Cooperation 67
11.8   Severability 67
11.9   Other Remedies; Specific Performance 67
11.12   Construction 68

 

Exhibits

 

Exhibit A Definitions A-1
Exhibit B Form of BLNE Stockholder Support Agreement B-1
Exhibit C Form of Lock-Up Agreement C-1
Exhibit D Illustrative Calculation of Exchange Ratio D-1
Exhibit E Form of Letter of Transmittal E-1
Exhibit F Form of Side Letter F-1

 

-iii-
 

 

AGREEMENT AND PLAN OF MERGER

 

THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of November 19, 2026, by and among (i) BEELINE HOLDINGS, INC., a Nevada corporation (“BLNE”), (ii) BLNE MERGER SUB, INC., a Delaware corporation and wholly owned subsidiary of BLNE (“Merger Sub”), (iii) TYTL Corp., a Delaware corporation (the “Company”), and (iv) Brendan Reilly, in his capacity as representative of the Pre-Closing Company Holders in connection with the Contemplated Transactions (the “Holders’ Representative”). Certain capitalized terms used in this Agreement are defined in Exhibit A or elsewhere in this Agreement.

 

RECITALS

 

A. BLNE and the Company intend to effect a merger of Merger Sub with and into the Company (the “Merger”), with the Company surviving the Merger, and in accordance with this Agreement and the DGCL. Upon consummation of the Merger, Merger Sub will cease to exist and the Company will become a wholly owned subsidiary of BLNE;

 

B. The Board of Directors of BLNE (the “BLNE Board”) has established a special committee thereof consisting only of independent and disinterested directors that the BLNE Board determined to be disinterested directors within the meaning of Nevada Law (the “Special Committee”) to, among other things, review, evaluate and negotiate, and/or to reject, this Agreement and the transactions contemplated hereby, and the material facts as to the interests of certain officers and directors of BLNE who are also stockholders of TYTL, were disclosed or known to all of the members of the Special Committee;

 

C. The Special Committee unanimously (i) determined that this Agreement and the Merger, including the Stock Issuance, the change of control of BLNE resulting therefrom and the other actions contemplated by this Agreement (collectively, the “Contemplated Transactions”), are fair to, advisable and in the best interests of BLNE and its stockholders, (ii) approved and declared advisable this Agreement and the Contemplated Transactions, (iii) recommended, upon the terms and subject to the conditions set forth in this Agreement, that the BLNE Board approve this Agreement and the Contemplated Transactions, and (iv) determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of BLNE vote to approve the Required BLNE Stockholder Matters;

 

D. In addition to customary conditions, the consummation of the Contemplated Transactions was conditioned upon the following non-waivable conditions (i) the approval of this Agreement and the Contemplated Transactions by the Special Committee, and (ii) the approval of this Agreement and the Contemplated Transactions by a fully informed vote of holders of a Majority of the Minority;

 

E. The Merger Sub Board has (i) determined that the Contemplated Transactions are fair to, advisable and in the best interests of Merger Sub and its sole stockholder, (ii) approved and declared advisable this Agreement and the Contemplated Transactions, and (iii) recommended, upon the terms and subject to the conditions set forth in this Agreement, that the sole stockholder of Merger Sub vote to adopt this Agreement and thereby approve the Contemplated Transactions;

 

-1-
 

 

F. The Company Board has (i) determined that the Contemplated Transactions are fair to, advisable and in the best interests of the Company and its stockholders, (ii) approved and declared advisable this Agreement and the Contemplated Transactions, and (iii) determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of the Company vote to adopt this Agreement and approve the Contemplated Transactions (the “Company Stockholder Matters”);

 

G. Concurrently with the execution and delivery of this Agreement and as a condition and inducement to the Company’s willingness to enter into this Agreement, the officers, directors and stockholders of BLNE listed on Section A-1 of the BLNE Disclosure Schedule (solely in their capacity as stockholders of BLNE) are executing support agreements in favor of the Company in substantially the form attached hereto as Exhibit B (the “BLNE Stockholder Support Agreement”), pursuant to which such Persons have, subject to the terms and conditions set forth therein and herein, agreed to vote all of their shares of BLNE Common Stock in favor of the Required BLNE Stockholder Matters, and against any Acquisition Proposals in respect of BLNE;

 

H. Concurrently with the execution and delivery of this Agreement and as a condition and inducement to each of BLNE and the Company’s willingness to enter into this Agreement, the directors and officers of BLNE listed in Section A-2 of the BLNE Disclosure Schedule (solely in their capacity as stockholders of BLNE) and all the directors, officers and stockholders of the Company listed in Section A-2 of the Company Disclosure Schedule (solely in their capacity as stockholders of the Company) are executing lock-up agreements in substantially the form attached as Exhibit C (each, a “Lock-Up Agreement”);

 

I. Concurrently with the execution and delivery of this Agreement and as a condition and inducement to each of BLNE and the Company’s willingness to enter into this Agreement, Nicholas R. Liuzza, Jr., BLNE’s Chief Executive Officer and a stockholder of the Company (“Mr. Liuzza”), has entered into a letter agreement, in the form attached hereto as Exhibit F (the “Side Letter”), with BLNE, pursuant to which Mr. Liuzza has agreed to (i) forfeit his rights to one-third of the shares of BLNE Common Stock received by him as Merger Consideration and to transfer such shares to BLNE immediately upon receipt thereof no consideration being paid to Mr. Liuzza in respect of such forfeiture and transfer, and (ii) agree to certain other terms that are set forth in the Side Letter relating to the remaining shares of BLNE Common Stock received by him as Merger Consideration; and

 

J. For U.S. federal (and, where applicable, state and local) income tax purposes, it is intended that (i) the Merger shall qualify as a “reorganization” within the meaning of Section 368(a) of the Code and (ii) this Agreement shall constitute, and is hereby adopted as, a “plan of reorganization” within the meaning of Treasury Regulations Sections 1.368-2(g) and 1.368-3(a) and for purposes of Sections 354 and 361 of the Code, to which BLNE, Merger Sub, and the Company are parties under Section 368(b) of the Code (the “Intended Tax Treatment”).

 

-2-
 

 

AGREEMENT

 

The Parties, intending to be legally bound, agree as follows:

 

Section 1 DESCRIPTION OF TRANSACTION

 

1.1 The Merger. Upon the terms and subject to the conditions set forth in this Agreement, at the Effective Time, Merger Sub shall be merged with and into the Company, and the separate corporate existence of Merger Sub shall cease. The Company will continue as the surviving corporation in the Merger (the “Surviving Corporation”).

 

1.2 Effects of the Merger. The Merger shall have the effects set forth in this Agreement, the Certificate of Merger and in the applicable provisions of the DGCL. As a result of the Merger, the Company will become a wholly owned subsidiary of BLNE.

 

1.3 Closing; Effective Time. Unless this Agreement is earlier terminated pursuant to Section 9.1, and subject to the satisfaction or waiver of the conditions set forth in Section 6, Section 7 and Section 8, the consummation of the Merger (the “Closing”) shall take place remotely as promptly as practicable (but in no event later than the second Business Day following the satisfaction or waiver of the last to be satisfied or waived of the conditions set forth in Section 6, Section 7 and Section 8, other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of each of such conditions), or at such other time, date and place as BLNE and the Company may mutually agree. The date on which the Closing actually takes place is referred to as the “Closing Date.” At the Closing, the Parties shall cause the Merger to be consummated by executing and filing with the Secretary of State of the State of Delaware a certificate of merger with respect to the Merger, satisfying the applicable requirements of the DGCL and in a form reasonably acceptable to the Special Committee, BLNE and the Company (the “Certificate of Merger”). The Merger shall become effective at the time of the filing of such Certificate of Merger with the Secretary of State of the State of Delaware or at such later time as may be specified in such Certificate of Merger with the consent of BLNE, acting at the sole direction of the Special Committee, and the Company (the time as of which the Merger becomes effective being referred to as the “Effective Time”).

 

1.4 Certificate of Incorporation and Bylaws; Directors and Officers. At the Effective Time:

 

(a) the certificate of incorporation of the Surviving Corporation shall be identical to the certificate of incorporation of Merger Sub as in effect immediately prior to the Effective Time (except that such certificate of incorporation shall be deemed amended to change the name of the Surviving Corporation to “TYTL Corp.”), until thereafter amended in accordance with the DGCL and such bylaws;

 

(b) the bylaws of the Surviving Corporation shall be identical to the bylaws of Merger Sub as in effect immediately prior to the Effective Time (except that such bylaws shall be deemed amended to change the name of the Surviving Corporation to “TYTL Corp.”), until thereafter amended in accordance with the DGCL and such bylaws; and

 

(c) the directors and officers of the Surviving Corporation, each to hold office in accordance with the certificate of incorporation and bylaws of the Surviving Corporation, shall be as set forth in Section 5.11 after giving effect to the provisions of Section 5.11, or such other persons as shall be mutually agreed upon by BLNE (acting at the sole direction of the Special Committee) and the Company.

 

-3-
 

 

1.5 Conversion of Shares.

 

(a) At the Effective Time, by virtue of the Merger and without any further action on the part of BLNE, Merger Sub, the Company or any stockholder of BLNE or the Company:

 

(i) Each share of Company Capital Stock issued and outstanding immediately prior to the Effective Time (other than any Excluded Shares or Dissenting Shares), after giving effect to the Preferred Stock Conversion and for purposes of the Company Preferred Stock, on an as-converted to Company Common Stock basis, shall thereupon be converted into and become exchangeable for a number of shares of BLNE Common Stock equal to the Exchange Ratio (the “Merger Consideration”). As of the Effective Time, all such shares of Company Common Stock shall no longer be outstanding and shall automatically be cancelled and shall cease to exist, and shall thereafter only represent the right to receive the Merger Consideration and any Fractional Share Cash Amount payable pursuant to Section 1.7(d), without interest. For purposes of this Agreement, the “Exchange Ratio” means, subject to Section 1.5(b), the ratio (rounded to four decimal places) equal to the quotient obtained by dividing (x) the Company Merger Shares by (y) the Company Outstanding Shares, in which:

 

(A) “BLNE Outstanding Shares” means the total number of shares of BLNE Common Stock outstanding immediately prior to the Effective Time expressed on a fully diluted and as-converted to BLNE Common Stock basis, assuming, without limitation or duplication, and calculated using the treasury stock method: (I) the conversion of each share of BLNE Preferred Stock into shares of BLNE Common Stock immediately prior to the Effective Time and in accordance with BLNE’s certificate of incorporation and the applicable certificate of designations for the BLNE Preferred Stock; (II) the exercise of all BLNE Options and all BLNE Warrants and the settlement of BLNE RSUs, and other derivative rights of BLNE; and (III) the issuance of shares of BLNE Common Stock in respect of all other options, warrants or rights to receive such shares that will be outstanding immediately after the Effective Time, in each case pursuant to the instruments governing such securities.

 

(B) “Company Merger Shares” means the product of (I) the Post-Closing BLNE Shares and (II) the Company Allocation Percentage.

 

(C) “Company Outstanding Shares” means the total number of shares of Company Common Stock outstanding immediately prior to the Effective Time expressed on a fully diluted and as-converted to Company Common Stock basis, assuming, without limitation or duplication, and calculated using the treasury stock method: (I) the conversion of each share of Company Preferred Stock into shares of Company Common Stock immediately prior to the Effective Time and in accordance with the Company’s certificate of incorporation; and (II) the exercise of all Company Options; and (III) the issuance of shares of Company Common Stock in respect of all other options, warrants or rights to receive such shares that will be outstanding immediately after the Effective Time, in each case pursuant to the instruments governing such securities.

 

-4-
 

 

(D) “Post-Closing BLNE Shares” means the quotient of (I) the BLNE Outstanding Shares divided by (II) the BLNE Allocation Percentage.

 

For illustrative purposes only, a sample “Exchange Ratio” calculation is attached hereto as Exhibit D.

 

(ii) Each share of BLNE Common Stock issued and outstanding immediately prior to the Effective Time shall remain outstanding. Immediately following the Effective Time, shares of BLNE Common Stock, if any, owned by the Surviving Corporation shall be surrendered to BLNE without payment therefor.

 

(iii) Each share of Company Common Stock held in the treasury of the Company or owned, directly or indirectly, by BLNE or Merger Sub immediately prior to the Effective Time (collectively, “Excluded Shares”) shall automatically be cancelled and shall cease to exist, and no consideration shall be delivered in exchange therefor.

 

(iv) Each share of common stock, par value $0.01 per share, of Merger Sub issued and outstanding immediately prior to the Effective Time shall be converted into and become one validly issued, fully paid and nonassessable share of common stock, par value $0.01 per share, of the Surviving Corporation.

 

(b) The calculation of the Exchange Ratio shall be adjusted to reflect fully the appropriate effect of any stock split, split-up, reverse stock split, stock dividend or distribution of securities convertible into Company Common Stock or BLNE Common Stock, reorganization, recapitalization, reclassification or other like change with respect to the Company Common Stock or BLNE Common Stock having a record date occurring on or after the date of this Agreement and prior to the Effective Time; provided that nothing in this Section 1.5(b) shall be construed to permit the Company or BLNE to take any action with respect to its securities that is prohibited by the terms of this Agreement.

 

1.6 Treatment of Options.

 

(a) At the Effective Time, each outstanding option (each, a “Company Option”) to purchase shares of Company Common Stock granted under the Company’s 2026 Equity Incentive Plan (“Company Equity Plan”), whether vested or unvested, that is outstanding immediately prior to the Effective Time shall cease to represent a right to acquire shares of Company Common Stock and shall be assumed and converted into an option to purchase shares of BLNE Common Stock (an “Assumed Option”), on the same terms and conditions (including any forfeiture and post-termination exercise provisions, but not taking into account any accelerated vesting provided for in the Company Equity Plan or in the related award document by reason of the Contemplated Transactions) as were applicable to such Company Option as of immediately prior to the Effective Time; provided, however, that (i) the number of shares of BLNE Common Stock subject to each such Assumed Option shall be equal to the number of shares of Company Common Stock subject to each Company Option immediately prior to the Effective Time multiplied by the Exchange Ratio, rounded to the nearest whole share, (ii) the exercise price per share of such Assumed Option shall be the exercise price per share of such Option immediately prior to the Effective Time divided by the Exchange Ratio, rounded to the nearest whole cent, and (iii) from and after the Effective Time, (x) references to the “Company” under the Company Equity Plan shall be deemed to refer to BLNE, (y) references to the “Board” under the Company Equity Plan shall be deemed to refer to the BLNE Board, and (z) the committee that administers the Company Equity Plan shall be a committee established by the BLNE Board. In all other respects, the Assumed Options shall continue to be governed by the terms of the Company Equity Plan from and after the Effective Time, subject to such additional modifications as the BLNE Board (or a committee appointed by the BLNE Board) deems appropriate to reflect the Merger. Notwithstanding the foregoing, the exercise price and the number of shares of BLNE Common Stock subject to each such Assumed Option shall be subject to such adjustments as are necessary in order to avoid the imposition of any additional Taxes under Section 409A of the Code (and regulations issued by the IRS thereunder) or, in the case of any Assumed Option to which Section 422 of the Code applies as of the Effective Time, in order to satisfy the requirements of Section 424(a) of the Code (and regulations issued by the IRS thereunder).

 

-5-
 

 

(b) Prior to the Effective Time, the Company shall take all actions that may be necessary under the Company Equity Plan and otherwise to effectuate the provisions of this Section 1.6 and to ensure that, from and after the Effective Time, holders of Company Options have no rights with respect thereto other than those specifically provided in this Section 1.6.

 

(c) As soon as practicable following the Effective Time, BLNE shall use its reasonable best efforts to file a registration statement on Form S-8 (or any successor form, or if Form S-8 is not available, other appropriate forms) with respect to the shares of BLNE Common Stock, on an as-converted basis, subject to the Assumed Options.

 

1.7 Exchange and Payment.

 

(a) Promptly after the Effective Time, BLNE, at the sole direction of the Special Committee, shall cause a bank or trust company designated by BLNE (the “Exchange Agent”) to issue in book-entry form that number of whole shares of BLNE Common Stock to which each holder of shares of Company Common Stock (other than with respect to Excluded Shares or Dissenting Shares) shall have become entitled on the account of Merger Consideration pursuant to the provisions of Section 1.5(a). All book-entry shares of BLNE Common Stock deposited with the Exchange Agent on account of Merger Consideration are hereinafter referred to as the “Exchange Fund”. Pursuant to the terms of the Lock-Up Agreements, the shares of BLNE Common Stock issued as Merger Consideration shall bear restricted legends and shall be subject to “stop transfer” instructions at BLNE’s transfer agent.

 

(b) If payment of the Merger Consideration is to be made to a Person other than the Person in whose name the share of Company Common Stock is registered, it shall be a condition of payment that such share of Company Common Stock shall be properly transferred and that the Person requesting such payment shall have paid any transfer and other Taxes required by reason of the payment of the Merger Consideration to a Person other than the registered holder of such share of Company Common Stock or shall have established to the satisfaction of BLNE that such Tax is not applicable.

 

-6-
 

 

(c) The Merger Consideration shall be deemed to have been issued and paid in full satisfaction of all rights pertaining to the shares of Company Common Stock. At the Effective Time, the stock transfer books of the Company shall be closed and there shall be no further registration of transfers of the shares of Company Common Stock that were outstanding immediately prior to the Effective Time. If, after the Effective Time, transfer is sought for uncertificated shares of Company Common Stock represented by book entry (“Book-Entry Shares”), such Book-Entry Shares shall be cancelled and exchanged as provided in this Section 1.7.

 

(d) No fractional shares of BLNE Common Stock shall be issued in connection with the Merger. Any holder of Company Common Stock who would otherwise be entitled to receive a fraction of a share of BLNE Common Stock pursuant to Section 1.5(a) (after aggregating all fractional shares of BLNE Common Stock otherwise issuable to such holder pursuant to Section 1.5(a)) shall, in lieu of such fraction of a share, be paid in cash the dollar amount (rounded to the nearest whole cent) equal to the cash value of such fractional share based on the same per-share value of BLNE Common Stock used to determine the Exchange Ratio (the “Fractional Share Cash Amount”). No such holder shall be entitled to dividends, voting rights or any other rights in respect of any fractional share of BLNE Common Stock that would otherwise have been issuable as part of the Merger Consideration. Promptly following the Effective Time, BLNE shall deposit with the Exchange Agent cash sufficient to pay all Fractional Share Cash Amounts, and the Exchange Agent shall pay the applicable Fractional Share Cash Amount to each holder entitled thereto at the time such holder receives its Merger Consideration. For clarity, the payment of the Fractional Share Cash Amount pursuant to this Section 1.7(d) is intended solely as cash in lieu of fractional shares of BLNE Common Stock that would otherwise be issuable pursuant to the Merger and is not separately negotiated consideration or additional consideration payable in connection with the Merger.

 

(e) Any portion of the Exchange Fund that remains undistributed or unallocated to the holders of Book-Entry Shares six months after the Effective Time shall be delivered to the Surviving Corporation, upon demand, and any remaining holders of Book-Entry Shares (except to the extent representing Excluded Shares or Dissenting Shares) shall thereafter look only to the Surviving Corporation, as general creditors thereof, for payment of the Merger Consideration (subject to abandoned property, escheat or other similar Laws), without interest.

 

(f) None of BLNE, the Surviving Corporation, the Exchange Agent or any other Person shall be liable to any Person in respect of shares of BLNE Common Stock, dividends or other distributions with respect thereto properly delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law. If any Book-Entry Shares shall not have been allocated their Merger Consideration prior to two (2) years after the Effective Time (or immediately prior to such earlier date on which the related Merger Consideration (and all dividends or other distributions with respect to shares of BLNE Common Stock) would otherwise escheat to or become the property of any Governmental Body), any such Merger Consideration (and such dividends, distributions and cash) in respect thereof shall, to the extent permitted by applicable Law, become the property of the Surviving Corporation, free and clear of all claims or interest of any Person previously entitled thereto.

 

(g) The Exchange Agent shall invest any cash included in the Exchange Fund as directed by BLNE on a daily basis. Any interest and other income resulting from such investments shall be paid to BLNE.

 

-7-
 

 

1.8 Dissenters Rights.

 

(a) Notwithstanding any provision of this Agreement to the contrary, each share of the Company Capital Stock (other than Excluded Shares) outstanding immediately prior to the Effective Time and held by a holder who is entitled to demand and has properly demanded appraisal for such shares of the Company Capital Stock in accordance with Section 262 of the DGCL (collectively, the “Dissenting Shares”) shall not be converted into or represent the right to receive the Merger Consideration described in Section 1.5 attributable to such Dissenting Shares. Such stockholders shall be entitled to receive payment of the appraised value of such shares of Company Capital Stock held by them in accordance with the DGCL unless and until such stockholders fail to perfect or effectively withdraw or otherwise lose their appraisal rights under the DGCL. All Dissenting Shares held by stockholders who shall have failed to perfect or shall have effectively withdrawn or lost their right to appraisal of such shares of Company Capital Stock under the DGCL (whether occurring before, at or after the Effective Time) shall thereupon be deemed to be converted into and to have become exchangeable for, as of the Effective Time, the right to receive the Merger Consideration, without interest, attributable to such Dissenting Shares upon their surrender in the manner provided in Sections 1.5 and 1.7.

 

(b) The Company shall give BLNE prompt written notice of any demands by dissenting stockholders or beneficial owners received by the Company, withdrawals of such demands and any other instruments served on the Company and any material correspondence received by the Company in connection with such demands, and BLNE shall have the right to participate in all negotiations and proceedings with respect to such demands. The Company shall not, except with BLNE’s prior written consent (not to be unreasonably withheld, delayed or conditioned), make any payment with respect to, or settle or offer to settle, any such demands, or approve any withdrawal of any such demands or agree to do any of the foregoing.

 

1.9 Withholding. Notwithstanding anything to the contrary in this Agreement, BLNE, Merger Sub, the Surviving Corporation, the Exchange Agent, the Holders’ Representative and any other applicable withholding agent shall be entitled to deduct and withhold (or cause to be deducted and withheld) from any consideration payable pursuant to this Agreement such amounts as are required to be deducted and withheld under applicable Law. To the extent that amounts are so withheld and remitted to the applicable Governmental Body, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction and withholding was made.

 

1.10 Further Action. If, at any time after the Effective Time, any further action is determined by the Surviving Corporation to be necessary or desirable to carry out the purposes of this Agreement or to vest the Surviving Corporation with full right, title and possession of and to all rights and property of the Company, then the officers and directors of the Surviving Corporation shall be fully authorized, and shall use their and its commercially reasonable efforts (in the name of the Company, in the name of Merger Sub, in the name of the Surviving Corporation and otherwise) to take such action.

 

Section 2 REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

Except as set forth in the disclosure schedule delivered by the Company to BLNE and Merger Sub concurrently with the execution of this Agreement (the “Company Disclosure Schedule”), the Company represents and warrants to BLNE and Merger Sub as follows:

 

2.1 Due Organization; Subsidiaries.

 

(a) The Company was duly incorporated on the Inception Date in the State of Wyoming. On January 23, 2026, the Company converted from a Wyoming corporation to a Delaware corporation. The Company is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware and has all necessary corporate power and authority: (i) to conduct its business in the manner in which its business is currently being conducted; (ii) to own or lease and use its property and assets in the manner in which its property and assets are currently owned or leased and used; and (iii) to perform its obligations under all Contracts by which it is bound, except where the failure to have such power or authority would not reasonably be expected to have a Company Material Adverse Effect.

 

(b) The Company is duly licensed and qualified to do business, and is in good standing (to the extent applicable in such jurisdiction), under the Laws of all jurisdictions where the nature of its business in the manner in which its business is currently being conducted requires such licensing or qualification, other than in jurisdictions where the failure to be so qualified individually or in the aggregate would not be reasonably expected to have a Company Material Adverse Effect.

 

(c) Except as set forth in Section 2.1(c) of the Company Disclosure Schedule, the Company has no Subsidiaries, and does not own any capital stock or membership interests of, or any equity, ownership or profit sharing interest of any nature in, or control directly or indirectly, any other Entity. Neither the Company nor any of its Subsidiaries has ever been, directly or indirectly, a party to, member of or participant in any partnership, joint venture or similar business entity. Neither the Company nor any of its Subsidiaries has agreed or is obligated to make any future investment in or capital contribution to any other Entity, nor is the Company or any of its Subsidiaries a party to any Contract pursuant to which it may become so obligated. Neither the Company nor any of its Subsidiaries has, at any time, been a general partner of, or has otherwise been liable for any of the debts or other obligations of, any general partnership, limited partnership or other Entity.

 

2.2 Organizational Documents. The Company has delivered to BLNE accurate and complete copies of the Organizational Documents of the Company and each of its Subsidiaries in effect as of the date of this Agreement. Neither the Company nor any of its Subsidiaries is in material breach or violation of its Organizational Documents.

 

-8-
 

 

2.3 Authority; Binding Nature of Agreement. The Company and each of its Subsidiaries has all necessary corporate or limited liability company power, as applicable, and authority to enter into and to perform its obligations under this Agreement and to consummate the Contemplated Transactions. The Company Board has (a) determined that the Contemplated Transactions are fair to, advisable and in the best interests of the Company and its stockholders, (b) approved and declared advisable this Agreement and the Contemplated Transactions and (c) determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of the Company vote to adopt this Agreement and approve the Contemplated Transactions, which resolutions have not been subsequently withdrawn, amended or modified as of the date of this Agreement. This Agreement has been duly executed and delivered by the Company and assuming the due authorization, execution and delivery by BLNE and Merger Sub, constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to the Enforceability Exceptions.

 

2.4 Vote Required. The affirmative vote (or written consent) of (a) the holders of a majority of the outstanding shares of Company Common Stock, (b) the holders of a majority of the outstanding shares of Company Preferred Stock, on an as-converted to Company Common Stock basis, and (c) the holders of a majority of the outstanding shares of Company Common Stock and Company Preferred Stock, voting together as a single class and on an as-converted to Company Common Stock basis (the “Required Company Stockholder Vote”) are the only votes (or written consent) of the holders of any class or series of Company Capital Stock necessary to adopt this Agreement and approve the Contemplated Transactions.

 

2.5 Non-Contravention; Consents.

 

(a) Subject to obtaining the Required Company Stockholder Vote and the filing of the Certificate of Merger required by the DGCL, neither (x) the execution, delivery or performance of this Agreement by the Company, nor (y) the consummation of the Contemplated Transactions, will directly or indirectly (with or without notice or lapse of time):

 

(i) contravene, conflict with or result in a violation of any of the provisions of the Company’s or any of its Subsidiaries’ Organizational Documents;

 

(ii) contravene, conflict with or result in a violation of, or give any Governmental Body or other Person the right to challenge the Contemplated Transactions or to exercise any remedy or obtain any relief under, any Law or any order, writ, injunction, judgment or decree to which the Company, or any of the assets owned or used by the Company or any of its Subsidiaries, is subject, except as would not reasonably be expected to be material to the business conducted by the Company and its Subsidiaries as a whole;

 

(iii) contravene, conflict with or result in a violation of any of the terms or requirements of, or give any Governmental Body the right to revoke, withdraw, suspend, cancel, terminate or modify, any Governmental Authorization that is held by the Company or any of its Subsidiaries, except as would not reasonably be expected to be material to the business conducted by the Company and its Subsidiaries as a whole;

 

(iv) contravene, conflict with or result in a violation or breach of, or result in a default under, any provision of any Company Material Contract, or give any Person the right to: (i) declare a default or exercise any remedy under any Company Material Contract; (ii) any material payment, rebate, chargeback, penalty or change in delivery schedule under any Company Material Contract; (iii) accelerate the maturity or performance of any Company Material Contract; or (iv) cancel, terminate or modify any term of any Company Material Contract, except in the case of any non-material breach, default, penalty or modification; or

 

-9-
 

 

(v) result in the imposition or creation of any Encumbrance upon or with respect to any asset owned or used by the Company or any of its Subsidiaries (except for Permitted Encumbrances).

 

(b) Except for (i) any Consent set forth on Section 2.5 of the Company Disclosure Schedule under any Company Contract, (ii) the Required Company Stockholder Vote, (iii) the filing of the Certificate of Merger with the Secretary of State of the State of Delaware pursuant to the DGCL, and (iv) such consents, waivers, approvals, orders, authorizations, registrations, declarations and filings as may be required under applicable federal and state securities Laws, neither the Company nor any of its Subsidiaries is required to make any filing with or give any notice to, or to obtain any Consent from, any Person in connection with (x) the execution, delivery or performance of this Agreement, or (y) the consummation of the Contemplated Transactions, which if individually or in the aggregate were not given or obtained, would reasonably be expected to prevent or materially delay the ability of the Company to consummate the Contemplated Transactions.

 

(c) The Company Board has taken and will take all actions necessary to ensure that the restrictions applicable to business combinations contained in Section 203 of the DGCL are, and will be, inapplicable to the execution, delivery and performance of this Agreement and to the consummation of the Contemplated Transactions. No other Takeover Statute applies or purports to apply to the Merger, this Agreement, or any of the Contemplated Transactions.

 

2.6 Capitalization.

 

(a) As of the date hereof, (i) the authorized Company Capital Stock consists of (x) 14,000,000 shares of Company Common Stock, 6,973,335 shares of which are issued and outstanding as of the date hereof and (y) 2,650,000 shares of Company Preferred Stock, all of which have been designated Series Seed 1 Preferred Stock, 2,559,999 shares of which are issued and outstanding, (ii) no shares of Company Capital Stock are held by the Company in its treasury, (iii) 1,666,666 shares of Company Common Stock are reserved for issuance and are subject to Company Options, and (iv) 2,650,000 shares of Company Common Stock were reserved for issuance for the conversion of the Series Seed 1 Preferred Stock.

 

(b) Section 2.6(b) of the Company Disclosure Schedule sets forth a list of each holder of each of the shares of the Company Common Stock, the Company Preferred Stock, the Series Seed 1 Preferred Stock, and each warrant to purchase tokens issued by the Company, including the purchase price and issue date for each such warrant (the “Token Warrants”). Except as set forth above in Section 2.6(a) or as set forth in Section 2.6(b) of the Company Disclosure Schedule, there is no: (A) outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to acquire any shares of capital stock of the Company or other securities of the Company; (B) outstanding security, instrument or obligation that is or may become convertible into or exchangeable for any shares of capital stock of the Company or other securities of the Company; or (C) condition or circumstance that could be reasonably likely to give rise to or provide a basis for the assertion of a claim by any Person to the effect that such Person is entitled to acquire or receive any shares of capital stock of the Company. There are no outstanding or authorized stock appreciation, phantom stock, profit participation or other similar rights with respect to the Company.

 

-10-
 

 

(c) All of the outstanding shares of capital stock of the Company have been duly authorized, validly issued, and are fully paid and nonassessable and are not subject to any preemptive rights. Except for the Company Stockholder Agreements, there is no Company Contract relating to the voting or registration of, or restricting any Person from purchasing, selling, pledging or otherwise disposing of (or granting any option or similar right with respect to), any shares of capital stock of the Company. The Company is not under any obligation, nor is it bound by any Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire any outstanding shares of capital stock of the Company or other securities. None of the outstanding shares of capital stock of the Company held by current or former Company employees or other service providers are subject to any repurchase or forfeiture rights held by the Company.

 

(d) Except as set forth on Section 2.6(d) of the Company Disclosure Schedule, the Company does not have any stock option plan or any other plan, program, agreement or arrangement providing for any equity-based compensation for any Person. Section 2.6(d) of the Company Disclosure Schedule sets forth the following information with respect to each Company Option outstanding as of the date of this Agreement: (i) the name of the holder; (ii) the number of shares of Company Common Stock subject to such Company Option at the time of grant; (iii) the number of shares of Company Common Stock subject to such Company Option as of the date of this Agreement; (iv) the exercise price; (v) the date on which such Company Option was granted; (vi) the applicable vesting schedule, including the number of vested and unvested shares as of the date of this Agreement; and (vii) whether such Company Option is intended to constitute an “incentive stock option” (as defined in the Code) or a non-qualified stock option. The Company has made available to BLNE accurate and complete copies of the Company Equity Plan and the form of the stock option agreement evidencing the outstanding Company Options granted thereunder. All stock option agreements evidencing outstanding Company Options are consistent with the Company’s standard form of stock option agreement. The exercise price of each Company Option is not and never has been less than the fair market value of one share of Company Common Stock as of the grant date of such Company Option as determined in good faith by the Company Board in a manner consistent with Section 409A of the Code.

 

(e) All outstanding Company Common Stock, Company Preferred Stock, Company Options, Token Warrants, and other securities of the Company have been issued and granted in material compliance with (i) all applicable securities Laws and other applicable Law and (ii) all requirements set forth in the applicable Company Contracts, in the Company’s Organizational Documents and in the Company Stockholder Agreements.

 

(f) As of the date hereof, the Token Warrants that have been issued by the Company remain exercisable for tokens but no such Token Warrants have been exercised. As of the date hereof, the Company has not issued any tokens in respect of any of the Token Warrants.

 

-11-
 

 

(g) Except as set forth in Section 2.6(g) of the Company Disclosure Schedule, no Subsidiary of the Company has any: (A) outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to acquire any shares of capital stock of such Subsidiary or other securities of such Subsidiary; (B) outstanding security, instrument or obligation that is or may become convertible into or exchangeable for any shares of capital stock of such Subsidiary or other securities of such Subsidiary; or (C) condition or circumstance that could be reasonably likely to give rise to or provide a basis for the assertion of a claim by any Person to the effect that such Person is entitled to acquire or receive any shares of capital stock of such Subsidiary. There are no outstanding or authorized stock appreciation, phantom stock, profit participation or other similar rights with respect to any such Subsidiary. The Company is not under any obligation, nor is it bound by any Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire any outstanding shares of capital stock of any of its Subsidiaries.

 

(h) The Company Capital Stock is uncertificated.

 

2.7 Financial Statements.

 

(a) Section 2.7(a) of the Company Disclosure Schedule sets forth a true and complete copy of the Company’s audited balance sheet as of December 31, 2025, together with related statements of operations, changes in stockholders’ equity and cash flows, and notes thereto, of the Company for the period from the Inception Date through December 31, 2025, and the Company’s unaudited balance sheet as of September 30, 2026, together with related unaudited statements of operations, changes in stockholders’ equity and cash flows, and notes thereto, of the Company for the fiscal period then ended (collectively, the “Company Financials”). The Company Financials were prepared in accordance with GAAP (except as may be indicated in the notes to such financial statements and except that the unaudited financial statements may not contain footnotes and are subject to normal and recurring year-end adjustments, none of which are material) and fairly present, in all material respects, the financial position and operating results of the Company as of the dates and for the periods indicated therein.

 

(b) The Company maintains accurate books and records reflecting its assets and liabilities and maintains a system of internal accounting controls designed to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of the financial statements of the Company and to maintain accountability of the Company’s assets; (iii) access to the Company’s assets is permitted only in accordance with management’s general or specific authorization; (iv) the recorded accountability for the Company’s assets is compared with the existing assets at regular intervals and appropriate action is taken with respect to any differences; and (v) accounts, notes and other receivables and inventory are recorded accurately, and proper and adequate procedures are implemented to effect the collection thereof on a current and timely basis. The Company maintains internal controls consistent with the practices of similarly situated private companies over financial reporting that provides reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP.

 

(c) Since the Inception Date, there have been no formal internal investigations regarding financial reporting or accounting policies and practices discussed with, reviewed by or initiated at the direction of the chief executive officer, chief financial officer or general counsel of the Company, the Company Board or any committee thereof. Since the Inception Date, neither the Company nor its independent auditors have identified (i) any fraud, whether or not material, that involves the Company, the Company’s management or other employees who have a role in the preparation of financial statements or the internal accounting controls utilized by the Company or (ii) any claim or allegation regarding any of the foregoing.

 

-12-
 

 

(d) The Company has not entered into any securitization transactions or “off-balance sheet arrangements” (as defined in Item 303(c) of Regulation S-K under the Exchange Act).

 

2.8 Absence of Changes. Except as set forth on Section 2.8 of the Company Disclosure Schedule, between the Company Unaudited Balance Sheet Date and the date of this Agreement, the Company and each of its Subsidiaries has conducted its business in the Ordinary Course of Business (except for the execution and performance of this Agreement and the discussions, negotiations and transactions related thereto) and there has not been any (a) Company Material Adverse Effect or (b) action, event or occurrence that would have required the consent of BLNE pursuant to Section 4.2(b) had such action, event or occurrence taken place after the execution and delivery of this Agreement.

 

2.9 Absence of Undisclosed Liabilities. Neither the Company nor any of its Subsidiaries has any liability, indebtedness, obligation, expense, claim, deficiency, guaranty or endorsement of any kind, whether accrued, absolute, contingent, matured or unmatured (whether or not required to be reflected in the financial statements in accordance with GAAP) (each a “Liability”), individually or in the aggregate, except for: (a) Liabilities disclosed, reflected or reserved against in the Company Financials as of the Company Unaudited Balance Sheet Date; (b) normal and recurring current Liabilities that have been incurred by the Company or any of its Subsidiaries since the Company Unaudited Balance Sheet Date in the Ordinary Course of Business and which are not in excess of $10,000 in the aggregate; (c) Liabilities incurred in connection with the Contemplated Transactions; (d) Liabilities which would not, individually or in the aggregate, reasonably be expected to be material to the Company and its Subsidiaries as a whole; and (e) Liabilities listed in Section 2.9 of the Company Disclosure Schedule.

 

2.10 Title to Assets. The Company owns, and has good and valid title to, or, in the case of leased properties and assets, valid leasehold interests in, all tangible properties or tangible assets and equipment used or held for use in its business or operations or purported to be owned by it, including (a) all assets reflected on the Company Financials and (b) all other assets reflected in the books and records of the Company or any of its Subsidiaries as being owned by the Company or its Subsidiary, as applicable. All of such assets are owned or, in the case of leased assets, leased by the Company or one of its Subsidiaries free and clear of any Encumbrances, other than Permitted Encumbrances.

 

-13-
 

 

2.11 Real Property. Section 2.11 of the Company Disclosure Schedule sets forth a list of all fractional real property interests held by the Company or any of its Subsidiaries, including the location of such real property interest and the name of the owner of such real property interest (“Fractional Real Property Interests”). The Company and/or each of its Subsidiaries, as applicable, owns good, valid and marketable title, free and clear of all Encumbrances (other than Permitted Encumbrances), to the Fractional Real Property Interests held by the Company or its Subsidiary, as applicable. Neither the Company nor any of its Subsidiaries is obligated under any Contract, or subject to any restriction, that presently materially impairs, has materially impaired, or might in the future materially impair the Company’s or any of its Subsidiaries’ right, title or interest in or to any of their respective Fractional Real Property Interests. Each Fractional Real Property Interest is custodied at Anchorage Digital Bank and recorded at the county in which the applicable real property is located. Except for the Fractional Real Property Interests set forth on Section 2.11 of the Company Disclosure Schedule, neither the Company nor any of its Subsidiaries (a) presently owns any real property, (b) has ever previously owned any real property, or (c) is presently bound by any Contract to acquire or otherwise own any real property. To the Company’s Knowledge, neither the whole nor any part of the real property that is the subject of the Fractional Real Property Interests is subject to any condemnation or eminent domain proceeding, or other taking by any Governmental Body and to the Company’s Knowledge, no such condemnation or other taking is threatened. The Company or one of its Subsidiaries has paid all Taxes relating to such Fractional Real Property Interests.

 

2.12 Intellectual Property.

 

(a) The Company or one of its Subsidiaries owns, or has the legal and valid right to use, as currently being used by the Company and its Subsidiaries, as applicable, all Company IP Rights.

 

(b) Section 2.12(b) of the Company Disclosure Schedule sets forth an accurate, true and complete listing of all Company Registered IP, specifying as to each such item, as applicable, the owner(s) of record (and, in the case of domain name registrations, the registrar), jurisdiction of application and/or registration, the application and/or registration number, the date of application and/or registration, and the status of application and/or registration. To the Knowledge of the Company, each item of Company IP Rights that is Company Registered IP is and at all times has been filed and maintained in compliance with all applicable Law and all filings, payments, and other actions required to be made or taken to maintain such item of Company Registered IP in full force and effect have been made by the applicable deadline.

 

(c) Neither the Company nor any of its Subsidiaries is a party to any Contract pursuant to which Company IP Rights are licensed to any other Person. Except as set forth on Section 2.12(c) of the Company Disclosure Schedule, neither the Company nor any of its Subsidiaries licenses any Intellectual Property from any other Person. Neither the Company nor any of its Subsidiaries has granted any right (whether or not currently exercisable) or interest in any Company IP Rights to any other Person. Neither the Company nor any of its Subsidiaries is party to a Contract that in any way limits or restricts the Company or its Subsidiaries’ ability to use, exploit, assert, enforce, sell, transfer or dispose of any such Company IP Rights anywhere in the world.

 

(d) Each Person who is or was an employee or contractor of the Company or any of its Subsidiaries, as applicable, and who is or was involved in the creation or development of any Company IP Rights purported to be owned by the Company or any of its Subsidiaries has signed a valid, enforceable agreement containing an assignment of such Intellectual Property to the Company or such Subsidiary and confidentiality provisions protecting confidential information of the Company and its Subsidiaries and the Company has no reason to believe that any such Person is unwilling to provide the Company and its Subsidiaries with cooperation as may be reasonably required to complete or prosecute all Company IP Rights.

 

-14-
 

 

(e) To the Knowledge of the Company, no employee of the Company or any of its Subsidiaries is (i) bound by or otherwise subject to any Contract restricting him or her from performing his or her duties for the Company or any such Subsidiary or (ii) in breach of any Contract with any former employer or other Person concerning Company IP Rights purported to be owned by the Company or any of its Subsidiaries or confidentiality provisions protecting Trade Secrets and confidential information comprising Company IP Rights purported to be owned by the Company or any of its Subsidiaries.

 

(f) Except as identified in Section 2.12(f) of the Company Disclosure Schedule, no Company IP Rights purported to be owned by the Company or any of its Subsidiaries were developed, in whole or in part (i) pursuant to or in connection with the development of any professional, technical or industry standard, (ii) under contract with or using the resources of any Governmental Body, academic institution or other entity that would subject any such Company IP Rights to the rights of any Governmental Body, academic institution or other entity or (iii) under any grants or other funding arrangements with third parties.

 

(g) The Company and each of its Subsidiaries has taken all commercially reasonable and appropriate steps to protect and maintain the Company IP Rights, including to preserve the confidentiality of all proprietary information that the Company or any such Subsidiary holds, or purports to hold, as a material Trade Secret. Any disclosure by the Company or any of its Subsidiaries of Trade Secrets to any third party has been pursuant to the terms of a written agreement with such Person or is otherwise lawful. The Company and each of its Subsidiaries has implemented and maintained a reasonable security plan consistent with industry practices of companies offering similar products or services. To the Knowledge of the Company, neither the Company nor any of its Subsidiaries has experienced any breach of security or otherwise unauthorized access by third parties to the confidential information in the Company’s or any of its Subsidiaries’ possession, custody or control.

 

(h) To the Knowledge of the Company, (i) the Company IP Rights are valid and enforceable and (ii) constitute all Intellectual Property necessary for the Company and its Subsidiaries to conduct their business as currently conducted and planned to be conducted. To the Knowledge of the Company, the conduct of the Company’s and each of its Subsidiaries’ respective businesses as presently conducted and presently proposed to be conducted does not infringe or misappropriate any Intellectual Property right of any third party. To the Knowledge of the Company, no third party is infringing upon any Company IP Rights or violating any license or agreement between the Company or one of its Subsidiaries, on one hand, and such third party, on the other hand. Neither the Company nor any of its Subsidiaries has sent any written communication to or asserted or threatened in writing any Legal Proceeding or claim against any Person involving or relating to any Company IP Rights.

 

(i) Neither the Company nor any of its Subsidiaries has incorporated Open Source Materials into, or combined Open Source Materials with, any products or services sold or licensed by the Company or any of its Subsidiaries, as applicable, in such a way that requires, as a condition of use, modification and/or distribution of such Open Source Materials that other Software incorporated into, derived from or distributed with such Open Source Materials be (i) disclosed or distributed in Source Code form, (ii) licensed for the purpose of making derivative works, or (iii) redistributable at no charge.

 

-15-
 

 

(j) The Systems that are used or relied on by the Company and its Subsidiaries are adequate for the operation of the business of the Company and its Subsidiaries as currently conducted, and contemplated to be conducted, are sufficient for the current needs of such business and the Company and each of its Subsidiaries has purchased a sufficient number of license seats for all licensed Software currently used by the Company and its Subsidiaries.

 

2.13 Privacy and Data Security.

 

(a) The Company has complied in all material respects with all applicable (i) Privacy Laws, (ii) contractual terms to which the Company is a party or is otherwise bound that impose obligations on the Company with respect to Personal Information, and (iii) the Company’s internal and external (including publicly posted) policies, notices, representations or guidelines relating to Personal Information, privacy and/or security of Personal Information (collectively, “Company Privacy and Data Security Requirements”). The Company has not received any complaint, inquiry or request for information or documents, and no Legal Proceeding is pending or to the Knowledge of the Company, threatened against the Company alleging that the Processing of Personal Information by the Company violates any applicable Company Privacy and Data Security Requirements.

 

(b) The Company has at all times implemented and maintained in place reasonable and appropriate physical, technical and administrative security programs, policies, procedures and such other measures required by applicable Company Privacy and Data Security Requirements, to protect Personal Information that the Company Processes in connection with the operation of its business from destruction, loss, alteration, damage, unauthorized access or disclosure or illegal or unauthorized Processing. There has not been any destruction, loss, alteration, damage, unauthorized access or disclosure or illegal or unauthorized Processing of any Personal Information that is in the possession or control of the Company.

 

2.14 Agreements, Contracts and Commitments.

 

(a) Section 2.14(a) of the Company Disclosure Schedule sets forth each Company Contract that:

 

(i) involves, or is reasonably expected to involve, aggregate consideration in excess of $10,000, and which, in each case, cannot be cancelled by the Company (or its Subsidiary) without penalty or without more than ninety (90) days’ notice;

 

(ii) relates to the acquisition or disposition of any business, a material amount of stock or assets of any other Person, or any real property, including any Fractional Real Property Interest (whether by merger, sale of stock, sale of assets, or otherwise);

 

(iii) relates to the Company Common Stock, the Company Preferred Stock, the Series Seed 1 Preferred Stock, or the Token Warrants;

 

-16-
 

 

(iv) is with any employee of the Company or any of its Subsidiaries and any Contracts with independent contractors or consultants (or similar arrangements) to the Company or any of its Subsidiaries;

 

(v) is with any Governmental Body;

 

(vi) limits or purports to limit the ability of the Company (or any of its Subsidiaries) to compete in any line of business or with any Person or in any geographic area or during any period of time;

 

(vii) provides for any joint venture, partnership, or similar arrangement by the Company;

 

(viii) has been entered into between or among the Company or one of its Subsidiaries, on the one hand, and any Pre-Closing Company Holder or any of their respective Affiliates (other than the Company or any of its Subsidiaries), on the other hand;

 

(ix) is a custody agreement entered into in connection with the Fractional Real Property Interests; and

 

(x) except for Contracts relating to trade payables, relates to Indebtedness (all such contracts, “Company Material Contracts”).

 

(b) The Company has delivered or made available to BLNE accurate and complete copies of all Company Material Contracts, including all amendments thereto. Neither the Company nor any of its Subsidiaries has breached, violated or defaulted under, or received notice that it breached, violated or defaulted under, any of the terms or conditions of any Company Material Contract. To the Company’s Knowledge, no other party who is a party to a Company Material Contract, has breached, violated or defaulted under, or received notice that it breached, violated or defaulted under, any of the terms or conditions of any Company Material Contract in such manner as would permit any other party to cancel or terminate any such Company Material Contract, or would permit any other party to seek damages which would reasonably be expected to be material to the business of the Company and its Subsidiaries. As to the Company, as of the date of this Agreement, each Company Material Contract is valid, binding, enforceable and in full force and effect, subject to the Enforceability Exceptions. No Person is renegotiating, or has a right pursuant to the terms of any Company Material Contract to change, any material amount paid or payable to the Company under any Company Material Contract or any other material term or provision of any Company Material Contract.

 

2.15 Compliance; Permits.

 

(a) The Company and each of its Subsidiaries are, and each of them has been since the Inception Date, in compliance in all material respects with all applicable Laws relating to the operation of the business conducted by the Company and its Subsidiaries and the maintenance and operation of the properties and assets owned or leased by the Company and its Subsidiaries. Except as set forth on Section 2.15(a) of the Company Disclosure Schedule, no written notices have been received by, and no Legal Proceedings have been initiated or, to the Knowledge of the Company threatened against, the Company or any of its Subsidiaries alleging or pertaining to a violation of any such Laws.

 

-17-
 

 

(b) The Company and each of its Subsidiaries (i) holds, and is the sole legal owner of, all Permits required for the conduct of its business and the ownership, lease and use of its assets and properties (including for the operation and use of any leased property including as required under applicable Laws) and (ii) is and has been since the Inception Date in compliance in all material respects with all terms and conditions of any such Permits. No written notice has been received by the Company or any of its Subsidiaries alleging the failure to hold or comply with any such Permits or the eligibility of the Company or any of its Subsidiaries to continue to hold any such Permits in the future. No suspension, modification, revocation or cancellation of any of such Permits is pending or, to the Knowledge of the Company, threatened.

 

(c) Neither the Company nor any of its Subsidiaries is a party to any Contract or subcontract to supply goods or services directly to the United States federal government.

 

2.16 Legal Proceedings; Orders. There is no pending Legal Proceeding and, to the Knowledge of the Company, no Person has threatened in writing to commence any Legal Proceeding, (a) that involves the Company, any Company Associate (in his or her capacity as such), any of the Company’s Subsidiaries or any of the material assets owned or used by the Company or any of its Subsidiaries or (b) that challenges, or that may have the effect of preventing, delaying, making illegal or otherwise interfering with, the Contemplated Transactions. Since the Inception Date, no Legal Proceeding has been pending against the Company or any of its Subsidiaries. There is no order, writ, injunction, judgment or decree to which the Company, or any of the material assets owned or used by the Company, is subject.

 

2.17 Tax Matters.

 

(a) The Company and its Subsidiary have timely filed all income Tax Returns and other Tax Returns required to be filed by the Company and its Subsidiary under applicable Law (taking into account automatic extensions of time to file Tax Returns that have been obtained by the Company and its Subsidiary in the Ordinary Course of Business). All Tax Returns filed by the Company and its Subsidiary are correct and complete in all material respects and have been prepared in compliance with all applicable Tax Law. No claim has been made by any Governmental Body in any jurisdiction where the Company or its Subsidiary does not file a particular Tax Return or pay a particular Tax that the Company is or may be subject to taxation by that jurisdiction. The Company and its Subsidiary have delivered or made available to BLNE true and complete copies of all Tax Returns filed by the Company and its Subsidiary.

 

(b) All income and other Taxes due and owing by the Company and its Subsidiary (whether or not shown on any Tax Return) have been fully and timely paid when due. The unpaid Taxes of the Company and its Subsidiary did not, as of the Company Unaudited Balance Sheet Date, exceed the reserve for Tax Liabilities (other than any reserve for deferred Taxes established to reflect timing differences between book and Tax income) set forth on the Company Unaudited Balance Sheet and, since the Company Unaudited Balance Sheet Date, the Company and its Subsidiary have not incurred any material Liability for Taxes outside the Ordinary Course of Business consistent with past practice.

 

-18-
 

 

(c) All Taxes that the Company and its Subsidiary are or were required by Law to withhold or collect have been duly and timely withheld or collected on behalf of its employees, independent contractors, stockholders, or other third parties, and have been timely paid to the proper Governmental Body or other Person or properly set aside in accounts for this purpose in accordance with applicable Law. The Company and its Subsidiary have properly maintained all records required to be maintained with respect to withholding of Taxes under applicable Law. The Company and its Subsidiary have complied with all applicable Laws relating to escheat and unclaimed property and its obligations to maintain all required records with respect thereto.

 

(d) There are no Encumbrances for Taxes (other than Taxes not yet due and payable) upon any of the assets of the Company or its Subsidiary.

 

(e) No deficiencies for Taxes with respect to the Company or its Subsidiary have been claimed, proposed or assessed by any Governmental Body in writing. There are no pending or ongoing, and, to the Knowledge of the Company, threatened, audits, assessments or other Legal Proceedings for or relating to any liability in respect of Taxes of the Company or its Subsidiary. Neither the Company nor its Subsidiary has extended or waived any statute of limitations in respect of the payment of any Taxes or the filing of any Tax Return (other than extensions automatically obtained in the Ordinary Course of Business) or agreed to any extension of time with respect to any Tax assessment or deficiency.

 

(f) Neither the Company nor its Subsidiary (i) is a party to any Tax allocation agreement, Tax sharing agreement, Tax indemnity agreement, or similar agreement or arrangement, other than customary commercial contracts entered into in the Ordinary Course of Business consistent with past practice, the principal subject matter of which is not Taxes, (ii) is or has been a member of a group (other than such a group the common parent of which is the Company) filing a consolidated, combined, affiliated, unitary or similar income Tax Return, (iii) has any liability for the Taxes of any Person (other than the Company and its Subsidiary) pursuant to Treasury Regulations Section 1.1502-6 (or any similar provision of state, local or foreign Law) as a transferee or successor, by Contract or otherwise by operation of Law, and (iv) is a party to any joint venture, partnership or other arrangement that is treated as a partnership for U.S. federal income Tax purposes.

 

(g) Neither the Company nor its Subsidiary will be required to include any item of income in, or exclude any item of deduction from, taxable income for any Tax period (or portion thereof) ending after the Closing Date as a result of any: (i) change in method of accounting for Tax purposes for a taxable period (or portion thereof) ending on or prior to the Closing Date; (ii) use of an improper method of accounting for a Tax period ending on or prior to the Closing Date; (iii) “closing agreement” as described in Section 7121 of the Code (or any similar provision of state, local or foreign Law) executed on or prior to the Closing Date; (iv) intercompany transaction or excess loss account described in Treasury Regulations under Section 1502 of the Code (or any similar provision of state, local or foreign Law) for any action taken on or prior to the Closing Date; (v) installment sale or open transaction disposition made on or prior to the Closing Date; or (vi) prepaid amount received or deferred revenue accrued on or prior to the Closing Date.

 

(h) Neither the Company nor its Subsidiary has distributed stock of another Person, or had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section 355 of the Code or Section 361 of the Code (or any similar provisions of state, local, or foreign Law).

 

-19-
 

 

(i) Neither the Company nor its Subsidiary has a permanent establishment (within the meaning of an applicable Tax treaty) or otherwise has an office or fixed place of business in a jurisdiction outside of the United States.

 

(j) Neither the Company nor its Subsidiary has participated in or been a party to a transaction that, as of the date of this Agreement, constitutes a “listed transaction” or “transaction of interest” that is required to be reported to the IRS pursuant to Section 6011 of the Code and applicable Treasury Regulations thereunder.

 

(k) Neither the Company nor its Subsidiary has engaged in any transaction with Affiliates that would make them subject to federal transfer pricing rules or Laws.

 

(l) The Company is (and has since formation been treated as) a corporation for U.S. federal income Tax purposes. Neither the Company nor its Subsidiary has taken, nor failed to take, any action nor knows of any fact or circumstance that, in each case, could reasonably be expected to prevent the Merger from qualifying for the Intended Tax Treatment.

 

(m) Neither the Company nor its Subsidiary is, nor has been, a “United States real property holding corporation” within the meaning of Section 897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii) of the Code.

 

(n) Neither the Company nor its Subsidiary has been, is, and immediately prior to the Effective Time will be, treated as an “investment company” within the meaning of Section 368(a)(2)(F) of the Code.

 

(o) No private letter rulings, technical advice memoranda, or similar agreements or rulings have been requested, entered into or issued by any taxing authority with respect to the Company or any of its Subsidiaries which rulings remain in effect.

 

(p) There are no outstanding shares of Company Capital Stock issued in connection with the performance of services (within the meaning of Section 83 of the Code) that immediately prior to the Effective Time are subject to a substantial risk of forfeiture (as such terms are defined in Section 83 of the Code) for which a valid election under Section 83(b) of the Code has not been made.

 

For purposes of this Section 2.17, each reference to the Company shall be deemed to include any Person that was liquidated into, merged with, or is otherwise a predecessor to, the Company.

 

2.18 Employee and Labor Matters; Benefit Plans.

 

(a) Neither the Company nor any of its Subsidiaries has any Company Benefit Plans. Neither the Company nor any of its Subsidiaries has ever maintained, operated, administered, or contributed to any Company Benefit Plan.

 

-20-
 

 

(b) Neither the Company nor any of its Subsidiaries currently has or has ever had any employees. Section 2.18(b) of the Company Disclosure Schedule includes a list of each of the Company and its Subsidiaries’ independent contractors, including for each such independent contractor: (i) name, (ii) employer, (iii) job title, (iv) work location, (v) first date of service (with the Company or one of its Affiliates), (vi) whether full or part-time, (vii) whether classified as exempt or non-exempt for wage and hour purposes, (viii) whether paid on a salary, hourly or commission basis, (ix) the annual base salary or rate of compensation for 2026, (x) most recent variable compensation or commission award, (xi) current annual target incentive compensation or commission opportunity, (xii) the independent contractor’s average scheduled hours per week and (xiii) status (i.e., active or inactive and if inactive, the type of leave and expected return date).

 

(c) Neither the execution of this Agreement, nor the consummation of the Contemplated Transactions (either alone or when combined with the occurrence of any other event, including a termination of employment) result in any payment or benefit becoming due to any current or former employee, director, officer, or independent contractor of the Company.

 

(d) No current or former employee, officer, director or independent contractor of the Company or any of its Subsidiaries has any “gross up” agreements or other assurance of reimbursement for any Taxes imposed under Code Section 409A or Code Section 4999.

 

(e) Neither the execution of this Agreement, nor the consummation of the Contemplated Transactions (either alone or when combined with the occurrence of any other event, including a termination of employment) will result in the receipt or retention by any person who is a “disqualified individual” (within the meaning of Code Section 280G) of any payment or benefit that is or could be characterized as an excess “parachute payment” (within the meaning of Code Section 280G), determined without regard to the application of Code Section 280G(b)(5).

 

(f) Neither the Company nor any of its Subsidiaries is a party to, bound by, or has a duty to bargain under, or has ever been a party to, any collective bargaining agreement or other Contract with a labor union, labor organization, or similar Person representing any of its employees.

 

(g) The Company and each of its Subsidiaries are, and since the Inception Date, have been, in material compliance with all applicable Laws respecting labor, employment, employment practices, and terms and conditions of employment, including worker classification, engagement of independent contractors, including proper classification of such independent contractors, tax withholding, prohibited discrimination and retaliation, equal employment opportunities, harassment, fair employment practices, meal and rest periods, immigration, employee safety and health, wages (including overtime wages), unemployment and workers’ compensation, leaves of absence, and hours of work.

 

2.19 Environmental Matters. The Company and each of its Subsidiaries are, and since the Inception Date have been, in compliance in all material respects with all applicable Environmental Laws, which compliance includes the possession by the Company of all permits and other Governmental Authorizations required under applicable Environmental Laws and compliance with the terms and conditions thereof. The Company has not received any written notice or other communication (in writing or otherwise), whether from a Governmental Body or other Person, that alleges that the Company is not in compliance with or has liability pursuant to any Environmental Law and, to the Knowledge of the Company, there are no circumstances that would reasonably be expected to prevent or interfere with the Company’s or any of its Subsidiaries’ compliance in any material respects with any Environmental Law.

 

-21-
 

 

2.20 Insurance. The Company has delivered or made available to BLNE accurate and complete copies of all material insurance policies and all material self-insurance programs and arrangements relating to the business, assets, liabilities and operations of the Company. Each of such insurance policies is in full force and effect and the Company is in compliance in all material respects with the terms thereof.

 

2.21 No Financial Advisors. No broker, finder or investment banker is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries.

 

2.22 Transactions with Affiliates. Except as set forth on ‎Section 2.22 of the Company Disclosure Schedule, since the Inception Date through the date of this Agreement, no event has occurred that would be required to be reported by the Company or any of its Subsidiaries pursuant to Item 404 of Regulation S-K under the Securities Act (assuming the Company and its Subsidiaries are subject to the requirements of the Exchange Act).

 

2.23 Anti-Bribery. To the Knowledge of the Company, none of the Company, its Subsidiaries or any of their respective officers, employees or agents or any other Person acting on its behalf has directly or indirectly made any bribes, rebates, payoffs, influence payments, kickbacks, illegal payments, illegal political contributions, or other payments, in the form of cash, gifts, or otherwise, or taken any other action, in violation of the Foreign Corrupt Practices Act of 1977, the UK Bribery Act of 2010 or any other applicable anti-bribery or anti-corruption Law (collectively, the “Anti-Bribery Laws”). Neither the Company nor any of its Subsidiaries is or has been the subject of any investigation or inquiry by any Governmental Body with respect to potential violations of Anti-Bribery Laws.

 

2.24 Disclaimer of Other Representations or Warranties. Except as expressly set forth in this Section 2 or in any certificate delivered by the Company to BLNE or Merger Sub pursuant to this Agreement, none of the Company, its Subsidiaries, any of its Affiliates or Representatives, or any other Person makes any representation or warranty, express or implied, at law or in equity, with respect to the Company or any of its Subsidiaries or any of their respective assets, liabilities or operations, and any such other representations or warranties are hereby expressly disclaimed.

 

-22-
 

 

Section 3 REPRESENTATIONS AND WARRANTIES OF BLNE AND MERGER SUB

 

Except (i) as set forth in the disclosure schedule delivered by BLNE to the Company concurrently with the execution of this Agreement (the “BLNE Disclosure Schedule”) or (ii) as disclosed in the BLNE SEC Documents prior to the date hereof and publicly available on the SEC’s Electronic Data Gathering Analysis and Retrieval system (but (A) without giving effect to any amendment thereof filed with, or furnished to the SEC on or after the date hereof, and (B) excluding any disclosures contained under the heading “Risk Factors” and any disclosure of risks included in any “forward-looking statements” disclaimer or in any other section to the extent they are forward-looking statements or cautionary, predictive or forward-looking in nature), it being understood that any matter disclosed in the BLNE SEC Documents (x) shall not be deemed disclosed for purposes of Section 3.1, Section 3.3, Section 3.4, Section 3.6 and Section 3.7 and (y) shall be deemed to be disclosed in a section of the BLNE Disclosure Schedule only to the extent that it is readily apparent from a reading of such BLNE SEC Documents, without independent knowledge of the matters disclosed therein, that such disclosure is applicable to such section of the BLNE Disclosure Schedule, BLNE and Merger Sub represent and warrant to the Company as follows:

 

3.1 Due Organization; Subsidiaries.

 

(a) BLNE is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Nevada and has all necessary corporate power and authority: (i) to conduct its business in the manner in which its business is currently being conducted; (ii) to own or lease and use its property and assets in the manner in which its property and assets are currently owned or leased and used; and (iii) to perform its obligations under all Contracts by which it is bound, except where the failure to have such power or authority would not reasonably be expected to have a BLNE Material Adverse Effect.

 

(b) BLNE is duly licensed and qualified to do business, and is in good standing (to the extent applicable in such jurisdiction), under the Laws of all jurisdictions where the nature of its business in the manner in which its business is currently being conducted requires such licensing or qualification, other than in jurisdictions where the failure to be so qualified individually or in the aggregate would not be reasonably expected to have a BLNE Material Adverse Effect.

 

(c) Except as disclosed in the BLNE SEC Documents or in Section 3.1(c) of the BLNE Disclosure Schedule, BLNE has no Subsidiaries, and does not own any capital stock or membership interests of, or any equity, ownership or profit sharing interest of any nature in, or control directly or indirectly, any other Entity. Except as disclosed in the BLNE SEC Documents or as set forth in Section 3.1(c) of the BLNE Disclosure Schedule, BLNE is not, and has never been, directly or indirectly, a party to, member of or participant in any partnership, joint venture or similar business entity. Except as set forth on Section 3.1(c) of the BLNE Disclosure Schedule, BLNE has not agreed, and is not obligated, to make any future investment in or capital contribution to any other Entity, and is not party to any Contract pursuant to which it may become so obligated. BLNE has not, at any time, been a general partner of, or has otherwise been liable for any of the debts or other obligations of, any general partnership, limited partnership or other Entity.

 

(d) Merger Sub is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware. Since the date of its incorporation, Merger Sub has not engaged in any activities other than activities incident to its formation or in connection with or as contemplated by this Agreement. Merger Sub is a wholly owned Subsidiary of BLNE.

 

-23-
 

 

3.2 Organizational Documents. BLNE has delivered to the Company accurate and complete copies of each of BLNE’s and Merger Sub’s Organizational Documents in effect as of the date of this Agreement. Neither BLNE nor Merger Sub is in material breach or violation of its respective Organizational Documents.

 

3.3 Authority; Binding Nature of Agreement.

 

(a) This Agreement has been duly executed and delivered by BLNE and, assuming the due authorization, execution and delivery by the Company and Merger Sub, constitutes the legal, valid and binding obligation of each of BLNE and Merger Sub, enforceable against BLNE or Merger Sub, as applicable, in accordance with its terms, subject to the Enforceability Exceptions. Subject to BLNE obtaining the Required BLNE Stockholder Vote, complying with any applicable rules and regulations of Nasdaq, and complying with the provisions of its Organizational Documents, each of BLNE and Merger Sub has all necessary corporate power and authority to enter into and perform its obligations under this Agreement and to consummate the Contemplated Transactions.

 

(b) The Special Committee has been duly constituted and at a meeting duly called and held, the Special Committee unanimously (i) determined that the Contemplated Transactions are fair to, advisable and in the best interests of BLNE and its stockholders, (ii) approved and declared advisable this Agreement and the Contemplated Transactions, and (iii) determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of BLNE vote to approve the Required BLNE Stockholder Matters, which resolutions have not been subsequently withdrawn, amended or modified as of the date of this Agreement (the “Special Committee Recommendation”).

 

(c) The Merger Sub Board (i) determined that the Contemplated Transactions are fair to, advisable and in the best interests of Merger Sub and its sole stockholder, (ii) approved and declared advisable this Agreement and the Contemplated Transactions, and (iii) determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the sole stockholder of Merger Sub vote to adopt this Agreement and thereby approve the Contemplated Transactions, which resolutions have not been subsequently withdrawn, amended or modified as of the date of this Agreement. This Agreement has been duly executed and delivered by Merger Sub and, assuming the due authorization, execution and delivery by the Company and BLNE, constitutes the legal, valid and binding obligation of Merger Sub, enforceable against Merger Sub in accordance with its terms, subject to the Enforceability Exceptions.

 

(d) The Special Committee has received the opinion of M&N Sarchet, Inc. to the effect that, as of the date of such opinion and based upon and subject to the assumptions, limitations, qualifications and other matters set forth in such opinion, the Merger Consideration is fair to the shareholders of BLNE from a financial point of view.

 

-24-
 

 

3.4 Vote Required. The affirmative vote of the votes cast by (a) the Majority of the Minority based upon votes cast, (b) a majority of the shares of the Series F Preferred Stock of BLNE, voting as a separate class, (c) a majority of the shares of the Series F-1 Preferred Stock of BLNE, voting as a separate class, and (d) a majority of the shares of the Series G Preferred Stock of BLNE, voting as a separate class, are necessary to approve the Contemplated Transactions (the votes described in this Section 3.4, the “Required BLNE Stockholder Vote”); provided that BLNE does not make any representation or warranty with respect to any vote of the holders of any class or series of BLNE Capital Stock necessary to approve any other proposals the Parties deem necessary or desirable to consummate the Contemplated Transactions. Notwithstanding the foregoing, if Nasdaq advises BLNE that a different voting standard is required, then Mr. Liuzza, in his capacity as the Chief Executive Officer of BLNE, may vote all shares of BLNE capital stock that are beneficially owned by him at the BLNE Stockholders’ Meeting. For the avoidance of doubt, (i) if a majority of the shares of a class or series of BLNE Capital Stock in which Mr. Liuzza is also a beneficial owner cast their votes in favor of the Contemplated Transactions, then Mr. Liuzza may vote his shares of that class or series in favor of the Contemplated Transactions, and if a majority of the shares of a class or series of BLNE Capital Stock in which Mr. Liuzza is also a beneficial owner cast their votes against the Contemplated Transactions, then Mr. Liuzza shall vote his shares of that class or series against the Contemplated Transactions, and (ii) abstentions and broker non-votes shall be disregarded in such event.

 

3.5 Non-Contravention; Consents.

 

(a) Subject to obtaining the Required BLNE Stockholder Vote, the filing of the Certificate of Merger required by the DGCL, and to the extent required by the rules and regulations of Nasdaq, except as set forth on Section 3.5 of the BLNE Disclosure Schedule, neither (x) the execution, delivery or performance of this Agreement by BLNE or Merger Sub, nor (y) the consummation of the Contemplated Transactions, will directly or indirectly (with or without notice or lapse of time):

 

(i) contravene, conflict with or result in a violation of any of the provisions of the Organizational Documents of BLNE, or Merger Sub (as applicable);

 

(ii) contravene, conflict with or result in a violation of, or give any Governmental Body or other Person the right to challenge the Contemplated Transactions or to exercise any remedy or obtain any relief under, any Law or any order, writ, injunction, judgment or decree to which BLNE or Merger Sub, or any of the assets owned or used by BLNE or Merger Sub, is subject, except as would not reasonably be expected to be material to the business conducted by BLNE and its Subsidiaries as a whole;

 

(iii) contravene, conflict with or result in a violation of any of the terms or requirements of, or give any Governmental Body the right to revoke, withdraw, suspend, cancel, terminate or modify, any Governmental Authorization that is held by BLNE, except as would not reasonably be expected to be material to the business conducted by BLNE and its Subsidiaries as a whole;

 

(iv) contravene, conflict with or result in a violation or breach of, or result in a default under, any provision of any BLNE Material Contract, or give any Person the right to: (i) declare a default or exercise any remedy under any BLNE Material Contract; (ii) any material payment, rebate, chargeback, penalty or change in delivery schedule under any BLNE Material Contract; (iii) accelerate the maturity or performance of any BLNE Material Contract; or (iv) cancel, terminate or modify any term of any BLNE Material Contract, except in the case of any non-material breach, default, penalty or modification; or

 

-25-
 

 

(v) result in the imposition or creation of any Encumbrance upon or with respect to any asset owned or used by BLNE (except for Permitted Encumbrances).

 

(b) Except for (i) any Consent set forth on Section 3.5 of the BLNE Disclosure Schedule under any BLNE Contract, (ii) the Required BLNE Stockholder Vote, (iii) the filing of the Certificate of Merger with the Secretary of State of the State of Delaware pursuant to the DGCL, (iv) the filing of the Listing of Additional Shares with Nasdaq and compliance with any applicable rules and regulations of Nasdaq, and (v) such consents, waivers, approvals, orders, authorizations, registrations, declarations and filings as may be required under applicable federal and state securities Laws, BLNE is not and will not be required to make any filing with or give any notice to, or to obtain any Consent from, any Person in connection with (x) the execution, delivery or performance of this Agreement, or (y) the consummation of the Contemplated Transactions, which if individually or in the aggregate were not given or obtained, would reasonably be expected to prevent or materially delay the ability of BLNE or Merger Sub to consummate the Contemplated Transactions.

 

(c) The Merger Sub Board has taken and will take all actions necessary to ensure that the restrictions applicable to business combinations contained in Section 203 of the DGCL are, and will be, inapplicable to the execution, delivery and performance of this Agreement and to the consummation of the Contemplated Transactions. No other Takeover Statute applies or purports to apply to the Merger, this Agreement or any of the Contemplated Transactions.

 

3.6 Capitalization.

 

(a) As of the date hereof, the authorized capital stock of BLNE consists of (i) 100,000,000 shares of BLNE Common Stock, par value $0.0001 per share, of which 35,510,578 shares have been issued and are outstanding as of November 10, 2026 (the “Capitalization Date”) and (ii) 100,000,000 shares of BLNE Preferred Stock, par value $0.0001 per share, of which (A) 2,250,000 shares are designated as Series B Preferred Stock, 2,250,000 of which are issued and outstanding, (B) 70,000,000 shares are designated as Series F Preferred Stock, 1,259,009 of which are issued and outstanding, (C) 1,000,000 shares are designated as Series F-1 Preferred Stock, 9,382 of which are issued and outstanding, and (D) 15,000,000 shares are designated as Series G Preferred Stock, 691,571 of which are issued and outstanding. The certificate of designations for each of BLNE’s Series A Convertible Redeemable Preferred Stock, Series C Preferred Stock, the Series D Preferred Stock, and the Series E Preferred Stock were each withdrawn.

 

(b) All of the outstanding shares of BLNE Common Stock have been duly authorized and validly issued, and are fully paid and nonassessable. None of the outstanding shares of BLNE Common Stock is entitled or subject to any preemptive right, right of participation, right of maintenance or any similar right and none of the outstanding shares of BLNE Common Stock is subject to any right of first refusal in favor of BLNE. Other than the BLNE Stockholder Support Agreements or as set forth on Section 3.6(b) of the BLNE Disclosure Schedule, there is no BLNE Contract relating to the voting or registration of, or restricting any Person from purchasing, selling, pledging or otherwise disposing of (or granting any option or similar right with respect to), any shares of BLNE Common Stock. BLNE is not under any obligation, nor is it bound by any Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire any outstanding shares of BLNE Common Stock or other securities. None of the outstanding shares of capital stock of BLNE held by current or former BLNE employees or other service providers are subject to any repurchase or forfeiture rights held by BLNE.

 

-26-
 

 

(c) Except for the BLNE Stock Plans, BLNE does not have any stock option plan or any other plan, program, agreement or arrangement providing for any equity-based compensation for any Person. Section 3.6(c) of the BLNE Disclosure Schedule sets forth the following information with respect to each BLNE Option, BLNE Warrant, and BLNE RSU outstanding as of the date of this Agreement: (i) the name of the holder; (ii) the number of shares of BLNE Common Stock subject to such BLNE Option, BLNE Warrant, and BLNE RSU at the time of grant; (iii) the number of shares of BLNE Common Stock subject to such BLNE Option, BLNE Warrant, and BLNE RSU as of the date of this Agreement; (iv) the exercise price; (v) the date on which such BLNE Option, BLNE Warrant, and BLNE RSU was granted; (vi) the applicable vesting schedule, including the number of vested and unvested shares as of the date of this Agreement; and (vii) whether such BLNE Option is intended to constitute an “incentive stock option” (as defined in the Code) or a non-qualified stock option. BLNE has made available to the Company accurate and complete copies of the BLNE Stock Plans and the form of the agreements evidencing the outstanding BLNE Options, BLNE Warrants, and BLNE RSUs granted thereunder. Except as set forth in Section 3.6(c) of the BLNE Disclosure Schedule, no vesting of BLNE Options or BLNE RSUs will accelerate in connection with the closing of the Contemplated Transactions.

 

(d) Except for the outstanding BLNE Options, BLNE Warrants, and BLNE RSUs, or as set forth on Section 3.6(d) of the BLNE Disclosure Schedule, there is no: (i) outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to acquire any shares of the capital stock or other securities of BLNE; (ii) outstanding security, instrument or obligation that is or may become convertible into or exchangeable for any shares of the capital stock or other securities of BLNE; or (iii) condition or circumstance that could be reasonably likely to give rise to or provide a basis for the assertion of a claim by any Person to the effect that such Person is entitled to acquire or receive any shares of capital stock or other securities of BLNE. There are no outstanding or authorized stock appreciation, phantom stock, profit participation or other similar rights with respect to BLNE.

 

(e) All outstanding shares of BLNE Common Stock, BLNE Options, BLNE Warrants, and BLNE RSUs and other securities of BLNE have been issued and granted in material compliance with (i) all applicable securities Laws and other applicable Law, and (ii) all requirements set forth in the applicable BLNE Contracts and in BLNE’s Organizational Documents.

 

-27-
 

 

3.7 SEC Filings; Financial Statements.

 

(a) Since January 1, 2025, BLNE has filed or furnished, as applicable, on a timely basis all forms, statements, certifications, reports and documents required to be filed or furnished by it with the SEC under the Exchange Act or the Securities Act (the “BLNE SEC Documents”). As of the time it was filed with the SEC (or, if amended or superseded by a filing prior to the date of this Agreement, then on the date of such filing), each of the BLNE SEC Documents complied in all material respects with the applicable requirements of the Securities Act or the Exchange Act (as the case may be) and, as of the time they were filed, none of the BLNE SEC Documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. To the Knowledge of BLNE, the certifications and statements required by (i) Rule 13a-14 under the Exchange Act and (ii) 18 U.S.C. §1350 (Section 906 of the Sarbanes-Oxley Act) relating to the BLNE SEC Documents (collectively, the “Certifications”) are accurate and complete and comply as to form and content with all applicable Laws. As used in this Section 3.7, the term “file” and variations thereof shall be broadly construed to include any manner in which a document or information is filed, furnished, supplied or otherwise made publicly available to or through the SEC.

 

(b) The financial statements (including any related notes) contained or incorporated by reference in the BLNE SEC Documents: (i) complied as to form in all material respects with the Securities Act and the Exchange Act, and the published rules and regulations of the SEC applicable thereto; (ii) were prepared in accordance with GAAP (except as may be indicated in the notes to such financial statements or, in the case of unaudited financial statements, except as permitted by Form 10-Q of the SEC, and except that the unaudited financial statements may not contain footnotes and are subject to normal and recurring year-end adjustments none of which are material) applied on a consistent basis unless otherwise noted therein throughout the periods indicated; and (iii) fairly present, in all material respects, the financial position of BLNE and its Subsidiaries as of the respective dates thereof and the results of operations and cash flows of BLNE for the periods covered thereby.

 

(c) BLNE is in compliance in all material respects with the applicable provisions of the Sarbanes-Oxley Act, the Exchange Act and the applicable listing and governance rules and regulations of Nasdaq.

 

(d) BLNE maintains a system of internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and to provide reasonable assurance (i) that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, (ii) that receipts and expenditures are made only in accordance with authorizations of management and the BLNE Board, (iii) regarding prevention or timely detection of the unauthorized acquisition, use or disposition of BLNE’s assets that could have a material effect on BLNE’s financial statements and (iv) that BLNE maintains records in reasonable detail which accurately and fairly reflect the transactions and dispositions of the assets of BLNE and any of its Subsidiaries. BLNE’s “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) are designed to ensure that all information (both financial and nonfinancial) required to be disclosed by BLNE in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and form of the SEC, except as disclosed in the BLNE SEC Documents. Based on their evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures were not effective as of June 30, 2026 as disclosed in its Form 10-Q for the quarterly period ended June 30, 2026 and filed with the SEC on August 14, 2026.

 

-28-
 

 

(e) BLNE has not entered into any securitization transactions or “off-balance sheet arrangements” (as defined in Item 303(c) of Regulation S-K under the Exchange Act).

 

3.8 Absence of Changes. Except as set forth on Section 3.8 of the BLNE Disclosure Schedule, between the BLNE Balance Sheet Date and the date of this Agreement, BLNE has conducted its business only in the Ordinary Course of Business (except for the execution and performance of this Agreement and the discussions, negotiations and transactions related thereto) and there has not been any (a) BLNE Material Adverse Effect or (b) action, event or occurrence that would have required the consent of the Company pursuant to Section 4.1(b) had such action, event or occurrence taken place after the execution and delivery of this Agreement.

 

3.9 Absence of Undisclosed Liabilities. As of the date hereof, BLNE does not have any Liability, individually or in the aggregate, of a type required to be recorded or reflected on a balance sheet or disclosed in the footnotes thereto under GAAP except for: (a) Liabilities disclosed, reflected or reserved against in the BLNE Balance Sheet as of the BLNE Balance Sheet Date, (b) normal and recurring current Liabilities that have been incurred by BLNE since the BLNE Balance Sheet Date in the Ordinary Course of Business; (c) Liabilities incurred in connection with the Contemplated Transactions; (d) Liabilities which would not, individually or in the aggregate, reasonably be expected to be material to BLNE and its Subsidiaries as a whole; and (e) Liabilities described in Section 3.9 of the BLNE Disclosure Schedule.

 

3.10 Title to Assets. BLNE owns, and has good and valid title to, or, in the case of leased properties and assets, valid leasehold interests in, all tangible properties or tangible assets and equipment used or held for use in its business or operations or purported to be owned by it, including (a) all assets reflected on the BLNE Balance Sheet and (b) all other assets reflected in the books and records of BLNE as being owned by BLNE. All of such assets are owned or, in the case of leased assets, leased by BLNE free and clear of any Encumbrances, other than Permitted Encumbrances.

 

3.11 Real Property; Leasehold. BLNE does not own any real property. Section 3.11 of the BLNE Disclosure Schedule sets forth an accurate and complete list of all real properties with respect to which BLNE directly or indirectly holds a valid leasehold interest as well as any other real estate that is in the possession of or leased by BLNE (the “BLNE Real Estate Leases”). BLNE has made available to the Company copies of all BLNE Real Estate Leases, each of which is in full force and effect, with no existing material default thereunder. BLNE’s use and operation of each such leased property conforms to all applicable Laws in all material respects.

 

3.12 Intellectual Property.

 

(a) BLNE owns, or has the legal and valid right to use, as currently being used by BLNE, all BLNE IP Rights.

 

(b) Section 3.12(b) of the BLNE Disclosure Schedule sets forth an accurate, true and complete listing of all BLNE Registered IP, specifying as to each such item, as applicable, the owner(s) of record (and, in the case of domain name registrations, the registrar), jurisdiction of application and/or registration, the application and/or registration number, the date of application and/or registration, and the status of application and/or registration. To the Knowledge of BLNE, each item of BLNE IP Rights that is BLNE Registered IP is and at all times has been filed and maintained in compliance with all applicable Law and all filings, payments, and other actions required to be made or taken to maintain such item of BLNE Registered IP in full force and effect have been made by the applicable deadline.

 

-29-
 

 

(c) Each Person who is or was an employee or contractor of BLNE and who is or was involved in the creation or development of any BLNE IP Rights purported to be owned by BLNE has signed a valid, enforceable agreement containing an assignment of such Intellectual Property to BLNE and confidentiality provisions protecting confidential information of BLNE and BLNE has no reason to believe that any such Person is unwilling to provide BLNE with cooperation as may be reasonably required to complete or prosecute all BLNE IP Rights.

 

(d) To the Knowledge of BLNE, no employee of BLNE is (i) bound by or otherwise subject to any Contract restricting him or her from performing his or her duties for BLNE or (ii) in breach of any Contract with any former employer or other Person concerning BLNE IP Rights purported to be owned by BLNE or confidentiality provisions protecting Trade Secrets and confidential information comprising BLNE IP Rights purported to be owned by BLNE.

 

(e) No BLNE IP Rights purported to be owned by BLNE were developed, in whole or in part (i) pursuant to or in connection with the development of any professional, technical or industry standard, (ii) under contract with or using the resources of any Governmental Body, academic institution or other entity that would subject any such BLNE IP Rights to the rights of any Governmental Body, academic institution or other entity or (iii) under any grants or other funding arrangements with third parties.

 

(f) BLNE has taken all commercially reasonable and appropriate steps to protect and maintain the BLNE IP Rights, including to preserve the confidentiality of all proprietary information that BLNE holds, or purports to hold, as a material Trade Secret. Any disclosure by BLNE of Trade Secrets to any third party has been pursuant to the terms of a written agreement with such Person or is otherwise lawful. BLNE has implemented and maintained a reasonable security plan consistent with industry practices of companies offering similar products or services. To the Knowledge of BLNE, BLNE has not experienced any breach of security or otherwise unauthorized access by third parties to the confidential information in BLNE’s possession, custody or control.

 

(g) To the Knowledge of BLNE, (i) the BLNE IP Rights are valid and enforceable and (ii) constitute all Intellectual Property necessary for BLNE to conduct its business as currently conducted and planned to be conducted. To the Knowledge of BLNE, the conduct of BLNE’s business as presently conducted and presently proposed to be conducted does not infringe or misappropriate any Intellectual Property right of any third party. To the Knowledge of BLNE, no third party is infringing upon any BLNE IP Rights or violating any license or agreement between BLNE and such third party, and BLNE has not sent any written communication to or asserted or threatened in writing any Legal Proceeding or claim against any Person involving or relating to any BLNE IP Rights.

 

-30-
 

 

(h) BLNE has not incorporated Open Source Materials into, or combined Open Source Materials with, any products or services sold or licensed by BLNE in such a way that requires, as a condition of use, modification and/or distribution of such Open Source Materials that other Software incorporated into, derived from or distributed with such Open Source Materials be (i) disclosed or distributed in Source Code form, (ii) licensed for the purpose of making derivative works, or (iii) redistributable at no charge.

 

(i) The Systems that are used or relied on by BLNE are adequate for the operation of the business conducted by BLNE as currently conducted, and contemplated to be conducted, are sufficient for the current needs of such business and BLNE has purchased a sufficient number of license seats for all licensed Software currently used by BLNE.

 

3.13 Privacy and Data Security.

 

(a) BLNE has complied in all material respects with all applicable (i) Privacy Laws, (ii) contractual terms to which BLNE is a party or is otherwise bound that impose obligations on BLNE with respect to Personal Information, and (iii) BLNE’s internal and external (including publicly posted) policies, notices, representations or guidelines relating to Personal Information, privacy and/or security of Personal Information (collectively, “BLNE Privacy and Data Security Requirements”). BLNE has not received any complaint, inquiry or request for information or documents, and no Legal Proceeding is pending or to the Knowledge of BLNE, threatened against BLNE alleging that the Processing of Personal Information by BLNE violates any applicable BLNE Privacy and Data Security Requirements.

 

(b) BLNE has at all times implemented and maintained in place reasonable and appropriate physical, technical and administrative security programs, policies, procedures and such other measures required by applicable BLNE Privacy and Data Security Requirements, to protect Personal Information that BLNE Processes in connection with the operation of its business from destruction, loss, alteration, damage, unauthorized access or disclosure or illegal or unauthorized Processing. There has not been any destruction, loss, alteration, damage, unauthorized access or disclosure or illegal or unauthorized Processing of any Personal Information that is in the possession or control of BLNE.

 

3.14 Agreements, Contracts and Commitments.

 

(a) Since October 7, 2024, BLNE has filed all “material contracts” that were required to be filed pursuant to Item 601(b)(10) of Regulation S-K under the Securities Act (excluding, however, any BLNE Benefit Plan) (all such contracts, “BLNE Material Contracts”) as exhibits to the BLNE SEC Documents.

 

(b) BLNE has delivered or made available to the Company accurate and complete copies of all BLNE Material Contracts, including all amendments thereto. BLNE has not, nor, to BLNE’s Knowledge, as of the date of this Agreement, has any other party to a BLNE Material Contract, breached, violated or defaulted under, or received notice that it breached, violated or defaulted under, any of the terms or conditions of any BLNE Material Contract in such manner as would permit any other party to cancel or terminate any such BLNE Material Contract, or would permit any other party to seek damages which would reasonably be expected to be material to BLNE or its business. As to BLNE, as of the date of this Agreement, each BLNE Material Contract is valid, binding, enforceable and in full force and effect, subject to the Enforceability Exceptions. No Person is renegotiating, or has a right pursuant to the terms of any BLNE Material Contract to change, any material amount paid or payable to BLNE under any BLNE Material Contract or any other material term or provision of any BLNE Material Contract.

 

-31-
 

 

3.15 Compliance; Permits.

 

(a) BLNE is, and for the past two (2) years has been, in compliance in all material respects with all applicable Laws relating to the operation of its business and the maintenance and operation of its properties and assets. Except as set forth on Section 3.15(a) of the BLNE Disclosure Schedule, no written notices have been received by, and no Legal Proceedings have been initiated or, to the Knowledge of BLNE, threatened against, BLNE alleging or pertaining to a violation of any such Laws.

 

(b) BLNE (i) holds, and is the sole legal owner of, all Permits required for the conduct of its business and the ownership, lease and use of its assets and properties (including for the operation and use of any leased property including as required under applicable Laws) and (ii) is and has for the past two (2) years been in compliance in all material respects with all terms and conditions of any such Permits. No written notice has been received by BLNE alleging the failure to hold or comply with any such Permits or the eligibility of BLNE to continue to hold any such Permits in the future. No suspension, modification, revocation or cancellation of any of such Permits is pending or threatened.

 

(c) BLNE does not have any Contracts or subcontracts to supply goods or services directly to the United States federal government.

 

3.16 Legal Proceedings; Orders. Except as disclosed in Section 3.16 of the BLNE Disclosure Schedule, there is no material pending Legal Proceeding and, to the Knowledge of BLNE, no Person has threatened in writing to commence any Legal Proceeding, (a) that involves BLNE or any of its Subsidiaries or any of the material assets owned or used by BLNE or any of its Subsidiaries or (b) that challenges, or that may have the effect of preventing, delaying, making illegal or otherwise interfering with, the Contemplated Transactions. Since January 1, 2025, no Legal Proceeding has resulted in material liability to BLNE. There is no order, writ, injunction, judgment or decree to which BLNE, or any of the material assets owned or used by BLNE, is subject.

 

3.17 Tax Reorganization.

 

(a) BLNE has timely filed all income Tax Returns and other Tax Returns required to be filed by BLNE under applicable Law (taking into account extensions of time to file Tax Returns that have been obtained by BLNE). All Tax Returns filed by BLNE are correct and complete in all material respects and have been prepared in compliance with all applicable Law. Within the last two (2) years, no claim has been made by any Governmental Body in any jurisdiction where BLNE does not file a particular Tax Return or pay a particular Tax that BLNE is subject to taxation by that jurisdiction.

 

(b) All income and other material Taxes due and owing by BLNE on or before the date hereof (whether or not shown on any Tax Return) have been fully and timely paid when due, other than Taxes being contested in good faith by appropriate proceedings and for which adequate reserves have been established in accordance with GAAP. Since the BLNE Balance Sheet Date, BLNE has not incurred any material Liability for Taxes outside the Ordinary Course of Business.

 

-32-
 

 

(c) There are no Encumbrances for Taxes (other than Permitted Encumbrances) upon any of the assets of BLNE.

 

(d) There are no pending or ongoing, and to the Knowledge of BLNE, threatened audits, assessments or other Legal Proceedings for or relating to any liability in respect of a material amount of Taxes of BLNE.

 

(e) BLNE has not participated in or been a party to a transaction that, as of the date of this Agreement, constitutes a “listed transaction” or “transaction of interest” that is required to be reported to the IRS pursuant to Section 6011 of the Code and applicable Treasury Regulations thereunder.

 

(f) Neither BLNE nor any of its Subsidiaries has taken, or failed to take, any action or knows of any fact or circumstance, in each case, that would reasonably be expected to prevent the Merger from qualifying for the Intended Tax Treatment.

 

(g) BLNE (i) has not been, is not, and immediately prior to the Effective Time will not be, treated as an “investment company” within the meaning of Section 368(a)(2)(F) of the Code, (ii) has no present plan or intention to liquidate the Company or to merge the Company with or into any other corporation or entity, or to cause the Company to sell or otherwise dispose of its assets, all except in the Ordinary Course of Business or if such liquidation, merger, disposition is described in Section 368(a)(2)(C) or Treasury Regulation Section 1.368-2(d)(4) or Section 1.368-2(k), and (iii) has no present plan or intention, following the Merger, to issue any additional shares of the Company or to create any new class of shares of the Company.

 

(h) Merger Sub is a wholly-owned subsidiary of BLNE, formed solely for the purpose of engaging in the Merger, and will carry on no business prior to the Merger.

 

(i) Immediately prior to the Merger, BLNE will be in control of Merger Sub within the meaning of Section 368(c) of the Code.

 

(j) Immediately following the Merger, the Company will hold all of the assets held by the Company immediately prior to the Merger.

 

(k) BLNE has no present plan or intention to reacquire any of the Merger Consideration.

 

(l) Merger Sub will have no liabilities assumed by the Company, and will not transfer to the Company any assets subject to liabilities in the transaction.

 

-33-
 

 

3.18 Employee and Labor Matters; Benefit Plans.

 

(a) Each BLNE Benefit Plan has been maintained, operated and administered in compliance in all material respects with its terms and applicable Law, including the applicable provisions of ERISA and the Code.

 

(b) Each BLNE Benefit Plan which is an “employee pension benefit plan” within the meaning of Section 3(2) of ERISA and which is intended to meet the qualification requirements of Section 401(a) of the Code has received a currently effective determination letter or opinion letter from the IRS to the effect that such plan is qualified under Section 401(a) of the Code and the related trust is exempt from federal income Taxes under Section 501(a) of the Code, respectively, and, to BLNE’s Knowledge, nothing has occurred that would reasonably be expected to materially adversely affect the qualification of such BLNE Benefit Plan or the tax-exempt status of the related trust.

 

(c) Neither BLNE nor any BLNE ERISA Affiliate maintains, contributes to, is required to contribute to, or has any actual or contingent liability with respect to or has, in the past six years, maintained, contributed to, or been required to contribute to, (i) any “employee pension benefit plan” (within the meaning of Section 3(2) of ERISA) that is subject to Title IV or Section 302 of ERISA or Section 412 of the Code, (ii) any “multiemployer plan” (within the meaning of Section 3(37) of ERISA), (iii) any “multiple employer plan” (within the meaning of Section 413 of the Code) or (iv) any “multiple employer welfare arrangement” (within the meaning of Section 3(40) of ERISA). Neither BLNE nor any BLNE ERISA Affiliate has ever incurred any liability under Title IV of ERISA.

 

(d) There are no pending audits or investigations by any Governmental Body involving any BLNE Benefit Plan, and no pending or, to the Knowledge of BLNE, threatened claims (except for individual claims and appeals for benefits payable in the normal operation of the BLNE Benefit Plans), suits or proceedings involving any BLNE Benefit Plan, any fiduciary thereof or service provider thereto, in any case except as would not be reasonably expected to result in material liability to BLNE.

 

(e) Neither the execution of, nor the performance of the transactions contemplated by, this Agreement will either alone or in connection with any other event(s) (i) result in any payment or benefit becoming due to any current or former employee, director, officer, or independent contractor of BLNE, (ii) increase any amount of compensation or benefits otherwise payable under any BLNE Benefit Plan, (iii) result in the acceleration of the time of payment, funding or vesting of any benefits under any BLNE Benefit Plan, (iv) require any contribution or payment to fund any obligation under any BLNE Benefit Plan or (v) limit the right to merge, amend or terminate any BLNE Benefit Plan.

 

(f) Neither the execution of, nor the consummation of the transactions contemplated by this Agreement (either alone or when combined with the occurrence of any other event, including a termination of employment) will result in the receipt or retention by any person who is a “disqualified individual” (within the meaning of Code Section 280G) of any payment or benefit that is or could be characterized as an “excess parachute payment” (within the meaning of Code Section 280G), determined without regard to the application of Code Section 280G(b)(5).

 

-34-
 

 

(g) No BLNE Benefit Plan is subject to the laws of any jurisdiction other than the United States of America.

 

(h) BLNE is not a party to, bound by, nor has a duty to bargain under, nor has ever been a party to, any collective bargaining agreement or other Contract with a labor union, labor organization, or similar Person representing any of its employees.

 

(i) Since January 1, 2025, BLNE has been in material compliance with all applicable Laws respecting labor, employment, employment practices, and terms and conditions of employment, including worker classification, tax withholding, prohibited discrimination and retaliation, equal employment opportunities, harassment, fair employment practices, meal and rest periods, immigration, employee safety and health, wages (including overtime wages), unemployment and workers’ compensation, leaves of absence, and hours of work.

 

3.19 Environmental Matters. Since January 1, 2025, BLNE has been in compliance with all applicable Environmental Laws, which compliance includes the possession by BLNE of all permits and other Governmental Authorizations required under applicable Environmental Laws and compliance with the terms and conditions thereof, except for any failure to be in such compliance that, either individually or in the aggregate, would not reasonably be expected to have a BLNE Material Adverse Effect. BLNE has not received any written notice or other communication (in writing or otherwise), whether from a Governmental Body or other Person, that alleges that BLNE is not in compliance with or has liability pursuant to any Environmental Law and, to the Knowledge of BLNE, there are no circumstances that would reasonably be expected to prevent or interfere with BLNE’s compliance in any material respects with any Environmental Law.

 

3.20 Insurance. BLNE has delivered or made available to the Company accurate and complete copies of all material insurance policies and all material self-insurance programs and arrangements relating to the business, assets, liabilities and operations of BLNE. Each of such insurance policies is in full force and effect and BLNE is in compliance in all material respects with the terms thereof.

 

3.21 No Financial Advisors. No broker, finder or investment banker, other than M&N Sarchet, Inc. (the “BLNE Financial Advisor”), who was engaged as the financial advisor to the Special Committee, is entitled to any brokerage fee, finder’s fee, opinion fee, success fee, transaction fee or other fee or commission in connection with the Contemplated Transactions based upon arrangements made by or on behalf of the Special Committee or BLNE. Any fee payable to the BLNE Financial Advisor in connection with the Contemplated Transactions shall be the sole responsibility of, and shall be paid by, BLNE.

 

3.22 Transactions with Affiliates. Except as set forth in the BLNE SEC Documents, since January 1, 2025, no event has occurred that would be required to be reported by BLNE pursuant to Item 404 of Regulation S-K under the Securities Act, which was not so reported in the BLNE SEC Documents.

 

-35-
 

 

3.23 Valid Issuance. The BLNE Common Stock to be issued in the Stock Issuance will, when issued in accordance with the provisions of this Agreement, be validly issued, fully paid and nonassessable.

 

3.24 Anti-Bribery. To the Knowledge of BLNE, neither it nor any of its officers, employees or agents or any other Person acting on its behalf has directly or indirectly made any bribes, rebates, payoffs, influence payments, kickbacks, illegal payments, illegal political contributions, or other payments, in the form of cash, gifts, or otherwise, or taken any other action, in violation of any Anti-Bribery Laws. BLNE is not, and has not been, the subject of any investigation or inquiry by any Governmental Body with respect to potential violations of Anti-Bribery Laws.

 

3.25 Disclaimer of Other Representations or Warranties. Except as set forth in this Section 3 or in any certificate delivered by BLNE or Merger Sub to the Company pursuant to this Agreement, neither BLNE nor Merger Sub, nor any of their respective Affiliates or Representatives, nor any other Person makes any representation or warranty, express or implied, at law or in equity, with respect to BLNE or any of its Subsidiaries or any of their respective assets, liabilities or operations, and any such other representations or warranties are hereby expressly disclaimed.

 

Section 4 CERTAIN COVENANTS OF THE PARTIES

 

4.1 Operation of BLNE’s Business.

 

(a) Except (i) as set forth on Section 4.1 of the BLNE Disclosure Schedule, (ii) as expressly permitted by or required in accordance with this Agreement, (iii) as required by applicable Law or (iv) unless the Company shall otherwise consent in writing (which consent shall not be unreasonably withheld, delayed or conditioned), during the period commencing on the date of this Agreement and continuing until the earlier to occur of the valid termination of this Agreement pursuant to Section 9 and the Effective Time (the “Pre-Closing Period”), BLNE shall, and shall cause its wholly owned Subsidiaries to, conduct their respective businesses and operations in the Ordinary Course of Business and in compliance with all applicable Laws and the requirements of all Contracts that constitute BLNE Material Contracts.

 

(b) Except as expressly permitted or required by this Agreement, as set forth in Section 4.1 of the BLNE Disclosure Schedule, as required by applicable Law, as required by any Organizational Document or any BLNE Material Contract in effect as of the date of this Agreement, or with the prior written consent of the Company (which consent shall not be unreasonably withheld, delayed or conditioned), at all times during the Pre-Closing Period, BLNE shall not (and shall cause its wholly owned Subsidiaries not to):

 

(i) declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of its capital stock or repurchase, redeem or otherwise reacquire any shares of its capital stock or other securities (except in connection with the payment of the exercise price and/or withholding Taxes incurred upon the exercise, settlement or vesting of any award granted under any BLNE Stock Plan or as may be required by the terms of the BLNE Preferred Stock or any BLNE Material Contract in effect as of the date of this Agreement);

 

-36-
 

 

(ii) sell, issue, grant, pledge or otherwise dispose of or encumber or authorize any of the foregoing with respect to: (A) any capital stock or other security of BLNE (except for BLNE Common Stock issued upon the valid exercise of outstanding BLNE Options, BLNE Warrants, or BLNE RSUs); (B) any option, warrant or right to acquire any capital stock or any other security; or (C) any instrument convertible into or exchangeable for any capital stock or other security of BLNE, other than in each case an Exempt Issuance;

 

(iii) except as required to give effect to anything in contemplation of the Closing, amend any of its Organizational Documents, or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse stock split or similar transaction except, for the avoidance of doubt, the Contemplated Transactions or as may otherwise be required to meet applicable requirements of Nasdaq;

 

(iv) enter into any material transaction other than in the Ordinary Course of Business;

 

(v) acquire any material asset or sell, lease or otherwise irrevocably dispose of any of its material assets or properties, or grant any Encumbrance with respect to such assets or properties, other than in the Ordinary Course of Business;

 

(vi) make, change or revoke any material Tax election, fail to pay any income or other material Tax as such Tax becomes due and payable, file any amendment making any material change to any Tax Return, settle or compromise any income or other material Tax liability, enter into any Tax allocation, sharing, indemnification or other similar agreement or arrangement (but excluding any agreement entered into in the Ordinary Course of Business the principal subject matter of which is not Taxes), request or consent to any extension or waiver of any limitation period with respect to any claim or assessment for any income or other material Taxes (other than in connection with any extension of time to file any Tax Return), or adopt or change any accounting method in respect of material Taxes;

 

(vii) other than obtaining “tail” insurance coverage in connection with the Closing, terminate or modify in any material respect, or fail to exercise renewal rights with respect to, any material insurance policy;

 

(viii) other than as required by Law or GAAP, take any action to change its accounting policies or procedures; or

 

(ix) agree, resolve or commit to do any of the foregoing.

 

(c) Nothing contained in this Agreement shall give the Company, directly or indirectly, the right to control or direct the operations of BLNE prior to the Effective Time. Prior to the Effective Time, BLNE shall exercise, consistent with the terms and conditions of this Agreement, complete unilateral control and supervision over its business operations.

 

-37-
 

 

4.2 Operation of the Company’s Business.

 

(a) Except (i) as set forth on Section 4.2 of the Company Disclosure Schedule, (ii) as expressly permitted by or required in accordance with this Agreement, (iii) as required by applicable Law or (iv) unless BLNE shall otherwise consent in writing (which consent shall not be unreasonably withheld, delayed or conditioned), during the Pre-Closing Period, the Company shall, and shall cause its wholly owned Subsidiaries to, conduct their respective businesses and operations in the Ordinary Course of Business and in compliance with all applicable Laws and the requirements of all Contracts that constitute Company Material Contracts.

 

(b) Except as expressly permitted or required by this Agreement, including with respect to a Qualifying Financing, as set forth in Section 4.2 of the Company Disclosure Schedule, as required by applicable Law, or with the prior written consent of BLNE (which consent shall not be unreasonably withheld, delayed or conditioned), at all times during the Pre-Closing Period, the Company shall not (and shall cause its wholly owned Subsidiaries not to):

 

(i) declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of its capital stock; or repurchase, redeem or otherwise reacquire any of its securities (except for repurchase or redemption of shares of Company Common Stock from terminated employees, directors or consultants of the Company);

 

(ii) sell, issue, grant, pledge or otherwise dispose of or encumber or authorize any of the foregoing with respect to: (A) any capital stock or other security of the Company (except for shares of Company Common Stock issued upon the valid exercise of Company Options issued and outstanding as of the date of this Agreement or shares of Company Common Stock issued in connection with the Preferred Stock Conversion); (B) any option, warrant or right to acquire any security, other than option grants to employees and service providers in the Ordinary Course of Business; (C) any instrument convertible into or exchangeable for any security of the Company; or (D) any Token Warrants;

 

(iii) except as required to give effect to anything in contemplation of the Closing, amend any of its Organizational Documents, or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse stock split or similar transaction except, for the avoidance of doubt, the Contemplated Transactions;

 

(iv) form any Subsidiary or acquire any equity interest or other interest in any other Entity or enter into a joint venture with any other Entity;

 

(v) (A) lend money to any Person, (B) incur or guarantee any indebtedness for borrowed money, (C) guarantee any debt securities of others, or (D) make any capital expenditure or commitment;

 

(vi) forgive any loans to any Person, including its employees, officers, directors or Affiliates;

 

-38-
 

 

(vii) (A) adopt, terminate, establish or enter into any Company Benefit Plan, (B) cause or permit any Company Benefit Plan to be amended in any material respect, (C) pay any bonus or make any profit-sharing or similar payment to, or increase the amount of the wages, salary, commissions, benefits or other compensation or remuneration payable to, any of its managers, officers or employees, other than increases in base salary and annual cash bonus opportunities and payments made in the Ordinary Course of Business consistent with past practice, (D) increase the severance or change of control benefits offered to any current or new employees, managers or consultants, or (E) hire, engage or appoint any individual who may reasonably be deemed to be an “executive officer” as defined under the Exchange Act;

 

(viii) recognize any labor union, labor organization, or similar Person;

 

(ix) enter into any material transaction, other than the acquisition of Fractional Real Property Interests in the Ordinary Course of Business;

 

(x) acquire any material asset or sell, lease or otherwise irrevocably dispose of any of its material assets or properties, or grant any Encumbrance with respect to such assets or properties, other than the acquisition of Fractional Real Property Interests in the Ordinary Course of Business;

 

(xi) sell, assign, transfer, license, sublicense or otherwise dispose of any material Company IP Rights (other than pursuant to non-exclusive licenses in the Ordinary Course of Business);

 

(xii) make, change or revoke any material Tax election, fail to pay any income or other material Tax as such Tax becomes due and payable, file any amendment making any material change to any Tax Return, settle or compromise any income or other material Tax liability, enter into any Tax allocation, sharing, indemnification or other similar agreement or arrangement (but excluding any agreement entered into in the Ordinary Course of Business the principal subject matter of which is not Taxes), request or consent to any extension or waiver of any limitation period with respect to any claim or assessment for any income or other material Taxes (other than in connection with any extension of time to file any Tax Return), or adopt or change any accounting method in respect of material Taxes;

 

(xiii) (A) terminate or enter into any Company Material Contract or (B) amend any Company Material Contract if such proposed amendment is not in the Ordinary Course of Business;

 

(xiv) other than obtaining “tail” insurance coverage in connection with the Closing, terminate or modify in any material respect, or fail to exercise renewal rights with respect to, any material insurance policy;

 

(xv) waive, settle or compromise any pending or threatened Legal Proceeding against the Company;

 

(xvi) delay or fail to repay when due any material obligation, including accounts payable and accrued expenses;

 

(xvii) other than as required by Law or GAAP, take any action to change its accounting policies or procedures; or

 

(xviii) agree, resolve or commit to do any of the foregoing.

 

-39-
 

 

(c) Nothing contained in this Agreement shall give BLNE, directly or indirectly, the right to control or direct the operations of the Company prior to the Effective Time. Prior to the Effective Time, the Company shall exercise, consistent with the terms and conditions of this Agreement, complete unilateral control and supervision over its business operations.

 

4.3 Access and Investigation. Subject to the terms of the Confidentiality Agreement, which the Parties agree will continue in full force following the date of this Agreement, during the Pre-Closing Period, upon reasonable notice, BLNE, on the one hand, and the Company, on the other hand, shall and shall use commercially reasonable efforts to cause such Party’s Representatives to: (a) provide the other Party and such other Party’s Representatives with reasonable access during normal business hours to such Party’s Representatives, personnel, property and assets and to all existing books, records, Tax Returns, work papers and other documents and information relating to such Party and its Subsidiaries; (b) provide the other Party and such other Party’s Representatives with such copies of the existing books, records, Tax Returns, work papers, product data, and other documents and information relating to such Party, and with such additional financial, operating and other data and information regarding such Party and its Subsidiaries as the other Party may reasonably request; (c) permit the other Party’s officers and other employees to meet, upon reasonable notice and during normal business hours, with the chief financial officer and other officers and managers of such Party responsible for such Party’s financial statements and the internal controls of such Party to discuss such matters as the other Party may deem necessary or appropriate; and (d) make available to the other Party copies of unaudited financial statements, material operating and financial reports prepared for senior management or the board of directors or managers of such Party, and any material notice, report or other document filed with or sent to or received from any Governmental Body in connection with the Contemplated Transactions. Any investigation conducted by either BLNE or the Company pursuant to this Section 4.3 shall be conducted in such manner as not to interfere unreasonably with the conduct of the business of the other Party. Notwithstanding the foregoing, any Party may restrict the foregoing access to the extent that any Law applicable to such Party requires such Party to restrict or prohibit access to any such properties or information or as may be necessary to preserve the attorney-client privilege under any circumstances in which such privilege may be jeopardized by such disclosure or access; provided that such Party shall use its commercially reasonable efforts to obtain any required consents for the disclosure of such information and take such other reasonable action (including, to the extent permitted, redacted versions of any such information or entering into a joint defense agreement or similar arrangement to avoid loss of attorney-client privilege) with respect to such information as is necessary to permit disclosure without jeopardizing such attorney-client privilege or violating applicable Law, as applicable.

 

4.4 BLNE Non-Solicitation.

 

(a) BLNE agrees that, during the Pre-Closing Period, BLNE (at the sole direction of the Special Committee) shall not, nor shall it authorize any of its Representatives to, directly or indirectly: (i) solicit, initiate or knowingly encourage, induce, discuss, negotiate or facilitate the communication, making, submission or announcement of any Acquisition Proposal or Acquisition Inquiry or take any action that would reasonably be expected to lead to an Acquisition Proposal; (ii) furnish any non-public information regarding BLNE or any of its Subsidiaries to any Person in connection with or in response to an Acquisition Proposal or Acquisition Inquiry; (iii) engage in discussions (other than to inform any Person of the existence of the provisions in this Section 4.4) or negotiations with any Person with respect to any Acquisition Proposal or Acquisition Inquiry; (iv) approve, endorse or recommend any Acquisition Proposal (subject to Section 5.3); (v) execute or enter into any letter of intent or any Contract contemplating or otherwise relating to any Acquisition Transaction (other than a confidentiality agreement permitted under this Section 4.4(a)); or (vi) publicly propose to do any of the foregoing; provided, however, that, notwithstanding anything contained in this Section 4.4 and subject to compliance with this Section 4.4, prior to obtaining the Required BLNE Stockholder Vote, BLNE may, at the direction of the Special Committee, furnish non-public information regarding BLNE and its Subsidiaries to, and enter into discussions or negotiations with, any Person in response to an unsolicited bona fide written Acquisition Proposal by such Person which the Special Committee determines in good faith, after consultation with its outside financial advisors and outside legal counsel, constitutes, or is reasonably likely to result in, a Superior Offer (which Acquisition Proposal is not withdrawn) if: (A) neither BLNE nor any of its Representatives shall have breached this Section 4.4 in any material respect, (B) the Special Committee concludes in good faith based on the advice of outside legal counsel, that the failure to take such action is reasonably likely to be inconsistent with the fiduciary duties under applicable Law; (C) BLNE (at the sole direction of the Special Committee) receives from such Person an executed confidentiality agreement containing provisions at least as favorable to BLNE as those contained in the Confidentiality Agreement (except such confidentiality agreement need not contain any standstill, non-solicitation or no hire provisions); and (D) substantially contemporaneously with furnishing any such nonpublic information to such Person, BLNE (at the sole direction of the Special Committee) furnishes such nonpublic information to the Company (to the extent such information has not been previously furnished by BLNE to the Company). Notwithstanding anything to the contrary in this Agreement, the Special Committee, BLNE (at the sole direction of the Special Committee) or any of their respective Representatives may, in response to any unsolicited Acquisition Proposal or Acquisition Inquiry from a third party, (x) seek to clarify the terms and conditions of such Acquisition Proposal or Acquisition Inquiry and (y) inform such third party or its Representatives of the restrictions imposed by this Section 4.4 (without conveying, requesting, or attempting to gather any other information except as otherwise specifically permitted).

 

-40-
 

 

(b) If the Special Committee, BLNE, any of its Subsidiaries or any Representative of the Special Committee or BLNE, as applicable, receives an Acquisition Proposal at any time during the Pre-Closing Period, then the Special Committee and BLNE (at the sole direction of the Special Committee) shall promptly (and in no event later than one Business Day after BLNE becomes aware of such Acquisition Proposal) advise the Company orally and in writing of such Acquisition Proposal (including the terms of such Acquisition Proposal). The Special Committee shall keep the Company reasonably informed with respect to the status and material terms of any such Acquisition Proposal and any material modification or proposed material modification thereto.

 

(c) BLNE (at the sole direction of the Special Committee) shall immediately cease and cause to be terminated any existing discussions, negotiations and communications with any Person that relate to any Acquisition Proposal or Acquisition Inquiry as of the date of this Agreement and request the destruction or return of any nonpublic information of BLNE provided to such Person.

 

4.5 Company Non-Solicitation.

 

(a) The Company agrees that, during the Pre-Closing Period, the Company shall not, nor shall it authorize any of its Representatives to, directly or indirectly: (i) solicit, initiate or knowingly encourage, induce, discuss, negotiate or facilitate the communication, making, submission or announcement of any Acquisition Proposal or Acquisition Inquiry or take any action that would reasonably be expected to lead to an Acquisition Proposal; (ii) furnish any non-public information regarding the Company or any of its Subsidiaries to any Person in connection with or in response to an Acquisition Proposal or Acquisition Inquiry; (iii) engage in discussions (other than to inform any Person of the existence of the provisions in this Section 4.5) or negotiations with any Person with respect to any Acquisition Proposal or Acquisition Inquiry; (iv) approve, endorse or recommend any Acquisition Proposal; (v) execute or enter into any letter of intent or any Contract contemplating or otherwise relating to any Acquisition Transaction; or (vi) publicly propose to do any of the foregoing.

 

(b) The Company shall immediately cease and cause to be terminated any existing discussions, negotiations and communications with any Person that relate to any Acquisition Proposal or Acquisition Inquiry as of the date of this Agreement and request the destruction or return of any nonpublic information of the Company provided to such Person.

 

4.6 Notification of Certain Matters.

 

(a) During the Pre-Closing Period, the Company shall promptly (and in no event later than one (1) Business Day after the Company becomes aware of same) notify the Special Committee (and, if in writing, furnish copies of) if any of the following occurs: (i) any notice or other communication is received from any Person alleging that the Consent of such Person is or may be required in connection with any of the Contemplated Transactions; (ii) any Legal Proceeding against or involving or otherwise affecting the Company or its Subsidiaries is commenced, or, to the Knowledge of the Company, threatened against the Company or its Subsidiaries or, to the Knowledge of the Company, any director, officer or employee of the Company or its Subsidiaries; (iii) the Company becomes aware of any inaccuracy in any representation or warranty made by it in this Agreement; or (iv) the failure of the Company to comply with any covenant or obligation of the Company; in each case in clauses (iii) or (iv) that could reasonably be expected to make the timely satisfaction of any of the conditions set forth in Sections 6 and 7, as applicable, impossible or materially less likely. No notification given to BLNE pursuant to this Section 4.6 shall change, limit or otherwise affect any of the representations, warranties, covenants or obligations of the Company or any of its Subsidiaries contained in this Agreement or the Company Disclosure Schedule for purposes of Sections 6 and 7, as applicable.

 

(b) During the Pre-Closing Period, BLNE (at the sole direction of the Special Committee) shall promptly (and in no event later than one (1) Business Day after BLNE becomes aware of the same) notify the Company (and, if in writing, furnish copies of) if any of the following occurs: (i) any notice or other communication is received from any Person alleging that the Consent of such Person is or may be required in connection with any of the Contemplated Transactions; (ii) any Legal Proceeding against or involving or otherwise affecting BLNE or its Subsidiaries is commenced, or, to the Knowledge of BLNE, threatened against BLNE or its Subsidiaries or, to the Knowledge of BLNE, any director, officer or employee of BLNE or its Subsidiaries; (iii) BLNE becomes aware of any inaccuracy in any representation or warranty made by it in this Agreement; or (iv) the failure of BLNE to comply with any covenant or obligation of BLNE; in each case in clauses (iii) or (iv) that could reasonably be expected to make the timely satisfaction of any of the conditions set forth in Sections 6 and 8, as applicable, impossible or materially less likely. No notification given to the Company pursuant to this Section 4.6 shall change, limit or otherwise affect any of the representations, warranties, covenants or obligations of BLNE or any of its Subsidiaries contained in this Agreement or the BLNE Disclosure Schedule for purposes of Sections 6 and 8, as applicable.

 

-41-
 

 

4.7 Continued Employment of Company Employees. During the period commencing as of the Closing on the Closing Date and ending on the date which is twelve (12) months from the Closing (or if earlier, the date of the employee’s termination of employment with the Company), BLNE shall and shall cause the Surviving Corporation to provide each employee who was employed by the Company as of the Closing with employment on terms and conditions that are in aggregate no less favorable than the terms and conditions applicable immediately prior to the Closing, including with respect to position, job location, seniority and remuneration (or such greater terms and conditions of employment as may be required by Law). This Section 4.7 shall be binding upon and inure solely to the benefit of each of the Parties to this Agreement, and nothing in this Section 4.7, express or implied, shall confer upon any other Person any rights or remedies of any nature whatsoever under or by reason of this Section 4.7. Nothing contained herein, express or implied, shall be construed to establish, amend, or modify any benefit plan, program, agreement, or arrangement. The Parties hereto acknowledge and agree that the terms set forth in this Section 4.7 shall not create any right in any employee or any other Person to any continued employment with the Surviving Corporation, BLNE or any of their respective Affiliates or compensation or benefits of any nature or kind whatsoever.

 

Section 5 ADDITIONAL AGREEMENTS OF THE PARTIES

 

5.1 Proxy Statement.

 

(a) As promptly as practicable after the date of this Agreement and receipt of the applicable Company Interim Financial Statements, the Parties shall prepare and, subject to the approval of the Special Committee, BLNE shall cause to be filed with the SEC, the Proxy Statement. The Company represents, covenants and agrees that the information provided by the Company to BLNE for inclusion in the Proxy Statement (including the Company Financials) will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. Subject to the other provisions of this Section 5.1(a), BLNE represents, covenants and agrees that the Proxy Statement, including any pro forma financial statements included therein (and the letter to stockholders, notice of meeting and form of proxy included therewith) will (i) comply as to form in all material respects with the requirements of applicable U.S. federal securities laws and Nevada Law and (ii) not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. BLNE shall use commercially reasonable efforts to take all actions required under any applicable federal, state, securities and other Laws in connection with the issuance of the shares of BLNE Common Stock to be delivered as Merger Consideration or otherwise to former holders of Company Capital Stock pursuant to this Agreement (the “Stock Issuance”). Notwithstanding the foregoing, BLNE makes no covenant, representation or warranty with respect to statements made in the Proxy Statement (and the letter to stockholders, notice of meeting and form of proxy included therewith), if any, based on information provided by the Company or any of its Representatives specifically for inclusion therein. The Company and its legal counsel shall be given reasonable opportunity to review and comment on the Proxy Statement, including all amendments and supplements thereto, prior to the filing thereof with the SEC and on the response to any comments of the SEC on the Proxy Statement, prior to the filing thereof with the SEC.

 

-42-
 

 

(b) The Parties shall use their respective commercially reasonable efforts to cause the Proxy Statement to comply with the applicable rules and regulations promulgated by the SEC and to respond promptly to any comments of the SEC or its staff. BLNE shall use commercially reasonable efforts to cause the Proxy Statement to be mailed to BLNE’s stockholders as promptly as practicable after the Parties respond to all comments of the SEC or its staff. Each Party shall promptly furnish to the other Party all information concerning such Party and such Party’s Affiliates and such Party’s stockholders that may be required or reasonably requested in connection with any action contemplated by this Section 5.1. If (i) BLNE, Merger Sub or the Company (A) becomes aware of any event or information that, pursuant to the Exchange Act, should be disclosed in an amendment or supplement to the Proxy Statement, (B) receives notice of any SEC request for a supplement to the Proxy Statement or for additional information related thereto, (C) receives SEC comments on the Proxy Statement, or (ii) the information provided in the Proxy Statement has become “stale” and new information should be or is required to be disclosed in a supplement to the Proxy Statement, as the case may be, then such Party, as the case may be, shall promptly inform the other Parties thereof and shall cooperate with such other Parties in filing such supplement with the SEC and, if appropriate, in mailing such supplement to the BLNE stockholders. No filing of, or amendment or supplement to, the Proxy Statement will be made by BLNE, in each case, without the prior written consent of the Company, which shall not be unreasonably withheld, conditioned or delayed. BLNE shall promptly provide to the Company copies of all written correspondence between it or any of its Representatives, on the one hand, and the SEC or staff of the SEC, on the other hand, with respect to the Proxy Statement.

 

(c) The Parties shall reasonably cooperate with each other and provide, and require their respective Representatives to provide, the other Party and its Representatives, with all true, correct and complete information regarding such Party or its Subsidiaries that is required by Law to be included in the Proxy Statement or is reasonably requested by the other Party to be included in the Proxy Statement or in any filing to be made by BLNE with the SEC.

 

5.2 Company Stockholder Written Consent.

 

(a) Concurrently with the date of this Agreement, the Company shall obtain the approval by written consent from the requisite Company stockholders in lieu of a meeting pursuant to Section 228 of the DGCL, for purposes of (i) adopting this Agreement and approving the Contemplated Transactions, in accordance with the Company’s Certificate of Incorporation, and Sections 228 and 251 of the DGCL, (ii) acknowledging that the approval given thereby is irrevocable and that such stockholder is aware of its rights to demand appraisal for its shares pursuant to Section 262 of the DGCL, a copy of which will be attached thereto, and that such stockholder has received and read a copy of Section 262 of the DGCL, and (iii) acknowledging that by its adoption of this Agreement it is not entitled to appraisal rights with respect to its shares in connection with the Merger and thereby waives any rights to receive payment of the fair value of its capital stock under the DGCL (the “Company Stockholder Written Consent”).

 

-43-
 

 

(b) Reasonably promptly following receipt of the Company Stockholder Written Consent, the Company shall prepare and mail a notice (the “Stockholder Notice”) to every stockholder of the Company that did not execute the Company Stockholder Written Consent. The Stockholder Notice shall (i) notify Company stockholders that the Company Board (A) determined that the Contemplated Transactions are fair to, advisable and in the best interests of the Company and its stockholders, (B) approved and declared advisable this Agreement and the Contemplated Transactions and (C) determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of the Company vote to adopt this Agreement and thereby approve the Contemplated Transactions, (ii) provide the stockholders of the Company to whom it is sent with notice of the actions taken in the Company Stockholder Written Consent, including the adoption and approval of this Agreement and the Contemplated Transactions in accordance with Section 228(e) of the DGCL and the certificate of incorporation and bylaws of the Company and (iii) include a description of the appraisal rights of the Company’s stockholders available under Section 262 of the DGCL, along with such other information as is required thereunder and pursuant to applicable Law. All materials (including any amendments thereto) proposed to be submitted to the stockholders of the Company in accordance with this Section 5.2(b) shall be provided to BLNE reasonably in advance for BLNE’s review and reasonable approval. The Stockholder Notice shall include therewith a copy of Section 262 of the DGCL and shall be sufficient in form and substance to start the 20-day period during which a stockholder seeking to assert appraisal rights must demand appraisal of such stockholder’s capital stock of the Company as contemplated by Section 262(d)(2) of the DGCL.

 

5.3 BLNE Stockholders’ Meeting.

 

(a) No later than sixty (60) days after the mailing of the definitive Proxy Statement, BLNE (at the sole direction of the Special Committee) shall take all action necessary under applicable Law to call, give notice of and hold a meeting of the holders of BLNE Common Stock to consider and vote to approve (i) the Contemplated Transactions and (ii) any other proposals the Parties deem necessary or desirable to consummate the Contemplated Transactions (clauses (i) and (ii), collectively, the “Required BLNE Stockholder Matters” and such meeting, the “BLNE Stockholders’ Meeting”).

 

(b) BLNE (at the sole direction of the Special Committee) shall take reasonable measures to ensure that all proxies solicited in connection with the BLNE Stockholders’ Meeting are solicited in compliance with all applicable Law. Notwithstanding anything to the contrary contained herein, if on the date of the BLNE Stockholders’ Meeting, or a date preceding the date on which the BLNE Stockholders’ Meeting is scheduled, BLNE reasonably believes that (i) it will not receive proxies sufficient to obtain the Required BLNE Stockholder Vote, whether or not a quorum would be present or (ii) it will not have sufficient shares of BLNE Common Stock represented (whether in person or by proxy) to constitute a quorum necessary to conduct the business of the BLNE Stockholders’ Meeting, BLNE shall postpone or adjourn, or make one or more successive postponements or adjournments of, the BLNE Stockholders’ Meeting as long as the date of the BLNE Stockholders’ Meeting is not, without the prior written consent of the Company (which consent shall not be unreasonably withheld, delayed or conditioned), postponed or adjourned more than an aggregate of 30 calendar days in connection with any postponements or adjournments.

 

-44-
 

 

(c) Subject to the requirements of this Section 5.3(c), each of the Special Committee and the BLNE Board shall not, directly or indirectly, (i) approve, adopt or recommend any Adverse Recommendation or (ii) approve, adopt or recommend, or propose to approve, adopt or recommend, any Acquisition Proposal.

 

(d) Notwithstanding anything to the contrary contained in Section 5.3(c), and subject to compliance with Section 4.4 and Section 5.3, if at any time prior to the approval of Required BLNE Stockholder Matters at the BLNE Stockholders’ Meeting by the applicable Required BLNE Stockholder Vote, BLNE or the Special Committee receives an unsolicited bona fide written Acquisition Proposal that the Special Committee determines, following consultation with its outside legal counsel and financial advisor, constitutes a Superior Offer, the Special Committee may make an Adverse Recommendation if, but only if, following the receipt of and on account of such Superior Offer, (i) the Special Committee determines in good faith, based on the advice of its outside legal counsel, that the failure to make an Adverse Recommendation would be reasonably likely to be inconsistent with its fiduciary duties under applicable Law, (ii) the Special Committee has negotiated, and has caused its financial advisors and outside legal counsel to, during the BLNE Notice Period, negotiate with the Company in good faith (if the Company so desires) to make such adjustments to the terms and conditions of this Agreement so that such Acquisition Proposal ceases to constitute a Superior Offer, and (iii) if after the Company shall have delivered to BLNE or the Special Committee a written offer to, and the Parties have negotiated in order to, alter the terms or conditions of this Agreement during the BLNE Notice Period, the Special Committee shall have determined in good faith, based on the advice of its outside legal counsel, that such Acquisition Proposal continues to constitute a Superior Offer and that the failure to effect an Adverse Recommendation would reasonably be expected to be inconsistent with its fiduciary duties under applicable Law (after taking into account the terms and conditions of such written offer to alter this Agreement, as so negotiated); provided that (x) the Company receives written notice from the Special Committee confirming that the Special Committee has determined to effect such an Adverse Recommendation at least five Business Days in advance thereof (the “BLNE Notice Period”), which notice shall include a description in reasonable detail of the reasons for such an Adverse Recommendation and written copies of any relevant proposed transaction agreements with any party making a potential Superior Offer. In the event of any material amendment to any such Acquisition Proposal, the Special Committee shall be required to provide the Company with notice of such material amendment and the BLNE Notice Period shall be extended, if applicable, to ensure that at least three Business Days remain in the BLNE Notice Period following such notification, during which the Parties shall comply again with the requirements of this Section 5.3(d) and the Special Committee shall not make an Adverse Recommendation prior to the end of such BLNE Notice Period as so extended (it being understood that there may be multiple such extensions).

 

(e) Nothing contained in this Agreement shall prohibit the Special Committee or BLNE (at the sole direction of the Special Committee) from (i) complying with Rules 14d-9 and 14e-2(a) promulgated under the Exchange Act, (ii) issuing a “stop, look and listen” communication or similar communication of the type contemplated by Section 14d-9(f) under the Exchange Act or (iii) otherwise making any disclosure to the BLNE stockholders; provided, however, that in the case of the foregoing clause (iii) BLNE (at the sole direction of the Special Committee) determines in good faith, after consultation with its outside legal counsel, that failure to make such disclosure would be reasonably likely to be inconsistent with applicable Law, including its fiduciary duties under applicable Law.

 

-45-
 

 

5.4 Regulatory Approvals. Each Party shall use reasonable best efforts to file or otherwise submit, as soon as practicable after the date of this Agreement (if required based on information as of the date of this Agreement or, if not so required, then within ten Business Days after such time at which the same shall become applicable to the Contemplated Transactions), all applications, notices, reports and other documents reasonably required to be filed by such Party with or otherwise submitted by such Party to any Governmental Body with respect to the Contemplated Transactions, and to submit promptly any additional information requested by any such Governmental Body. Each Party shall (a) promptly supply the other with any information which may be required in order to effectuate such filings, (b) submit promptly any additional information which may be reasonably requested by any such Governmental Body, and (c) coordinate with the other Party in making any such filings or information submissions pursuant to and in connection with the foregoing that may be necessary, proper, or advisable in order to consummate and make effective the Contemplated Transactions.

 

5.5 Indemnification of Officers and Directors.

 

(a) From the Effective Time through the sixth anniversary of the date on which the Effective Time occurs, each of BLNE and the Surviving Corporation shall indemnify and hold harmless each person who is now, or has been at any time prior to the date hereof, or who becomes prior to the Effective Time, a director, manager, officer, fiduciary or agent of BLNE or the Company and their respective Subsidiaries, respectively (the “D&O Indemnified Parties”), against all claims, losses, liabilities, damages, judgments, fines and reasonable fees, costs and expenses, including attorneys’ fees and disbursements, incurred in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, arising out of or pertaining to the fact that the D&O Indemnified Party is or was a director, manager, officer, fiduciary or agent of BLNE or of the Company or their respective Subsidiaries, whether asserted or claimed prior to, at or after the Effective Time, in each case, to the fullest extent permitted under applicable Law. Each D&O Indemnified Party will be entitled to advancement of expenses incurred in the defense of any such claim, action, suit, proceeding or investigation from each of BLNE and the Surviving Corporation, jointly and severally, upon receipt by BLNE or the Surviving Corporation from the D&O Indemnified Party of a request therefor; provided that any such person to whom expenses are advanced provides an undertaking to BLNE, to the extent then required under applicable Law, to repay such advances if it is ultimately determined that such person is not entitled to indemnification.

 

(b) From and after the Effective Time, (i) the Surviving Corporation shall fulfill and honor in all respects the obligations of the Company to its D&O Indemnified Parties as of immediately prior to the Closing pursuant to any indemnification provisions under the Company’s Organizational Documents and pursuant to any indemnification agreements between the Company and such D&O Indemnified Parties, with respect to claims arising out of matters occurring at or prior to the Effective Time and (ii) BLNE shall fulfill and honor in all respects the obligations of BLNE to its D&O Indemnified Parties as of immediately prior to the Closing pursuant to any indemnification provisions under BLNE’s Organizational Documents and pursuant to any indemnification agreements between BLNE and such D&O Indemnified Parties, with respect to claims arising out of matters occurring at or prior to the Effective Time.

 

-46-
 

 

(c) From and after the Effective Time, BLNE shall maintain directors’ and officers’ liability insurance policies, with an effective date as of the Closing Date, on commercially available terms and conditions and with coverage limits customary for U.S. public companies similarly situated to BLNE. In addition, the Company shall purchase, prior to the Effective Time, a six (6) year prepaid “D&O tail policy” for the non-cancelable extension of the directors’ and officers’ liability coverage of the Company’s existing directors’ and officers’ insurance policies for a claims reporting or discovery period of at least six (6) years from and after the Effective Time with respect to any claim related to any period of time at or prior to the Effective Time with terms, conditions, retentions and limits of liability that are no less favorable than the coverage provided under the Company’s existing policies as of the date of this Agreement, except that the Company will not commit or spend on such “D&O tail policy” annual premiums in excess of 300% of the annual premiums paid by the Company in its last full fiscal year prior to the date hereof for the Company’s current policies of directors’ and officers’ liability insurance and fiduciary liability insurance, and if such premiums for such “D&O tail policy” would exceed 300% of such annual premium, then the Company shall purchase policies that provide the maximum coverage available at an annual premium equal to 300% of such annual premium. BLNE shall in good faith cooperate with the Company prior to the Effective Time with respect to the procurement of such “D&O tail policy.”

 

(d) The provisions of this Section 5.5 are intended to be in addition to the rights otherwise available to the current and former officers and directors of BLNE and the Company by Law, charter, statute, bylaw or agreement, and shall operate for the benefit of, and shall be enforceable by, each of the D&O Indemnified Parties, their heirs and their representatives.

 

5.6 Additional Agreements. The Parties shall (a) use commercially reasonable efforts to cause to be taken all actions necessary to consummate the Contemplated Transactions and (b) reasonably cooperate with the other Parties and provide the other Parties with such assistance as may be reasonably requested for the purpose of facilitating the performance by each Party of its respective obligations under this Agreement and to enable the Surviving Corporation to continue to meet its obligations under this Agreement following the Closing. Without limiting the generality of the foregoing, each Party: (i) shall make all filings and other submissions (if any) and give all notices (if any) required to be made and given by such Party in connection with the Contemplated Transactions; (ii) shall use reasonable best efforts to obtain each Consent (if any) reasonably required to be obtained (pursuant to any applicable Law or Contract, or otherwise) by such Party in connection with the Contemplated Transactions or for such Contract to remain in full force and effect; (iii) shall use commercially reasonable efforts to lift any injunction prohibiting, or any other legal restraint to, the Contemplated Transactions; and (iv) shall use commercially reasonable efforts to satisfy the conditions set forth in Sections 6, 7 and 8.

 

-47-
 

 

5.7 Disclosure. The initial press release relating to this Agreement shall be a joint press release issued by BLNE and the Company and thereafter, without limiting any Party’s obligations under the Confidentiality Agreement, no Party shall, and no Party shall permit any of its Subsidiaries or Representatives to, issue any press release or make any disclosure (to any customers or employees of such Party, to the public or otherwise) regarding the Contemplated Transactions unless: (a) the other Party shall have approved such press release or disclosure in writing, such approval not to be unreasonably conditioned, withheld or delayed; or (b) such disclosure is requested by a Governmental Body or such Party shall have determined in good faith that such disclosure is required by applicable Law or by obligations pursuant to any listing agreement with or rules of any national securities exchange or interdealer quotation service and, to the extent practicable, before such press release or disclosure is issued or made, such Party shall have used commercially reasonable efforts to advise the other Party of, and consult with the other Party regarding, the text of such press release or disclosure; provided, however, that BLNE may make any public statement in response to specific questions by the press, analysts, investors or those attending industry conferences or financial analyst conference calls, so long as any such statements are consistent with previous press releases, public disclosures or public statements made by BLNE or the Company in compliance with this Section 5.7.

 

5.8 Listing. BLNE shall use its commercially reasonable efforts to, and the Company shall use its commercially reasonable efforts to cooperate with BLNE in order to, (a) maintain its existing listing of the BLNE Common Stock on Nasdaq until the Effective Time and obtain approval of the listing of BLNE as the post-Closing combined corporation on Nasdaq; and (b) prepare and submit to Nasdaq a Listing of Additional Shares for the shares of BLNE Common Stock to be issued in the Stock Issuance. Each Party will reasonably promptly inform the other Party of all verbal or written communications between Nasdaq and such Party or its representatives. The Parties will use commercially reasonable efforts to coordinate with respect to compliance with Nasdaq rules and regulations. The Company will cooperate with BLNE as reasonably requested by BLNE with respect to the Nasdaq Listing Application and promptly furnish to BLNE all information concerning the Company and its stockholders that may be required or reasonably requested in connection with any action contemplated by this Section 5.8.

 

5.9 BLNE SEC Documents. From the date of this Agreement to the Effective Time, BLNE shall timely file with the SEC all registration statements, proxy statements, certifications, reports, schedules, exhibits, forms and other documents required to be filed by BLNE with the SEC under the Exchange Act or the Securities Act (“SEC Documents”). As of its filing date, or if amended after the date of this Agreement, as of the date of the last such amendment, each SEC Document filed by BLNE with the SEC (a) shall comply in all material respects with the applicable requirements of the Exchange Act and the Securities Act, and (b) shall not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading.

 

-48-
 

 

5.10 Tax Matters.

 

(a) Prior to and following the Closing, the Parties shall use their respective reasonable best efforts to cause the Merger to qualify, and will not take (or fail to take) any action or cause any action to be taken (or to fail to be taken) which action could reasonably be expected to prevent or impede the Merger from qualifying, for the Intended Tax Treatment. The Parties shall not file (or cause their Affiliates, including the Company, to file) any U.S. federal, state or local Tax Return after the Closing Date in a manner that is inconsistent with the treatment of the Merger as a transaction qualifying for the Intended Tax Treatment for U.S. federal, state income and other relevant Tax purposes, and shall not take any inconsistent position during the course of any audit, litigation or other proceeding with respect to Taxes, in each case, unless otherwise required by a determination within the meaning of Section 1313(a) of the Code or a corresponding event with respect to state or local income Tax law. Notwithstanding the foregoing or anything to the contrary in this Agreement, the Parties acknowledge and agree that (i) no Party is making any representation or warranty as to the qualification of the Merger for the Intended Tax Treatment or as to the effect, if any, that any transaction consummated on, after or prior to the Effective Time has or may have on the qualification of the Merger for the Intended Tax Treatment, and (ii) neither BLNE nor any Affiliate of BLNE (including the Company and any of its Subsidiaries after the Closing) shall have any liability or obligation to the Holders’ Representative or any Pre-Closing Company Holder (or any direct or indirect holder of any share of BLNE Common Stock) in the event the Merger fails to qualify for the Intended Tax Treatment. In addition, each of the Parties acknowledges that no tax opinion regarding the Intended Tax Treatment has been or will be sought in connection with the Merger.

 

(b) Following the Merger, BLNE (either directly or through one or more members of its qualified group, as defined in Section 1.368-1(d)(4)(ii) of the Treasury Regulations) shall continue at least one significant historic business line of the Company or use at least a significant portion of the Company’s historic business assets in a business, in each case within the meaning of Treasury Regulations Section 1.368-1(d).

 

(c) All transfer, documentary, sales, use, stamp, registration, excise, recording, value added and other such similar Taxes and fees (including any penalties and interest, but excluding any Taxes on income or gains) that become payable in connection with or by reason of the execution of this Agreement and the Contemplated Transactions (“Transfer Taxes”) shall be borne fifty percent (50%) by BLNE and fifty percent (50%) by the Pre-Closing Company Holders, severally and not jointly, in accordance with their Pro Rata Shares. The party primarily responsible under applicable Law shall timely prepare and file any Tax Return or other document with respect to such Taxes or fees (and the other Parties shall reasonably cooperate with respect thereto as necessary).

 

(d) On or prior to the Closing Date, the Company shall provide BLNE with (i) a certificate, dated as of the Closing Date, on behalf of the Company, prepared in a manner consistent and in accordance with the requirements of Treasury Regulations Sections 1.897-2(g) and 1.1445-2(c)(3), certifying that the Company is not, nor has it been, a “United States real property holding corporation” (as defined in Section 897(c)(2) of the Code) during the applicable period specified in Section 897(c) of the Code and that no interest in the Company is, or has been during the relevant period specified in Section 897(c)(1)(A)(ii) of the Code, a “United States real property interest” within the meaning of Section 897(c) of the Code, (ii) a notice to the IRS prepared in accordance with the provisions of Treasury Regulations Section 1.897-2(h)(2) (in each case in the foregoing clauses (i) and (ii), in forms that are reasonably satisfactory to the Special Committee), and (iii) proof of mailing of such certificate and notice to the IRS (all of the foregoing, together, the “FIRPTA Certificate”). Notwithstanding anything to the contrary herein, including Section 5.10(a), BLNE shall be authorized to withhold any Taxes in respect of the payment of the Merger Consideration that it is required to withhold if the Company fails to provide to BLNE a valid, true and correct (i) FIRPTA Certificate and (ii) IRS Form W-9, in each case, prior to the Closing, and any amount withheld pursuant to this Section 5.10(d) shall be treated as part of the Merger Consideration and shall reduce the Merger Consideration to be paid pursuant to this Agreement.

 

-49-
 

 

(e) Tax Returns. BLNE shall prepare or cause to be prepared and timely file or cause to be timely filed all Tax Returns of the Company and its Subsidiary that are due after the Closing Date for any Pre-Closing Tax Period and any Straddle Tax Period. Any such Tax Return that relates to a Pre-Closing Tax Period or a Straddle Tax Period and that could give rise to an indemnification obligation of the Pre-Closing Company Holders pursuant to Section 10.2(d) shall be prepared in accordance with the prior positions and practices of the Company, unless otherwise required by applicable Law, and shall be provided to the Holders’ Representative for review and comment no later than thirty (30) days before the due date thereof (or, in the case of non-income Tax Returns, as soon as reasonably practicable prior to the due date of such Tax Return) (giving effect to applicable extensions), and BLNE shall consider in good faith all reasonable comments of the Holders’ Representative. The Holders’ Representative (on behalf of the Pre-Closing Company Holders) will pay (i) all Taxes shown as due on such Tax Returns (and with respect to any such Tax Return for a Straddle Tax Period, as allocated in a manner consistent with Section 5.10(f)) and (ii) BLNE’s costs and expenses of preparing any such Tax Return (subject to Section 5.10(f)), in each case, no later than five (5) days prior to the due date thereof.

 

(f) Straddle Tax Period. In the case of Taxes related to a Straddle Tax Period, the portion of such Taxes which are deemed ‎allocable to the portion of such taxable period ending on the Closing Date shall (x) in the case of any real, personal, or intangible property Tax, be deemed to be ‎the amount of such Tax for the entire taxable period multiplied by a fraction the numerator of ‎which is the number of days in the taxable period ending on the Closing Date and the ‎denominator of which is the number of days in the entire taxable period, and (y) in the case of any other Tax (including income Taxes, and all ‎sales, use, value added, and other similar Taxes, and all employment, payroll, ‎withholding, and other similar Taxes), be deemed equal to the amount of such Tax that ‎would be payable if the relevant taxable period ended on the Closing Date, provided, that, any ‎exemptions, allowances, or deductions that are calculated on an annual basis ‎(or on a monthly basis, where required)‎ shall be ‎apportioned on a daily basis. The costs and expenses of preparing any Tax Return for a Straddle Tax Period shall be allocated in the same proportion as the Taxes payable with respect to such Tax Return.

 

(g) Contests. BLNE shall control the defense of any audit, examination, claim, assessment, or similar event or action with respect to Taxes of the Company or its Subsidiary (“Action”); provided that, with respect to any such Action relating to a Pre-Closing Tax Period that could give rise to an indemnification obligation of the Pre-Closing Company Holders, (i) BLNE shall keep the Holders’ Representative reasonably informed, (ii) the Holders’ Representative shall be entitled, at the expense of the Pre-Closing Company Holders, to participate in such Action, and (iii) BLNE shall not settle or compromise such Action without the prior written consent of the Holders’ Representative (not to be unreasonably withheld or delayed).

 

(h) Cooperation. The Holders’ Representative, BLNE, and the Surviving Corporation shall cooperate fully, as and to the extent reasonably requested, in connection with the filing of Tax Returns and any audit, litigation or other Action with respect to Taxes, including the retention and provision of records and information and making personnel available on a mutually convenient basis. The Parties shall retain all books and records with respect to Tax matters pertinent to the Company and its Subsidiary relating to any Pre-Closing Tax Period until the expiration of the applicable statute of limitations.

 

-50-
 

 

(i) Tax Year. The Parties intend that the Surviving Corporation will be included in BLNE’s consolidated U.S. federal income Tax group upon the consummation of the Merger and, as a result, the Tax year of the Company will end for U.S. federal income tax purposes on (and including) the Closing Date, and the Parties agree to prepare and file all Tax Returns in a manner consistent with such intention.

 

5.11 Directors and Officers.

 

(a) Until successors are duly elected or appointed and qualified in accordance with applicable Law, the Parties shall use reasonable best efforts and take all necessary action so that immediately after the Effective Time, (i) the BLNE Board shall be comprised of no more than seven (7) members, (ii) if the BLNE Board is comprised of five (5) members, then the majority of the Pre-Closing Company Holders shall be entitled to designate one member of the BLNE Board, (iii) if the BLNE Board is comprised of six (6) or seven (7) members, then the majority of the Pre-Closing Company Holders shall be entitled to designate two (2) members of the BLNE Board; provided, that the foregoing provisions shall terminate immediately if at any time the Pre-Closing Company Holders in the aggregate own less than ten percent (10%) of the outstanding shares of BLNE Common Stock; provided, further, that BLNE shall not increase the size of the BLNE Board to more than seven (7) members without the prior written consent of the Pre-Closing Company Holders for so long as the Pre-Closing Company Holders in the aggregate own at least ten percent (10%) of the outstanding shares of BLNE Common Stock; provided, further that any member of the BLNE Board to be designated by the Pre-Closing Company Holders shall be designated prior to the mailing of the Proxy Statement to the holders of the BLNE Common Stock and any Persons so designated to the BLNE Board shall be required to meet (x) BLNE’s independence criteria, (y) Nasdaq’s independence criteria, and (z) any other criteria pursuant to applicable Law, the rules or regulations of Nasdaq, or any policy of BLNE that is generally applicable to nominees or members of the BLNE Board that is in effect as of the applicable time.

 

(b) Until successors are duly elected or appointed and qualified in accordance with applicable Law, the Parties shall use reasonable best efforts and take all necessary action so that immediately after the Effective Time, the Persons listed on Section 5.11(b) of the Company Disclosure Schedule are elected or appointed, as applicable, to the positions of officers of BLNE and of directors or officers of the Surviving Corporation, as respectively set forth therein, to serve in such positions indicated on Section 5.11(b) of the Company Disclosure Schedule, effective as of the Effective Time.

 

(c) If any such Person referred to in this Section 5.11 is unable or unwilling to serve as director or officer of BLNE or a director or officer of the Surviving Corporation, as the case may be, the Company may, with the prior written consent of the Special Committee, replace such individual with another individual to serve as such director or officer.

 

-51-
 

 

5.12 Section 16 Matters. Prior to the Effective Time, BLNE and the Company shall take all such steps as may be required (to the extent permitted under applicable Laws) to cause any acquisitions of BLNE Common Stock and any options to purchase BLNE Common Stock in connection with the Contemplated Transactions, by each individual who is reasonably expected to become subject to the reporting requirements of Section 16(a) of the Exchange Act with respect to BLNE, to be exempt under Rule 16b-3 promulgated under the Exchange Act. At least thirty (30) days prior to the Anticipated Closing Date, the Company shall furnish the following information to BLNE for each individual who, immediately after the Effective Time, will become subject to the reporting requirements of Section 16(a) of the Exchange Act with respect to BLNE, (a) the number of shares of capital stock of the Company owned by such individual and expected to be exchanged for shares of BLNE Common Stock pursuant to the Merger and (b) the number of other derivative securities (if any) with respect to capital stock of the Company owned by such individual and expected to be converted into shares of BLNE Common Stock or derivative securities with respect to BLNE Common Stock in connection with the Merger.

 

5.13 Allocation Certificate.

 

(a) The Company will prepare and deliver to BLNE no later than two (2) Business Days prior to the Anticipated Closing Date, a certificate signed by the Chief Executive Officer or Chief Financial Officer of the Company in a form reasonably acceptable to BLNE setting forth (as of immediately prior to the Effective Time): (i) each holder of Company Capital Stock and Company Options; (ii) such holder’s name and address; (iii) the number and type of Company Capital Stock held or underlying the Company Options as of immediately prior to the Effective Time for such holder; (iv) the number of shares of BLNE Common Stock to be issued to such holder pursuant to this Agreement, or to underlie any Company Option of such holder that will be assumed by BLNE, pursuant to this Agreement in respect of the Company Capital Stock or Company Options held by such holder as of immediately prior to the Effective Time; and (v) each such holder’s Pro Rata Share (the “Allocation Certificate”); provided, however, that such Allocation Certificate shall specify the number of shares of BLNE Common Stock to be forfeited by Mr. Liuzza pursuant to the terms of the Side Letter and the number of shares of BLNE Common Stock to be received by Mr. Liuzza after giving effect to the terms of the Side Letter.

 

(b) BLNE will prepare and deliver to the Company no later than five (5) Business Days prior to the Anticipated Closing Date, a certificate signed by the Chief Financial Officer of BLNE in a form reasonably acceptable to the Company, setting forth, as of immediately prior to the Effective Time, the number of BLNE Outstanding Shares and each component thereof (broken down by outstanding shares of BLNE Common Stock, BLNE Options, BLNE Warrants, BLNE RSUs and other relevant securities) (the “BLNE Outstanding Shares Certificate”).

 

5.14 Company Financials. As promptly as reasonably practicable following the date of this Agreement, the Company will furnish to BLNE the unaudited interim financial statements for each interim period completed prior to Closing that would be required to be included in any periodic report due prior to the Closing if the Company were subject to the periodic reporting requirements under the Securities Act or the Exchange Act, including any pro forma financial information that is required to be included in the Proxy Statement (the “Company Interim Financial Statements”). To the extent required to be included in the Proxy Statement, the Company will, as promptly as reasonably practicable, complete the audit of its financial statements for the period ending December 31, 2026, including any pro forma financial information that is required to be included in the Proxy Statement (the “Company 2026 Financial Statements”). The Company Interim Financial Statements and the Company 2026 Financial Statements will be suitable for inclusion in the Proxy Statement and prepared in accordance with GAAP as applied on a consistent basis during the periods involved (except in each case as described in the notes thereto) and on that basis will present fairly, in all material respects, the financial position and the results of operations, changes in members’ equity, and cash flows of the Company as of the dates of and for the periods referred to in the Company Interim Financial Statements and the Company 2026 Financial Statements, as applicable.

 

-52-
 

 

5.15 Takeover Statutes. If any Takeover Statute is or may become applicable to the Contemplated Transactions, each of the Company, the Company Board, BLNE, the BLNE Board, as applicable, shall grant such approvals and take such actions as are necessary so that the Contemplated Transactions may be consummated as promptly as practicable on the terms contemplated by this Agreement and otherwise act to eliminate or minimize the effects of such statute or regulation on the Contemplated Transactions.

 

5.16 Stockholder Litigation. BLNE shall conduct and control the settlement and defense of any stockholder litigation against BLNE or any of its directors in consultation with the Special Committee and its counsel; provided that prior to the Closing no such settlement shall be agreed to without the prior written consent of the Company, which consent shall not be unreasonably withheld, conditioned or delayed. Without limiting the foregoing, prior to the Closing, BLNE shall promptly notify the Special Committee and the Company of any litigation against BLNE or its directors relating to the Contemplated Transactions and BLNE shall give the Special Committee and the Company the opportunity to consult with BLNE in connection with the defense and settlement of any such stockholder litigation. BLNE shall keep each of the Special Committee and the Company reasonably apprised of any material developments in connection with any such stockholder litigation.

 

5.17 Company Stockholder Agreements. Prior to the Effective Time, the Company shall cause all Company Stockholder Agreements to be terminated in accordance with the terms thereof and as of immediately prior to the Effective Time, without any liability being imposed on the part of BLNE or the Surviving Corporation with respect thereto.

 

5.18 Preferred Stock Conversion. Prior to the Effective Time, the Company shall take all action necessary in order to cause the Preferred Stock Conversion to occur, effective immediately prior to the Effective Time, including delivering (a) written consents of each holder of Company Preferred Stock agreeing to convert such shares of Company Preferred Stock, (b) copies of the stock certificates (if any) representing such shares of Company Preferred Stock marked as cancelled, (c) copies of the stock certificates (if any) representing the shares of Company Common Stock issued upon conversion of the Company Preferred Stock, (d) any updated stock ledger of the Company setting forth the capitalization of the Company after giving effect to the Preferred Stock Conversion, (e) a receipt acknowledged and agreed to by each of the Company and each holder of Company Preferred Stock setting forth the number of shares of Company Preferred Stock issued to each such holder of Company Preferred Stock, and (f) such other documents, agreements, instruments or certificates that may be reasonably requested by the Special Committee and in a form that is reasonably satisfactory to the Special Committee.

 

-53-
 

 

5.19 Qualifying Financing. After the date hereof and prior to the Effective Time, the Company shall use commercially reasonable efforts to secure one or more financing arrangements providing for aggregate proceeds or committed capital of not less than $15,000,000, including, but not limited to, (a) one or more forward purchase commitments, forward flow agreements or warehouse financing arrangements, or (b) one or more other off-balance sheet arrangements (“Qualifying Financing”); provided, however, that any portion of such financing may not be any of the following: (x) indebtedness for borrowed money, (y) debt securities that are not convertible or exchangeable into equity, or (z) any similar arrangement that would result in an Encumbrance on the assets of the Company that is not released on or prior to the Effective Time.

 

Section 6 CONDITIONS PRECEDENT TO OBLIGATIONS OF EACH PARTY

 

The obligations of each Party to effect the Merger and otherwise consummate the Contemplated Transactions to be consummated at the Closing are subject to the satisfaction or, to the extent permitted by applicable Law, the written waiver by each of the Parties, at or prior to the Closing, of each of the following conditions:

 

6.1 No Restraints. No temporary restraining order, preliminary or permanent injunction or other order preventing the consummation of the Contemplated Transactions shall have been issued by any court of competent jurisdiction or other Governmental Body of competent jurisdiction and remain in effect and there shall not be any Law which has the effect of making the consummation of the Contemplated Transactions illegal.

 

6.2 Stockholder Approval. (a) BLNE shall have obtained the Required BLNE Stockholder Vote and (b) the Company shall have obtained the Required Company Stockholder Vote.

 

6.3 Listing. The shares of BLNE Common Stock to be issued in the Stock Issuance at the Effective Time will have been submitted to the Listing Qualifications Department of Nasdaq and listed on Nasdaq upon submission to Nasdaq of the Listing of Additional Shares for the shares of BLNE Common Stock to be issued in the Stock Issuance.

 

6.4 Lock-Up Agreements. Each of the individuals listed on Section A-2 of the Company Disclosure Schedule or Section A-2 of the BLNE Disclosure Schedule shall have executed and delivered a Lock-Up Agreement, and each such Lock-Up Agreement shall be in full force and effect in accordance with the terms thereof as of the Closing.

 

-54-
 

 

Section 7 ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATIONS OF BLNE AND MERGER SUB

 

The obligations of BLNE and Merger Sub to effect the Merger and otherwise consummate the Contemplated Transactions to be consummated at the Closing are subject to the satisfaction or the written waiver by BLNE, at or prior to the Closing, of each of the following conditions:

 

7.1 Accuracy of Representations. The Company Fundamental Representations shall have been true and correct in all respects as of the date of this Agreement and shall be true and correct in all respects on and as of the Closing Date with the same force and effect as if made on and as of such date (except to the extent such representations and warranties are specifically made as of a particular date, in which case such representations and warranties shall be true and correct in all material respects as of such date). The Company Capitalization Representations shall have been true and correct in all respects as of the date of this Agreement and shall be true and correct on and as of the Closing Date with the same force and effect as if made on and as of such date, except, in each case, (a) for such inaccuracies which are de minimis, individually or in the aggregate and (b) for those representations and warranties which address matters only as of a particular date (which representations and warranties shall have been true and correct, subject to the qualifications as set forth in the preceding clause (a), as of such particular date). The representations and warranties of the Company contained in this Agreement (other than the Company Fundamental Representations and Company Capitalization Representations) shall have been true and correct as of the date of this Agreement and shall be true and correct on and as of the Closing Date with the same force and effect as if made on the Closing Date except (i) in each case, or in the aggregate, where the failure to be true and correct would not reasonably be expected to have a Company Material Adverse Effect (without giving effect to any references therein to any Company Material Adverse Effect or other materiality qualifications), or (ii) for those representations and warranties which address matters only as of a particular date (which representations shall have been true and correct, subject to the qualifications as set forth in the preceding clause (i), as of such particular date) (it being understood that, for purposes of determining the accuracy of such representations and warranties, any update of or modification to the Company Disclosure Schedule made or purported to have been made after the date of this Agreement shall be disregarded).

 

7.2 Performance of Covenants. The Company shall have performed or complied with in all material respects all agreements and covenants required to be performed or complied with by it under this Agreement at or prior to the Effective Time.

 

7.3 Documents. BLNE shall have received the following documents, each of which shall be in full force and effect:

 

(a) a certificate executed by the Chief Executive Officer or Chief Financial Officer of the Company certifying that (i) the conditions set forth in Sections 7.1, 7.2, and 7.5 have been duly satisfied and (ii) the information set forth in the Allocation Certificate, as adjusted pursuant to the terms of the Side Letter, delivered by the Company in accordance with Section 5.13 is true and accurate in all respects as of the Closing Date;

 

(b) documentation, in a form reasonably satisfactory to BLNE, that the Preferred Stock Conversion has been effected immediately prior to the Closing;

 

(c) documentation, in a form reasonably satisfactory to BLNE, of one or more Qualifying Financings where the Company shall have received aggregate cash proceeds or committed capital from such financings of not less than $15,000,000, which proceeds or capital are available to the Company;

 

(d) a written instrument (or instruments, as the case may be) evidencing termination of each of the Company Stockholder Agreements, in accordance with Section 5.17;

 

-55-
 

 

(e) a legal opinion from the Company’s external legal counsel, in a form reasonably satisfactory to BLNE, opining as to the treatment of the Company’s tokens under applicable Law, including the Securities Act and Exchange Act;

 

(f) a Letter of Transmittal, duly executed by each Pre-Closing Company Holder;

 

(g) the Employment Agreement executed by Mr. Brendan Reilly;

 

(h) the Advisory Agreement executed by Mr. Andrew Reilly; and

 

(i) a written resignation, in a form reasonably satisfactory to BLNE, and effective as of the Closing, executed by each of the officers and directors of the Company who are not to continue as officers or directors of the Surviving Corporation after the Closing pursuant to Section 5.11.

 

7.4 Tax Certificate. BLNE shall have received a FIRPTA Certificate from the Company in accordance with Section 5.10(d).

 

7.5 No Company Material Adverse Effect. Since the date of this Agreement, there shall not have occurred any Company Material Adverse Effect that is continuing.

 

7.6 Company Stockholder Written Consent. The Company Stockholder Written Consent executed by the stockholders of the Company shall be in full force and effect.

 

Section 8 ADDITIONAL CONDITIONS PRECEDENT TO OBLIGATION OF THE COMPANY

 

The obligations of the Company to effect the Merger and otherwise consummate the transactions to be consummated at the Closing are subject to the satisfaction or the written waiver by the Company, at or prior to the Closing, of each of the following conditions:

 

8.1 Accuracy of Representations. The BLNE Fundamental Representations shall have been true and correct in all respects as of the date of this Agreement and shall be true and correct in all respects on and as of the Closing Date with the same force and effect as if made on and as of such date (except to the extent such representations and warranties are specifically made as of a particular date, in which case such representations and warranties shall be true and correct in all material respects as of such date). The BLNE Capitalization Representations shall have been true and correct in all respects as of the date of this Agreement and shall be true and correct on and as of the Closing Date with the same force and effect as if made on and as of such date, except, in each case, (a) for such inaccuracies which are de minimis, individually or in the aggregate and (b) for those representations and warranties which address matters only as of a particular date (which representations and warranties shall have been true and correct, subject to the qualifications as set forth in the preceding clause (a), as of such particular date). The representations and warranties of BLNE and Merger Sub contained in this Agreement (other than the BLNE Fundamental Representations and BLNE Capitalization Representations) shall have been true and correct as of the date of this Agreement and shall be true and correct on and as of the Closing Date with the same force and effect as if made on the Closing Date except (i) in each case, or in the aggregate, where the failure to be true and correct would not reasonably be expected to have a BLNE Material Adverse Effect (without giving effect to any references therein to any BLNE Material Adverse Effect or other materiality qualifications), or (ii) for those representations and warranties which address matters only as of a particular date (which representations shall have been true and correct, subject to the qualifications as set forth in the preceding clause (i), as of such particular date) (it being understood that, for purposes of determining the accuracy of such representations and warranties, any update of or modification to the BLNE Disclosure Schedule made or purported to have been made after the date of this Agreement shall be disregarded).

 

-56-
 

 

8.2 Performance of Covenants. Each of BLNE and Merger Sub shall have performed or complied with in all material respects all of their agreements and covenants required to be performed or complied with by each of them under this Agreement at or prior to the Effective Time.

 

8.3 Documents. The Company shall have received the following documents, each of which shall be in full force and effect: a certificate executed by the Chief Executive Officer or Chief Financial Officer of BLNE confirming that the conditions set forth in Sections 8.1, 8.2, and 8.4 have been duly satisfied.

 

8.4 No BLNE Material Adverse Effect. Since the date of this Agreement, there shall not have occurred any BLNE Material Adverse Effect that is continuing.

 

Section 9 TERMINATION

 

9.1 Termination. This Agreement may be terminated prior to the Effective Time (whether before or after approval of the Required BLNE Stockholder Matters by BLNE’s stockholders, unless otherwise specified below):

 

(a) by mutual written consent of BLNE, at the sole direction of the Special Committee, and the Company;

 

(b) by either BLNE, at the sole direction of the Special Committee, or the Company if the Merger shall not have been consummated by March 19, 2027 (subject to possible extension as provided in this Section 9.1(b), the “End Date”); provided, however, that the right to terminate this Agreement under this Section 9.1(b) shall not be available to the Company, on the one hand, or to BLNE, on the other hand, if such Party’s action or failure to act has been a principal cause of the failure of the Merger to occur on or before the End Date and such action or failure to act constitutes a breach of this Agreement;

 

(c) by either BLNE, at the sole direction of the Special Committee, or the Company if a court of competent jurisdiction or other Governmental Body shall have issued a final and non-appealable order, decree or ruling, or shall have taken any other action, having the effect of permanently restraining, enjoining or otherwise prohibiting the Contemplated Transactions;

 

(d) by either BLNE, at the sole direction of the Special Committee, or the Company if (i) the BLNE Stockholders’ Meeting (including any adjournments and postponements thereof) shall have been held and completed and BLNE’s stockholders shall have taken a final vote on the Required BLNE Stockholder Matters and (ii) the Required BLNE Stockholder Matters shall not have been approved at the BLNE Stockholders’ Meeting (or at any adjournment or postponement thereof) by the Required BLNE Stockholder Vote applicable to such Required BLNE Stockholder Matters; provided, however, that the right to terminate this Agreement under this Section 9.1(d) shall not be available to BLNE where the failure to obtain such Required BLNE Stockholder Vote shall have been primarily caused by the action or failure to act of BLNE and such action or failure to act constitutes a material breach by BLNE of this Agreement;

 

-57-
 

 

(e) by the Company (at any time prior to such time when the Required BLNE Stockholder Vote with respect to the Required BLNE Stockholder Matters is obtained) if a BLNE Triggering Event shall have occurred;

 

(f) by the Company, upon a breach of any representation, warranty, covenant or agreement set forth in this Agreement by BLNE or Merger Sub or if any representation or warranty of BLNE or Merger Sub shall have become inaccurate, in either case, such that the conditions set forth in Section 8.1 or Section 8.2 would not be satisfied as of the time of such breach or as of the time such representation or warranty shall have become inaccurate; provided that the Company is not then in material breach of any representation, warranty, covenant or agreement under this Agreement; provided, further, that if such inaccuracy in BLNE’s or Merger Sub’s representations and warranties or breach by BLNE or Merger Sub is curable by the End Date by BLNE or Merger Sub, as applicable, then this Agreement shall not terminate pursuant to this Section 9.1(f) as a result of such particular breach or inaccuracy until the earlier of (i) the End Date or (ii) the expiration of a 30-day calendar period commencing upon delivery of written notice from the Company to BLNE or Merger Sub of such breach or inaccuracy and its intention to terminate pursuant to this Section 9.1(f) (it being understood that this Agreement shall not terminate pursuant to this Section 9.1(f) as a result of such particular breach or inaccuracy if such breach by BLNE or Merger Sub is cured prior to such termination becoming effective);

 

(g) by BLNE, at the sole direction of the Special Committee, upon a breach of any representation, warranty, covenant or agreement set forth in this Agreement by the Company or if any representation or warranty of the Company shall have become inaccurate, in either case, such that the conditions set forth in Section 7.1 or Section 7.2 would not be satisfied as of the time of such breach or as of the time such representation or warranty shall have become inaccurate; provided that BLNE is not then in material breach of any representation, warranty, covenant or agreement under this Agreement; provided, further, that if such inaccuracy in the Company’s representations and warranties or breach by the Company is curable by the End Date by the Company then this Agreement shall not terminate pursuant to this Section 9.1(g) as a result of such particular breach or inaccuracy until the earlier of (i) the End Date or (ii) the expiration of a 30-day calendar period commencing upon delivery of written notice from BLNE to the Company of such breach or inaccuracy and its intention to terminate pursuant to this Section 9.1(g) (it being understood that this Agreement shall not terminate pursuant to this Section 9.1(g) as a result of such particular breach or inaccuracy if such breach by the Company is cured prior to such termination becoming effective); or

 

(h) by BLNE, at the sole direction of the Special Committee, at any time prior to such time when the Required BLNE Stockholder Vote with respect to the Required BLNE Stockholder Matters is obtained, if (i) BLNE or the Special Committee has received a Superior Offer, (ii) BLNE has complied with its obligations under Section 5.3(d) in order to accept such Superior Offer, and (iii) BLNE concurrently enters into a Permitted Alternative Agreement with respect to such Superior Offer.

 

-58-
 

 

The Party desiring to terminate this Agreement pursuant to this Section 9.1 (other than pursuant to Section 9.1(a)) shall give a notice of such termination to the other Party specifying the provisions hereof pursuant to which such termination is made and the basis therefor described in reasonable detail.

 

9.2 Effect of Termination. In the event of the termination of this Agreement as provided in Section 9.1, this Agreement shall be of no further force or effect; provided, however, that (a) Section 5.7, Section 9.1, Section 9.2, Section 11 (other than Section 11.7) and the definitions of the defined terms in such Sections (including the definitions of such defined terms on Exhibit A) shall survive the termination of this Agreement and shall remain in full force and effect, and (b) the termination of this Agreement shall not relieve any Party of any liability for fraud or for any willful and material breach of any representation, warranty, covenant, obligation or other provision contained in this Agreement.

 

Section 10 INDEMNIFICATION

 

10.1 Survival. Subject to the limitations and other provisions of this Agreement, the representations and warranties contained herein shall survive the Closing and shall remain in full force and effect until the date that is eighteen (18) months from the Closing Date; provided, that the BLNE Fundamental Representations, the Company Fundamental Representations, the Individual Fundamental Representations, and the representations and warranties set forth in Section 2.17 and Section 3.17 shall survive until sixty (60) days following the expiration of the applicable statute of limitations in respect of the matters addressed by such representations and warranties (taking into account any extensions or waivers thereof). All other covenants and agreements of the Parties contained herein shall survive the Closing indefinitely or for the period explicitly specified therein. Notwithstanding the foregoing, any claims asserted in good faith with reasonable specificity (to the extent known at such time) and in writing by notice from the Indemnified Party to the Indemnifying Party prior to the expiration date of the applicable survival period shall not thereafter be barred by the expiration of the relevant representation or warranty and such claims shall survive until finally resolved.

 

10.2 Indemnification by Company Stockholders and Company Option Holders. Subject to the other terms and conditions of this Section 10, from and after Closing, the Pre-Closing Company Holders, severally and not jointly, in their capacities as Pre-Closing Company Holders and in accordance with their Pro Rata Share, shall indemnify and defend each of BLNE, Merger Sub and their respective Affiliates (which, for the avoidance of doubt shall include the Company following the Closing) and their respective Representatives (collectively, the “BLNE Indemnitees”) against, and shall hold each of them harmless from and against, and shall pay and reimburse each of them for, any and all Losses incurred or sustained by, or imposed upon, the BLNE Indemnitees based upon, arising out of, with respect to or by reason of:

 

(a) any inaccuracy in or breach of any of the representations or warranties of the Company contained in this Agreement or in any certificate or instrument delivered by or on behalf of the Company pursuant to this Agreement as of the date such representation or warranty was made or as if such representation or warranty was made on and as of the Closing Date (except for representations and warranties that are specifically made as of a particular date, the inaccuracy in or breach of which will be determined with reference to such date);

 

-59-
 

 

(b) any inaccuracy in or breach of an Individual Fundamental Representation by a Pre-Closing Company Holder;

 

(c) any breach or non-fulfillment of any covenant, agreement or obligation to be performed by the Company or the Holders’ Representative prior to the Effective Time pursuant to this Agreement; or

 

(d) any (i) Taxes of the Company and its Subsidiary attributable to any Pre-Closing Tax Period (including the portion of any Straddle Tax Period ending on the Closing Date, determined in accordance with Section 5.10(f)) that are not otherwise paid by the Holders’ Representative pursuant to Section 5.10(e); (ii) Taxes imposed on the Company or its Subsidiary (or any predecessors) as a result of having been a member of an affiliated, consolidated, combined or unitary Tax group prior to the Closing Date (other than the group with the Company as parent), including pursuant to Treasury Regulation Section 1.1502-6 or any analogous or similar state, local or foreign Law relating to Taxes; (iii) Taxes of any Person (other than the Company) imposed on the Company or its Subsidiary as a transferee or successor, by Contract or pursuant to any Law, which Taxes relate to an event or transaction occurring before the Closing; (iv) Taxes of any Person receiving any payment (including Merger Consideration) under this Agreement imposed on or payable by BLNE, the Company or any of their Affiliates (including any amounts payable by BLNE or the Company arising from the failure to withhold the correct amount from any such payment), (v) employer-side payroll Taxes attributable to compensatory payments made in connection with the transactions contemplated hereby; and (vi) any Transfer Taxes required to be borne by the Pre-Closing Company Holders pursuant to Section 5.10(c).

 

10.3 Indemnification by BLNE. Subject to the other terms and conditions of this Section 10, from and after Closing, BLNE shall indemnify and defend each of the Pre-Closing Company Holders and their respective Affiliates (which, for the avoidance of doubt, shall exclude BLNE, Merger Sub and the Company following the Closing) and Representatives (collectively, the “Stockholder Indemnitees”) against, and shall hold each of them harmless from and against, and shall pay and reimburse each of them for, any and all Losses incurred or sustained by, or imposed upon, the Stockholder Indemnitees based upon, arising out of, with respect to or by reason of:

 

(a) any inaccuracy in or breach of any of the representations or warranties of BLNE or Merger Sub contained in this Agreement or in any certificate or instrument delivered by or on behalf of BLNE or Merger Sub pursuant to this Agreement as of the date such representation or warranty was made or as if such representation or warranty was made on and as of the Closing Date (except for representations and warranties that are specifically made as of a particular date, the inaccuracy in or breach of which will be determined with reference to such date); or

 

(b) any breach or non-fulfillment of any covenant, agreement or obligation to be performed by BLNE or Merger Sub prior to the Effective Time pursuant to this Agreement.

 

-60-
 

 

10.4 Certain Limitations. The indemnification provided for in Section 10.2 and Section 10.3 shall be subject to the following limitations:

 

(a) The Pre-Closing Company Holders shall not be liable to the BLNE Indemnitees for indemnification under Section 10.2(a) until the aggregate amount of all Losses in respect of indemnification under Section 10.2(a) exceeds $219,000 (the “Basket”), in which event Pre-Closing Company Holders shall be required to pay or be liable for all such Losses from the first dollar. The aggregate amount of all Losses for which the Pre-Closing Company Holders shall be liable pursuant to Section 10.2(a) shall not exceed $4,380,000 (the “Cap”); provided, however, that the limitations set forth in this Section 10.4(a) shall not apply to any claim based upon fraud or willful misconduct.

 

(b) Each Pre-Closing Company Holder’s Liability with respect to the indemnification obligations set forth in Section 10.2(a) shall not exceed such Pre-Closing Company Holder’s Pro Rata Share of such Losses. In addition, no Pre-Closing Company Holder shall have any Liability with respect to the indemnification obligations set forth in Section 10.2(b) with respect to an Individual Fundamental Representation made by another Pre-Closing Company Holder.

 

(c) BLNE shall not be liable to the Stockholder Indemnitees for indemnification under Section 10.3(a) until the aggregate amount of all Losses in respect of indemnification under Section 10.3(a) exceeds the Basket, in which event BLNE shall be required to pay or be liable for all such Losses from the first dollar. The aggregate amount of all Losses for which BLNE shall be liable pursuant to Section 10.3(a) shall not exceed the Cap; provided, however, that the limitations set forth in this Section 10.4(c) shall not apply to any claim based upon fraud or willful misconduct.

 

(d) Notwithstanding the foregoing, the limitations set forth in Section 10.4(a) and Section 10.4(c) shall not apply to Losses based upon, arising out of, with respect to or by reason of any inaccuracy in or breach of any Company Fundamental Representations, Company Capitalization Representations, the representations and warranties set forth in Section 2.17 or Section 3.17, BLNE Fundamental Representations or BLNE Capitalization Representations.

 

(e) For purposes of this Section 10 (including for purposes of determining the existence of any inaccuracy in, or breach of, any representation or warranty and for calculating the amount of any Loss with respect thereto), any inaccuracy in or breach of any representation or warranty shall be determined without regard to any materiality, Company Material Adverse Effect, BLNE Material Adverse Effect, or other similar qualification contained in or otherwise applicable to such representation or warranty.

 

(f) BLNE shall satisfy any Losses that are finally determined to be due to any Stockholder Indemnitees, at the Pre-Closing Company Holders’ option, through the payment of cash or the issuance of additional shares of BLNE Common Stock. Any Losses payable to a BLNE Indemnitee pursuant to Section 10 shall be satisfied by the Pre-Closing Company Holders, severally and not jointly, in accordance with their Pro Rata Shares, at the option of each such Pre-Closing Company Holder (i) in cash, (ii) by surrendering to BLNE for cancellation, for no additional consideration, shares of BLNE Common Stock received as Merger Consideration, or (iii) any combination of the foregoing. Any surrender of shares pursuant to this Section 10.4(f) shall be permitted notwithstanding any restriction in any Lock-Up Agreement, and BLNE shall instruct its transfer agent to cancel such shares upon receipt.

 

-61-
 

 

(g) For all purposes under this Section 10, the dollar value of each share of BLNE Common Stock for the purposes of satisfying any indemnification claim under this Section 10 shall be deemed to be the VWAP.

 

10.5 Indemnification Procedures.

 

(a) The Party making a claim under this Section 10 is referred to as the “Indemnified Party”, and the party against whom such claims are asserted under this Section 10 is referred to as the “Indemnifying Party”. For purposes of this Section 10, (i) if BLNE (or any other BLNE Indemnitee) comprises the Indemnified Party, any references to Indemnifying Party (except provisions relating to an obligation to make payments) shall be deemed to refer to the Holders’ Representative, and (ii) if any Pre-Closing Company Holder comprises the Indemnifying Party, any references to the Indemnified Party shall be deemed to refer to such Holders’ Representative on behalf of such Pre-Closing Company Holder. Any payment received by the Holders’ Representative as the Indemnified Party shall be distributed to the Pre-Closing Company Holders in accordance with this Agreement.

 

(b) Third Party Claims.

 

(i) If any Indemnified Party receives notice of the assertion or commencement of any Action made or brought by any Person who is not a party to this Agreement or an Affiliate of a party to this Agreement or a Representative of the foregoing (each, a “Third-Party Claim”) against such Indemnified Party with respect to which the Indemnifying Party is obligated to provide indemnification under this Agreement, the Indemnified Party shall give the Indemnifying Party reasonably prompt written notice thereof, but in any event not later than thirty (30) calendar days after receipt of such notice of such Third-Party Claim. The failure to give such prompt written notice shall not, however, relieve the Indemnifying Party of its indemnification obligations, except and only to the extent that the Indemnifying Party forfeits rights or defenses by reason of such failure. Such notice by the Indemnified Party shall describe the Third-Party Claim in reasonable detail, shall include copies of all material written evidence thereof and shall indicate the estimated amount, if reasonably practicable, of the Loss that has been or may be sustained by the Indemnified Party. The Indemnifying Party shall have the right to participate in, or by giving written notice to the Indemnified Party, to assume the defense of any Third-Party Claim at the Indemnifying Party’s expense and by the Indemnifying Party’s own counsel, and the Indemnified Party shall cooperate in good faith in such defense; provided, that if the Indemnifying Party is a Pre-Closing Company Holder, such Indemnifying Party shall not have the right to defend or direct the defense of any such Third-Party Claim that (x) is asserted directly by or on behalf of a Person that is a supplier or customer of the Company, or (y) seeks an injunction or other equitable relief against the Indemnified Parties. In the event that the Indemnifying Party assumes the defense of any Third-Party Claim, subject to Section 10.5(b)(ii), it shall have the right to take such action as it deems necessary to avoid, dispute, defend, appeal or make counterclaims pertaining to any such Third-Party Claim in the name and on behalf of the Indemnified Party. The Indemnified Party shall have the right to participate in the defense of any Third-Party Claim with counsel selected by it subject to the Indemnifying Party’s right to control the defense thereof. The fees and disbursements of such counsel shall be at the expense of the Indemnified Party, provided, that if in the reasonable opinion of counsel to the Indemnified Party, (A) there are legal defenses available to an Indemnified Party that are different from or additional to those available to the Indemnifying Party or (B) there exists a conflict of interest between the Indemnifying Party and the Indemnified Party that cannot be waived, the Indemnifying Party shall be liable for the reasonable fees and expenses of counsel to the Indemnified Party in each jurisdiction for which the Indemnified Party determines counsel is required. If the Indemnifying Party elects not to compromise or defend such Third-Party Claim, fails to promptly notify the Indemnified Party in writing of its election to defend as provided in this Agreement, or fails to diligently prosecute the defense of such Third-Party Claim, the Indemnified Party may, subject to Section 10.5(b)(ii), pay, compromise, defend such Third-Party Claim and seek indemnification for any and all Losses based upon, arising from or relating to such Third-Party Claim. The Holders’ Representative and BLNE shall cooperate with each other in all reasonable respects in connection with the defense of any Third-Party Claim, including making available records relating to such Third-Party Claim and furnishing, without expense (other than reimbursement of actual out-of-pocket expenses) to the defending party, management employees of the non-defending party as may be reasonably necessary for the preparation of the defense of such Third-Party Claim.

 

(ii) Notwithstanding any other provision of this Agreement, the Indemnifying Party shall not enter into settlement of any Third-Party Claim without the prior written consent of the Indemnified Party, except as provided in this Section 10.5(b)(ii). If a firm offer is made to settle a Third-Party Claim without leading to Liability or the creation of a financial or other obligation on the part of the Indemnified Party and provides, in customary form, for the unconditional release of each Indemnified Party from all Liabilities and obligations in connection with such Third-Party Claim and the Indemnifying Party desires to accept and agree to such offer, the Indemnifying Party shall give written notice to that effect to the Indemnified Party. If the Indemnified Party fails to consent to such firm offer within ten (10) days after its receipt of such notice, the Indemnified Party may continue to contest or defend such Third-Party Claim and in such event, the maximum liability of the Indemnifying Party as to such Third-Party Claim shall not exceed the amount of such settlement offer. If the Indemnified Party fails to consent to such firm offer and also fails to assume defense of such Third-Party Claim, the Indemnifying Party may settle the Third-Party Claim upon the terms set forth in such firm offer to settle such Third-Party Claim. If the Indemnified Party has assumed the defense pursuant to Section 10.5(b)(i), it shall not agree to any settlement without the written consent of the Indemnifying Party (which consent shall not be unreasonably withheld, conditioned or delayed).

 

-62-
 

 

(c) Direct Claims. Any Legal Proceeding by an Indemnified Party on account of a Loss which does not result from a Third-Party Claim (each, a “Direct Claim”) shall be asserted by the Indemnified Party giving the Indemnifying Party reasonably prompt written notice thereof, but in any event not later than thirty (30) days after the Indemnified Party becomes aware of such Direct Claim. The failure to give such prompt written notice shall not, however, relieve the Indemnifying Party of its indemnification obligations, except and only to the extent that the Indemnifying Party forfeits rights or defenses by reason of such failure. Such notice by the Indemnified Party shall describe the Direct Claim in reasonable detail, shall include copies of all material written evidence thereof and shall indicate the estimated amount, if reasonably practicable, of the Loss that has been or may be sustained by the Indemnified Party. The Indemnifying Party shall have thirty (30) days after its receipt of such notice to respond in writing to such Direct Claim. The Indemnified Party shall allow the Indemnifying Party and its professional advisors to investigate the matter or circumstance alleged to give rise to the Direct Claim, and whether and to what extent any amount is payable in respect of the Direct Claim and the Indemnified Party shall assist the Indemnifying Party’s investigation by giving such information and assistance (including access to the Company’s premises and personnel and the right to examine and copy any accounts, documents or records) as the Indemnifying Party or any of its professional advisors may reasonably request. If the Indemnifying Party does not so respond within such thirty (30) day period, the Indemnifying Party shall be deemed to have rejected such claim, in which case the Indemnified Party shall be free to pursue such remedies as may be available to the Indemnified Party on the terms and subject to the provisions of this Agreement.

 

(d) Payment Procedures. Once a Loss is finally determined pursuant to this Section 10.5, the Indemnifying Party shall satisfy its obligations within ten (10) Business Days either through the payment of cash in immediately available funds or the transfer of shares of BLNE Common Stock, as applicable. The Parties hereto agree that should an Indemnifying Party not make full payment of any such obligations within such ten (10) Business Day period, any amount payable shall accrue interest from and including the date of agreement of the Indemnifying Party or final, non-appealable adjudication to and including the date such payment has been made at a rate per annum equal to five percent (5%). Such interest shall be calculated daily on the basis of a 365-day year and the actual number of days elapsed, compounding monthly.

 

10.6 Effect of Investigation. The representations, warranties and covenants of the Indemnifying Party, and the Indemnified Party’s right to indemnification with respect thereto, shall not be affected or deemed waived by reason of any investigation made by or on behalf of the Indemnified Party (including by any of its Representatives) or by reason of the fact that the Indemnified Party or any of its Representatives knew or should have known that any such representation or warranty is, was or might be inaccurate or by reason of the Indemnified Party’s waiver of any condition set forth in Section 6 or Section 7, as applicable.

 

10.7 Holders’ Representative; Power of Attorney. By virtue of the adoption of this Agreement and approving the Contemplated Transactions pursuant to the Company Stockholder Written Consent, each Pre-Closing Company Holder hereby (a) acknowledges that he, she or it has been provided with a copy of this Agreement and (b) initially appoints, as of the date of this Agreement, the Holders’ Representative, as his, her or its true and lawful agent and attorney-in-fact with respect to the Contemplated Transactions and to (i) give and receive notices and communications to or from BLNE (on behalf of itself or any other Indemnified Party), (ii) authorize deliveries to BLNE of shares of BLNE Common Stock and/or cash in satisfaction of claims asserted by BLNE (on behalf of itself or any other Indemnified Party, including by not objecting to claims thereto), (iii) object to any claims by BLNE, (iv) consent or agree to, negotiate, enter into settlements and compromises of, and agree to arbitration and comply with orders of courts and awards of arbitrators with respect to such claims, (v) assert, negotiate, enter into settlements and compromises of, and agree to arbitration and comply with orders of courts and awards of arbitrators with respect to, any other claim by any Indemnified Party against any Pre-Closing Company Holder or by any Pre-Closing Company Holder against any Indemnified Party or any dispute between any Indemnified Party and any such Pre-Closing Company Holder, in each case relating to this Agreement or the Contemplated Transactions, (vi) amend this Agreement or any other agreement referred to herein or contemplated hereby or thereby, and (vii) take all actions necessary or appropriate in the judgment of the Pre-Closing Company Holders for the accomplishment of the foregoing, in each case without having to seek or obtain the consent of any Person under any circumstance. BLNE, Merger Sub and, after the Closing, the Surviving Corporation may conclusively and absolutely rely, without inquiry, upon any such decision, act, consent or instruction of the Holders’ Representative as being the decision, act, consent or instruction of the Pre-Closing Company Holders and no Pre-Closing Company Holder shall have any claim or the right to object, dissent, protest or otherwise contest the same against BLNE, Merger Sub or, after the Closing, the Surviving Corporation or any of their respective Affiliates and Representatives for any action or inaction taken in reliance on the decision, act, consent or instruction of the Pre-Closing Company Holders.

 

-63-
 

 

10.8 Tax Treatment. All indemnification payments made under this Agreement shall be treated by the Parties as an adjustment to the Merger Consideration for Tax purposes, and the Parties agree to file their respective Tax Returns accordingly, unless otherwise required by Law.

 

10.9 Exclusive Remedies. Subject to and except for Section 9.2 and Section 11.9, the Parties acknowledge and agree that from and after Closing their sole and exclusive remedy with respect to any and all claims (other than claims arising from fraud or willful misconduct on the part of a Party hereto in connection with the transactions contemplated by this Agreement) for any breach of any representation, warranty, covenant, agreement or obligation set forth herein or otherwise relating to the subject matter of this Agreement, shall be pursuant to the indemnification provisions set forth in this Section 10. Nothing in this Section 10.9 shall limit any Person’s right to seek and obtain any equitable relief to which any Person shall be entitled or to seek any remedy on account of any Party’s fraud or willful misconduct.

 

Section 11 MISCELLANEOUS PROVISIONS

 

11.1 Amendment. This Agreement may be amended with the approval of the Special Committee, the BLNE Board, the Merger Sub Board, the Company Board and the Holders’ Representative at any time (whether before or after obtaining the Required Company Stockholder Vote or before or after obtaining the Required BLNE Stockholder Vote); provided, however, that after any such approval of this Agreement by a Party’s stockholders, no amendment shall be made which by Law would require further approval of such stockholders without the further approval of such stockholders. This Agreement may not be amended except by an instrument in writing signed on behalf of each of the Company, the Holders’ Representative, BLNE and Merger Sub.

 

11.2 Waiver.

 

(a) Any provision hereof may be waived by the waiving Party solely on such Party’s own behalf, without the consent of any other Party. No failure on the part of any Party to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part of any Party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power, right, privilege or remedy; and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. Notwithstanding the foregoing, any waiver by BLNE shall be subject to the approval of the Special Committee.

 

-64-
 

 

(b) No Party shall be deemed to have waived any claim arising out of this Agreement, or any power, right, privilege or remedy under this Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such Party and any such waiver shall not be applicable or have any effect except in the specific instance in which it is given.

 

11.3 Entire Agreement; Counterparts; Exchanges by Electronic Transmission. This Agreement and the other schedules, exhibits, certificates, instruments and agreements referred to in this Agreement constitute the entire agreement and supersede all prior agreements and understandings, both written and oral, among or between any of the Parties with respect to the subject matter hereof and thereof; provided, however, that the Confidentiality Agreement shall not be superseded and shall remain in full force and effect in accordance with its terms, but shall be terminated effective as of the Effective Time. This Agreement may be executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed Agreement (in counterparts or otherwise) by all Parties by electronic transmission shall be sufficient to bind the Parties to the terms and conditions of this Agreement.

 

11.4 Applicable Law; Jurisdiction. This Agreement and all disputes or controversies arising out of or relating to this Agreement or the Contemplated Transactions shall be governed by, and construed in accordance with, the Laws of the State of Delaware, regardless of the Laws that might otherwise govern under applicable principles of conflicts of laws. In any action or proceeding between any of the Parties arising out of or relating to this Agreement or any of the Contemplated Transactions, each of the Parties: (a) irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of the Court of Chancery of the State of Delaware or, to the extent such court does not have subject matter jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court of the State of Delaware; (b) agrees that all claims in respect of such action or proceeding shall be heard and determined exclusively in accordance with clause (a) of this Section 11.4; (c) waives any objection to laying venue in any such action or proceeding in such courts; (d) waives any objection that such courts are an inconvenient forum or do not have jurisdiction over any Party; (e) agrees that service of process upon such Party in any such action or proceeding shall be effective if notice is given in accordance with Section 11.6 of this Agreement; and (f) irrevocably and unconditionally waives the right to trial by jury.

 

11.5 Assignability. This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the Parties and their respective successors and permitted assigns; provided, however, that neither this Agreement nor any of a Party’s rights or obligations hereunder may be assigned or delegated by such Party without the prior written consent of the other Parties, and any attempted assignment or delegation of this Agreement or any of such rights or obligations by such Party without the other Parties’ prior written consent shall be void and of no effect.

 

-65-
 

 

11.6 Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly delivered and received hereunder (a) one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable international overnight courier service, (b) upon delivery in the case of delivery by hand, or (c) on the date delivered in the place of delivery if sent by email (with a written or electronic confirmation of delivery) prior to 5:00 p.m. Eastern time, otherwise on the next succeeding Business Day, in each case to the intended recipient as set forth below:

 

if to the Special Committee, BLNE or Merger Sub:

 

c/o Beeline Holdings, Inc.

188 Valley Street, Suite 225

Providence, RI 02909

E-mail: ______________

Attention: Nicholas R. Liuzza, Jr. Frank Knuettel II

 

with copies to (which shall not constitute notice):

 

Thompson Hine LLP

300 Madison Avenue, 27th Floor

New York, NY 10017

E-mail: ______________

Attention: Faith Charles, Esq.; Corby J. Baumann, Esq.

 

Nason Yeager Gerson Harris & Fumero, P.A.

3001 PGA Blvd., Suite 305

Palm Beach Gardens, FL 33410

E-mail: ______________

Attention: Michael D. Harris, Esq.

 

if to the Company (prior to Closing):

 

TYTL Corp.

188 Valley Street

Providence, RI 02909

E-mail: _____________

Attention: Brendan Reilly

 

with a copy to (which shall not constitute notice):

 

Verrill Dana LLP

One Federal Street, 20th Floor

Boston, MA 02110

E-mail: _____________

Attention: Eugene H. Ho, Esq.

 

if to the Holders’ Representative:

 

188 Valley Street

Providence, RI 02909

E-mail: _____________

Attention: Brendan Reilly

 

-66-
 

 

11.7 Cooperation. Each Party agrees to cooperate fully with the other Parties and to execute and deliver such further documents, certificates, agreements and instruments and to take such other actions as may be reasonably requested by the other Parties to evidence or reflect the Contemplated Transactions and to carry out the intent and purposes of this Agreement.

 

11.8 Severability. Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Agreement is invalid or unenforceable, the Parties agree that the court making such determination shall have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power granted to it in the prior sentence, the Parties agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term or provision.

 

11.9 Other Remedies; Specific Performance. Except as otherwise provided herein, any and all remedies herein expressly conferred upon a Party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such Party, and the exercise by a Party of any one remedy will not preclude the exercise of any other remedy. The Parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur in the event that any Party does not perform the provisions of this Agreement (including failing to take such actions as are required of it hereunder to consummate this Agreement) in accordance with its specified terms or otherwise breaches such provisions. Accordingly, the Parties acknowledge and agree that the Parties shall be entitled to an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity. Each of the Parties agrees that it will not oppose the granting of an injunction, specific performance or other equitable relief on the basis that any other Party has an adequate remedy at law or that any award of specific performance is not an appropriate remedy for any reason at law or in equity. Any Party seeking an injunction or injunctions to prevent breaches of this Agreement shall not be required to provide any bond or other security in connection with any such order or injunction.

 

11.10 Obligations of BLNE and Subsidiaries. Whenever this Agreement requires a Subsidiary of BLNE to take any action, such requirement shall be deemed to include an undertaking on the part of BLNE to cause such Subsidiary to take such action. Whenever this Agreement requires a Subsidiary of the Company to take any action, such requirement shall be deemed to include an undertaking on the part of the Company to cause such Subsidiary to take such action and, after the Effective Time, on the part of the Surviving Corporation to cause such Subsidiary to take such action. Whenever this Agreement requires BLNE to take any action at the sole direction of the Special Committee, then such action (including any such action required by this Section 11.10) shall only be taken at the sole direction of the Special Committee.

 

-67-
 

 

11.11 No Third Party Beneficiaries. Nothing in this Agreement, express or implied, is intended to or shall confer upon any Person (other than the Parties and the D&O Indemnified Parties to the extent of their respective rights pursuant to Section 5.5) any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.

 

11.12 Construction.

 

(a) References to “cash,” “dollars” or “$” are to U.S. dollars.

 

(b) For purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine and feminine genders.

 

(c) The Parties have participated jointly in the negotiating and drafting of this Agreement and agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting Party shall not be applied in the construction or interpretation of this Agreement, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any provision of this Agreement.

 

(d) As used in this Agreement, the words “include” and “including,” and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words “without limitation.”

 

(e) The use of the word “or” shall not be exclusive.

 

(f) Except as otherwise indicated, all references in this Agreement to “Sections,” “Exhibits” and “Schedules” are intended to refer to Sections of this Agreement and Exhibits and Schedules to this Agreement, respectively.

 

(g) Any reference to legislation or to any provision of any legislation shall include any modification, amendment, re-enactment thereof, any legislative provision substituted therefor and all rules, regulations, and statutory instruments issued or related to such legislation.

 

(h) The bold-faced headings and table of contents contained in this Agreement are for convenience of reference only, shall not be deemed to be a part of this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement.

 

(i) Each of the Company Disclosure Schedule and the BLNE Disclosure Schedule shall be arranged in sections and subsections corresponding to the numbered and lettered sections and subsections contained in this Agreement. The disclosures in any section or subsection of the Company Disclosure Schedule or the BLNE Disclosure Schedule shall qualify other sections and subsections in this Agreement to the extent it is readily apparent on its face from a reading of the disclosure that such disclosure is applicable to such other sections and subsections.

 

(j) Each of “delivered” or “made available,” and words of similar import means, with respect to any documentation, that prior to 11:59 p.m. (Eastern time) on the date that is two Business Days prior to the date of this Agreement (i) a copy of such material has been posted to and made available by a Party to the other Party and its Representatives in the electronic data room maintained by such disclosing Party or (ii) such material is disclosed in the BLNE SEC Documents publicly made available on the SEC’s Electronic Data Gathering Analysis and Retrieval system.

 

(k) Whenever the last day for the exercise of any privilege or the discharge of any duty hereunder shall fall upon a Saturday, Sunday, or any date on which banks in Wilmington, Delaware or Providence, Rhode Island are authorized or obligated by Law to be closed, the Party having such privilege or duty may exercise such privilege or discharge such duty on the next succeeding day which is a regular Business Day.

 

(Remainder of page intentionally left blank)

 

-68-
 

 

IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the date first above written.

 

  BEELINE HOLDINGS, INC.
   
  By: /s/ Christopher R. Moe
  Name:

Christopher R. Moe

  Title: Chief Financial Officer
     
  BLNE MERGER SUB, INC.
   
  By: /s/ Christopher R. Moe
  Name: Christopher R. Moe
  Title:

President

 

[Signature Page to Agreement and Plan of Merger]

 

 
 

 

  TYTL CORP.
     
  By: /s/ Brendan Reilly
  Name: Brendan Reilly
  Title: President

 

  HOLDERS’ REPRESENTATIVE:
     
  By: /s/ Brendan Reilly
  Name: Brendan Reilly
  Title: In his capacity as the Holders’ Representative

 

[Signature Page to Agreement and Plan of Merger]

 

 
 

 

EXHIBIT A

 

CERTAIN DEFINITIONS

 

For purposes of this Agreement (including this Exhibit A):

 

“Acquisition Inquiry” means, with respect to a Party, an inquiry, indication of interest or request for information (other than an inquiry, indication of interest or request for information made or submitted by the Company, on the one hand, or BLNE, on the other hand, to the other Party) that would reasonably be expected to lead to an Acquisition Proposal.

 

“Acquisition Proposal” means, with respect to a Party, any offer or proposal, whether written or oral (other than an offer or proposal made or submitted by or on behalf of the Company or any of its Affiliates, on the one hand, or by or on behalf of BLNE or any of its Affiliates, on the other hand, to the other Party) contemplating or otherwise relating to any Acquisition Transaction with such Party, other than with respect to the Merger, any Contemplated Transaction.

 

“Acquisition Transaction” means, with respect to the relevant Party, any transaction or series of related transactions (other than the Merger or any Contemplated Transaction) involving:

 

(a) any merger, consolidation, amalgamation, share exchange, business combination, issuance of securities, acquisition of securities, reorganization, recapitalization, tender offer, exchange offer or other similar transaction: (i) in which a Party is a constituent entity; (ii) in which a Person or “group” (as defined in the Exchange Act and the rules promulgated thereunder) of Persons directly or indirectly acquires beneficial or record ownership of securities representing more than 20% of the outstanding securities of any class of voting securities of a Party or any of its Subsidiaries; or (iii) in which a Party or any of its Subsidiaries issues securities representing more than 20% of the outstanding securities of any class of voting securities of such Party or any of its Subsidiaries; or

 

(b) any sale, lease, exchange, transfer, license, acquisition or disposition of any business or businesses or assets that constitute or account for 20% or more of the consolidated book value or the fair market value of the assets of a Party and its Subsidiaries, taken as a whole.

 

“Adverse Recommendation” means withholding or withdrawing, in a manner adverse to the Company, the Special Committee Recommendation.

 

“Advisory Agreement” means an advisory agreement to be entered into between BLNE and Mr. Andrew Reilly, which shall be effective as of the Closing.

 

“Affiliate” of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such Person. The term “control” (including the terms “controlled by” and “under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

 

A-1

 

 

“Agreement” means the Agreement and Plan of Merger to which this Exhibit A is attached, as it may be amended from time to time.

 

“Anticipated Closing Date” means the anticipated Closing Date (as mutually agreed in good faith by BLNE, at the sole direction of the Special Committee, and the Company).

 

“BLNE Associate” means any current or former employee, independent contractor, officer or manager of BLNE.

 

“BLNE Balance Sheet” means the unaudited balance sheet of BLNE as of June 30, 2026 (the “BLNE Balance Sheet Date”), included in BLNE’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026, as filed with the SEC.

 

“BLNE Benefit Plan” means each (i) “employee benefit plan” as defined in Section 3(3) of ERISA, whether or not subject to ERISA, and (ii) other pension, retirement, deferred compensation, excess benefit, profit sharing, bonus, incentive, equity or equity-based, phantom equity, employment, individual consulting, severance, change-of-control, retention, health, life, disability, group insurance, paid-time off, holiday, perquisites, welfare and fringe benefit plan, program, policy, contract, or arrangement (whether written or unwritten, qualified or nonqualified, funded or unfunded and including any that have been frozen or terminated, but not including any at-will employment offer letters that do not provide for severance or transaction benefits or any restrictive covenant agreements that do not provide for compensation), in any case, sponsored, maintained, administered, contributed to, or required to be contributed to, by BLNE or any BLNE ERISA Affiliate for the benefit of any current or former employee, director, officer or independent contractor of BLNE or any of its Subsidiaries or under which BLNE has any actual or contingent liability (including as to the result of it being treated as a single employer under Code Section 414 with any other person).

 

“BLNE Board” means the board of directors of BLNE.

 

“BLNE Capital Stock” means the BLNE Common Stock and the BLNE Preferred Stock.

 

“BLNE Capitalization Representations” means the representations and warranties of BLNE set forth in Section 3.6(a).

 

“BLNE Common Stock” means the Common Stock, $0.0001 par value per share, of BLNE.

 

“BLNE Contract” means any Contract: (a) to which BLNE is a party; (b) by which BLNE or any BLNE IP Rights or any other asset of BLNE is or may become bound or under which BLNE has, or may become subject to, any obligation; or (c) under which BLNE has or may acquire any right or interest.

 

“BLNE ERISA Affiliate” means any corporation or trade or business (whether or not incorporated) which is treated with BLNE or any of its Subsidiaries as a single employer within the meaning of Section 414 of the Code.

 

A-2

 

 

“BLNE Fundamental Representations” means the representations and warranties of BLNE and Merger Sub set forth in Sections 3.1 (Due Organization; Subsidiaries), 3.3 (Authority; Binding Nature of Agreement), 3.4 (Vote Required), 3.6 (Capitalization), and 3.20 (No Financial Advisors).

 

“BLNE IP Rights” means all Intellectual Property owned by, licensed to, or controlled by BLNE.

 

“BLNE Material Adverse Effect” means any Effect that, considered together with all other Effects that have occurred prior to the date of determination of the occurrence of a BLNE Material Adverse Effect, has or would reasonably be expected to (a) have a material adverse effect on the business, condition (financial or otherwise), assets, liabilities or results of operations of BLNE or (b) prevent or materially impair or materially delay BLNE’s ability to consummate the Contemplated Transactions taken as a whole; provided, however, that Effects arising or resulting from the following shall not be taken into account in determining whether there has been a BLNE Material Adverse Effect: (i) general business or economic conditions affecting the industry in which BLNE operates, (ii) acts of war, the outbreak or escalation of armed hostilities, acts of terrorism, earthquakes, wildfires, hurricanes or other natural disasters, health emergencies, including pandemics and related or associated epidemics, disease outbreaks or quarantine restrictions, (iii) changes in financial, banking or securities markets, (iv) the taking of any action expressly required to be taken by this Agreement, (v) any change in the stock price or trading volume of BLNE Common Stock (it being understood, however, that any Effect causing or contributing to any change in stock price or trading volume of BLNE Common Stock may be taken into account in determining whether a BLNE Material Adverse Effect has occurred, unless such Effects are otherwise excepted from this definition), (vi) any change in, or any compliance with or action taken for the purpose of complying with, any Law or GAAP (or interpretations of any Law or GAAP) (it being understood and agreed that this clause (vi) shall not apply with respect to any representation or warranty the purpose of which is to address compliance with applicable Laws, GAAP or any other accounting standards), or (vii) the announcement of this Agreement or the pendency of the Contemplated Transactions (it being understood and agreed that this clause (vii) shall not apply with respect to any representation or warranty the purpose of which is to address matters resulting from the announcement of this Agreement or the pendency of the Contemplated Transactions); except in each case with respect to clauses (i) through (iii), to the extent disproportionately affecting BLNE relative to other similarly situated companies in the industries in which BLNE operates.

 

“BLNE Options” means options or other rights to purchase shares of BLNE Common Stock issued by BLNE.

 

“BLNE Preferred Stock” means the Preferred Stock, par value $0.001 per share, of BLNE, of which the following series are currently designated as Series A Convertible Redeemable Preferred Stock, Series B Preferred Stock, Series F Preferred Stock, Series F-1 Preferred Stock, and Series G Preferred Stock.

 

“BLNE Registered IP” means all BLNE IP Rights that are owned by or exclusively licensed to BLNE that are registered, filed or issued under the authority of, with or by any Governmental Body, including all Patents, registered Copyrights, and registered Trademarks (including domain name registrations) and all applications for any of the foregoing.

 

A-3

 

 

“BLNE RSUs” means restricted stock units issued by BLNE.

 

“BLNE Stock Plans” means the Amended and Restated 2025 Equity Incentive Plan.

 

“BLNE Triggering Event” means any of the following: (a) BLNE shall have failed to include in the Proxy Statement the Special Committee Recommendation or shall have made an Adverse Recommendation (other than in compliance with Section 5.3(d)); (b) the Special Committee, the BLNE Board or any committee thereof shall have publicly approved, endorsed or recommended any Acquisition Proposal; or (c) BLNE, at the sole direction of the Special Committee, shall have entered into any letter of intent or similar document or any Contract relating to any Acquisition Proposal (other than a confidentiality agreement permitted pursuant to Section 4.4) in violation of the terms of this Agreement.

 

“BLNE Warrant” means each warrant entitling the holder to purchase shares of BLNE Common Stock.

 

“Business Day” means any day other than a Saturday, Sunday or other day on which banks in Wilmington, Delaware or Providence, Rhode Island are authorized or obligated by Law to be closed.

 

“Code” means the Internal Revenue Code of 1986, as amended.

 

“Company Associate” means any current or former employee, independent contractor, officer or manager of the Company or any of its Subsidiaries.

 

“Company Benefit Plan” means each (i) “employee benefit plan” as defined in Section 3(3) of ERISA, whether or not subject to ERISA, and (ii) other pension, retirement, deferred compensation, excess benefit, profit sharing, bonus, incentive, equity or equity-based, phantom equity, employment, individual consulting, severance, change-of-control, retention, health, life, disability, group insurance, paid-time off, holiday, perquisites, welfare and fringe benefit plan, program, policy, contract, or arrangement (whether written or unwritten, qualified or nonqualified, funded or unfunded and including any that have been frozen or terminated, but not including any at-will employment offer letters that do not provide for severance or transaction benefits or any restrictive covenant agreements that do not provide for compensation), in any case, sponsored, maintained, administered, contributed to, or required to be contributed to, by the Company, any of its Subsidiaries or Affiliates or any Company ERISA Affiliate for the benefit of any current or former employee, director, officer or independent contractor of the Company or any of its Subsidiaries or under which the Company or any of its Subsidiaries has any actual or contingent liability (including as to the result of it being treated as a single employer under Code Section 414 with any other person).

 

“Company Board” means the board of directors of the Company.

 

“Company Capital Stock” means the Company Common Stock and the Company Preferred Stock.

 

A-4

 

 

“Company Capitalization Representations” means the representations and warranties of the Company set forth in Section 2.6.

 

“Company Common Stock” means the common stock, $0.01 par value per share, of the Company.

 

“Company Contract” means any Contract: (a) to which the Company or any of its Subsidiaries is a Party; (b) by which the Company, any of its Subsidiaries or any Company IP Rights or any other asset of the Company or any of its Subsidiaries is or may become bound or under which the Company has, or may become subject to, any obligation; or (c) under which the Company or any of its Subsidiaries has or may acquire any right or interest.

 

“Company ERISA Affiliate” means any corporation or trade or business (whether or not incorporated) which is treated with the Company as a single employer within the meaning of Section 414 of the Code.

 

“Company Fundamental Representations” means the representations and warranties of the Company set forth in Sections 2.1 (Due Organization; Subsidiaries), 2.3 (Authority; Binding Nature of Agreement), 2.4 (Vote Required), 2.6 (Capitalization), and 2.21 (No Financial Advisors).

 

“Company IP Rights” means all Intellectual Property owned by, licensed to, or controlled by the Company or any of its Subsidiaries.

 

“Company Material Adverse Effect” means any Effect that, considered together with all other Effects that have occurred prior to the date of determination of the occurrence of a Company Material Adverse Effect, has or would reasonably be expected to (a) have a material adverse effect on the business, condition (financial or otherwise), assets, liabilities or results of operations of the Company and its Subsidiaries taken as a whole or (b) prevent or materially impair or materially delay the Company’s ability to consummate the Contemplated Transactions taken as a whole; provided, however, that Effects arising or resulting from the following shall not be taken into account in determining whether there has been a Company Material Adverse Effect: (i) general business or economic conditions affecting the industry in which the Company and its Subsidiaries operate, (ii) acts of war, the outbreak or escalation of armed hostilities, acts of terrorism, earthquakes, wildfires, hurricanes or other natural disasters, health emergencies, including pandemics and related or associated epidemics, disease outbreaks or quarantine restrictions, (iii) changes in financial, banking or securities markets, (iv) any change in, or any compliance with or action taken for the purpose of complying with, any Law or GAAP (or interpretations of any Law or GAAP) (it being understood and agreed that this clause (iv) shall not apply with respect to any representation or warranty the purpose of which is to address compliance with applicable Laws, GAAP or any other accounting standards), (v) the announcement of this Agreement or the pendency of the Contemplated Transactions (it being understood and agreed that this clause (v) shall not apply with respect to any representation or warranty the purpose of which is to address matters resulting from the announcement of this Agreement or the pendency of the Contemplated Transactions), or (vi) the taking of any action expressly required to be taken by this Agreement; except in each case with respect to clauses (i) through (iii), to the extent disproportionately affecting the Company and its Subsidiaries, relative to other similarly situated companies in the industries in which the Company and its Subsidiaries operate.

 

A-5

 

 

“Company Preferred Stock” means the preferred stock, $0.01 par value per share, of the Company, which has been designated as the Series Seed 1 Preferred Stock.

 

“Company Registered IP” means all Company IP Rights that are owned by or exclusively licensed to the Company or any of its Subsidiaries that are registered, filed or issued under the authority of, with or by any Governmental Body, including all Patents, registered Copyrights, and registered Trademarks (including domain name registrations) and all applications for any of the foregoing.

 

“Company Stockholder Agreements” means, collectively, (i) the Voting Agreement, dated as of January 26, 2026, by and among the Company, the Investors, the Key Holders, and the other Stockholders that are signatories thereto, (ii) the Rights of First Refusal and Co-Sale Agreement, dated as of January 26, 2026, by and among the Company, the Investors and the Key Holders that are signatories thereto, (iii) the Investor Rights Agreement, dated as of January 26, 2026, by and among the Company, the Investors and the Key Holders that are signatories thereto, (iv) the Management Rights Letter, dated as of January 26, 2026, from the Company in favor of Strobe Master Fund I, L.P., (v) the Side Letter, dated as of January 26, 2026, by and among the Company, Strobe Master Fund I, LP, and certain individuals signatory thereto, and (vi) the Side Letter, dated as of January 22, 2026, by and among the Company, Mr. Nicholas R. Liuzza, and Fifth Era Coinvestors LLC, and the First Addendum to the Side Letter.

 

“Company Unaudited Balance Sheet Date” means September 30, 2026.

 

“Company Unaudited Balance Sheet” means the balance sheet of the Company and its Subsidiaries as of September 30, 2026, which is a part of the Company Financials.

 

“Confidentiality Agreement” means the Confidentiality Agreement, dated as of July 13, 2026, by and between the Company and BLNE.

 

“Consent” means any approval, consent, ratification, permission, waiver or authorization (including any Governmental Authorization).

 

“Contract” means, with respect to any Person, any agreement, contract, subcontract, lease (whether for real or personal property), mortgage, license, sublicense or other legally binding commitment or undertaking of any nature to which such Person is a party or by which such Person or any of its assets are bound or affected under applicable Law.

 

“DGCL” means the General Corporation Law of the State of Delaware.

 

“Effect” means any effect, change, event, circumstance, or development.

 

“Employment Agreement” means an employment agreement to be entered into between BLNE and Mr. Brendan Reilly, which shall be effective as of the Closing.

 

A-6

 

 

“Encumbrance” means any lien, pledge, hypothecation, charge, mortgage, security interest, lease, license, option, easement, reservation, servitude, adverse title, claim, infringement, interference, option, right of first refusal, preemptive right, community property interest or restriction or encumbrance of any nature (including any restriction on the voting of any security, any restriction on the transfer of any security or other asset, any restriction on the receipt of any income derived from any asset, any restriction on the use of any asset and any restriction on the possession, exercise or transfer of any other attribute of ownership of any asset).

 

“Enforceability Exceptions” means the (a) Laws of general application relating to bankruptcy, insolvency and the relief of debtors; and (b) rules of law governing specific performance, injunctive relief and other equitable remedies.

 

“Entity” means any corporation (including any non-profit corporation), partnership (including any general partnership, limited partnership or limited liability partnership), joint venture, estate, trust, company (including any company limited by shares, limited liability company or joint stock company), firm, society or other enterprise, association, organization or entity, and each of its successors.

 

“Environmental Law” means any federal, state, local or foreign Law relating to pollution or protection of human health or the environment (including ambient air, surface water, ground water, land surface or subsurface strata), including any Law or regulation relating to emissions, discharges, releases or threatened releases of hazardous materials, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials.

 

“ERISA” means the Employee Retirement Income Security Act of 1974.

 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Exempt Issuance” means any sale of any capital stock or securities of BLNE (i) under BLNE’s existing At-the-Market Offering and Equity Line of Credit, as each may be amended, (ii) in order to provide working capital under its existing business, (iii) in order to continue to comply with existing lending agreements, and (iv) in order to compensate consultants, employees, officers and directors.

 

“GAAP” means generally accepted accounting principles and practices in effect from time to time within the United States applied consistently throughout the period involved.

 

“Governmental Authorization” means any: (a) permit, license, certificate, franchise, permission, variance, exception, order, clearance, registration, qualification or authorization issued, granted, given or otherwise made available by or under the authority of any Governmental Body or pursuant to any Law; or (b) right under any Contract with any Governmental Body.

 

“Governmental Body” means any: (a) nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature; (b) federal, state, local, municipal, foreign or other government; (c) governmental or quasi-governmental authority of any nature (including any governmental division, department, agency, commission, bureau, instrumentality, official, ministry, fund, foundation, center, organization, unit, body or Entity and any court or other tribunal, and for the avoidance of doubt, any Taxing authority); or (d) self-regulatory organization (including Nasdaq).

 

A-7

 

 

“Holders’ Representative” means Brendan Reilly.

 

“Inception Date” means October 20, 2025, the date on which the Company was formed by filing of the Articles of Incorporation with the Secretary of State of the State of Wyoming.

 

“Individual Fundamental Representations” means the representations and warranties of each Pre-Closing Company Holder in such holder’s Letter of Transmittal.

 

“Intellectual Property” means any and all intellectual and industrial property rights and other similar proprietary rights, in any jurisdiction throughout the world, whether registered or unregistered, including all rights pertaining to or deriving from: (a) patents and patent applications, (including any and all provisionals, continuations, continuations-in-part, continued prosecution, divisionals and patents of addition; requests for, and grants of, continued examination, extensions, supplemental protection certificates, re-examinations, post-grant confirmations or amendments, counterparts claiming priority from, or reissues of, any of the foregoing; and any patents or patent applications that claim priority to or from any of the foregoing) and all rights to claim priority arising from or related to any of the foregoing (collectively, “Patents”); (b) inventions, invention disclosures, discoveries and improvements, whether or not patentable; (c) copyrights and works of authorship, whether or not copyrightable and including any rights to Software (“Copyrights”); (d) computer software and firmware, including data files, source code, object code and software-related specifications and documentation; (e) trademarks, trade names, service marks, certification marks, service names, brands, trade dress and logos, applications therefore, and the goodwill associated therewith (collectively, “Trademarks”); (f) trade secrets (including those trade secrets defined in the Uniform Trade Secrets Act and under corresponding foreign statutory Law and common law), non-public information, and confidential information, know-how, business and technical information, and rights to limit the use or disclosure thereof by any Person (collectively “Trade Secrets”); (g) mask works; (h) domain name registrations; (i) proprietary databases and data compilations and all documentation relating to the foregoing; (j) rights under which an employee, inventor, author or other person is obligated to assign ownership any of the foregoing; (k) registrations of, applications to register, and renewals of, any of the foregoing with or by any Governmental Body in any jurisdiction throughout the world; (l) rights of action arising from the foregoing, including all claims for damages by reason of present, past and future infringement, misappropriation, violation misuse or breach of contract in respect of the foregoing, and present, past and future rights to sue and collect damages or seek injunctive relief for any such infringement, misappropriation, violation, misuse or breach; and (m) income, royalties and any other payments now and hereafter due or payable in respect of the foregoing.

 

“IRS” means the United States Internal Revenue Service.

 

“Knowledge” means, with respect to an individual, that such individual is actually aware of the relevant fact or such individual would reasonably be expected to know such fact in the ordinary course of the performance of such individual’s employment responsibilities. Any Person that is an Entity shall have Knowledge if any officer or manager of such Person as of the date such Knowledge is imputed has Knowledge of such fact or other matter.

 

A-8

 

 

“Law” means any federal, regional, provincial, state, foreign, local, municipal or other law, bylaw, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body and any orders, writs, injunctions, awards, judgments and decrees.

 

“Legal Proceeding” means any action, suit, litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative or appellate proceeding), hearing, inquiry, audit, examination or investigation commenced, brought, conducted or heard by or before, or otherwise involving, any court or other Governmental Body or any arbitrator or arbitration panel.

 

“Letter of Transmittal” means the letter of transmittal to be executed by each Pre-Closing Company Holder, substantially in the form attached hereto Exhibit E.

 

“Listing of Additional Shares” means the Listing of Additional Shares Notification Form for Nasdaq.

 

“Losses” means losses, damages, Liabilities, deficiencies, Legal Proceedings, judgments, interest, awards, penalties, fines, costs or expenses of whatever kind, including reasonable attorneys’ fees and the cost of enforcing any right to indemnification hereunder and the cost of pursuing any insurance providers; provided, however, that “Losses” shall not include punitive damages, except to the extent actually awarded to a Governmental Body or other third party.

 

“Majority of the Minority” means the vote of holders of a majority of the shares of BLNE Common Stock and Preferred Stock voting on an as converted basis held by stockholders who are not Related Party Holders.

 

“Merger Sub Board” means the board of directors of Merger Sub.

 

“Nasdaq” means The Nasdaq Stock Market LLC.

 

“Nevada Law” means Chapter 78 of the Nevada Revised Statutes of the State of Nevada.

 

“Open Source Materials” means any Software or other material that is distributed as “free software”, “open source software” or under a similar licensing or distribution terms (including the GNU General Public License (GPL), GNU Lesser General Public License (LGPL), Mozilla Public License (MPL), BSD licenses, the Artistic License, the Netscape Public License, the Sun Community Source License (SCSL) the Sun Industry Standards License (SISL) and the Apache License).

 

“Ordinary Course of Business” means, in the case of each of the Company and BLNE, such actions taken in the ordinary course of its normal operations and consistent with its past practices and taking into account any actions taken in preparation of or in connection with the Contemplated Transactions.

 

A-9

 

 

“Organizational Documents” means, with respect to any Entity, (a) the certificate or articles of association or incorporation or organization or limited partnership or limited liability company, and any joint venture, limited liability company, operating or partnership agreement and other similar documents adopted or filed in connection with the creation, formation or organization of such Entity and (b) all bylaws, regulations and similar documents or agreements relating to the organization or governance of such Entity, in each case, as amended or supplemented.

 

“Parties” means, collectively, the Company, BLNE, Merger Sub, and the Holders’ Representative or each individually a “Party”.

 

“Permits” means permits, licenses, certificates, authorizations, franchises, filings, registrations, qualifications, variances, exemptions, orders, consents and approvals issued by any applicable Governmental Body.

 

“Permitted Alternative Agreement” means a definitive agreement that contemplates or otherwise relates to an Acquisition Transaction that constitutes a Superior Offer.

 

“Permitted Encumbrance” means: (a) any liens for current Taxes not yet due and payable or for Taxes that are being contested in good faith and for which adequate reserves have been made on the Company Unaudited Balance Sheet or the BLNE Balance Sheet, as applicable; (b) minor liens that have arisen in the Ordinary Course of Business and that do not (in any case or in the aggregate) materially detract from the value of the assets or properties subject thereto or materially impair the operations of the Company or any of its Subsidiaries or BLNE, as applicable; (c) statutory liens to secure obligations to landlords, lessors or renters under leases or rental agreements; (d) deposits or pledges made in connection with, or to secure payment of, workers’ compensation, unemployment insurance or similar programs mandated by Law; (e) non-exclusive licenses of Intellectual Property granted by the Company or any of the Company’s Subsidiaries or BLNE, as applicable, in the Ordinary Course of Business and that do not (in any case or in the aggregate) materially detract from the value of the Intellectual Property subject thereto; and (f) statutory liens in favor of carriers, warehousemen, mechanics and materialmen, to secure claims for labor, materials or supplies.

 

“Person” means any individual, Entity or Governmental Body.

 

“Personal Information” means any information: (a) that can be used to identify, contact, or precisely locate a natural person, household or device; (b) defined as “personal data,” “personal information,” “personally identifiable information,” “nonpublic personal information,” or “individually identifiable health information” under any Company Privacy and Data Security Requirements or BLNE Privacy and Data Security Requirements, as applicable, and (c) associated, directly or indirectly (by, for example, records linked via unique keys), with any of the foregoing.

 

“Preferred Stock Conversion” means the conversion of all outstanding shares of Company Preferred Stock into shares of Company Common Stock immediately prior to the Effective Time pursuant to the terms of the Certificate of Incorporation of the Company.

 

“Pre-Closing Company Holders” means, collectively, each holder of Company Capital Stock and Company Options immediately prior to the Effective Time.

 

A-10

 

 

“Pre-Closing Tax Period” means any taxable period beginning before and ending on or prior to the Closing Date and the portion of any Straddle Tax Period ending on the Closing Date.

 

“Privacy Laws” means (a) all applicable Laws that relate to data privacy, data security, data use, data protection, marketing and the Processing and transfer (including cross-border transfer) of Personal Information;(b) any requirements of self-regulatory frameworks or organizations which the Company and its Subsidiaries or BLNE and its Subsidiaries (as applicable) is, or has been, contractually obligated to comply with or any self-certification mechanisms to which the Company and its Subsidiaries or BLNE and its Subsidiaries (as applicable) has committed; (c) any laws that provide rights of privacy or publicity to individuals; and (d) PCI-DSS.

 

“Process” or “Processing” means any operation or set of operations, whether or not by automatic means, including collection, recording, organization, storage, retention, access, adaptation, alteration, retrieval, consultation, use, disclosure, dissemination, making available, alignment, combination, blocking, deleting, erasure, or destruction.

 

“Pro Rata Share” means, with respect to any holder of Company Capital Stock or Company Options, such Person’s ownership interest in the Company as of immediately prior to the Effective Time but after giving effect to the Preferred Stock Conversion, determined by dividing (a) the number of shares of Company Common Stock owned of record by such Person as of immediately prior to the Effective Time, plus the number of shares of Company Common Stock issuable upon exercise of all Company Options held by such Person as of immediately prior to the Effective Time, by (b) the Company Outstanding Shares. For the avoidance of doubt, Mr. Liuzza’s Pro Rata Share shall not take into account or give effect to the provisions of the Side Letter.

 

“Proxy Statement” means the proxy statement to be sent to BLNE’s stockholders in connection with the BLNE Stockholders’ Meeting.

 

“Related Party Holders” means, collectively, Mr. Liuzza, Christopher R. Moe, Joseph Freedman, and any Person that directly holds shares of BLNE Common Stock that are beneficially owned by any of the foregoing Persons.

 

“Representatives” of a Party means such Party’s directors, managers, officers, employees, agents, attorneys, accountants, investment bankers, advisors and representatives.

 

“Sarbanes-Oxley Act” means the Sarbanes-Oxley Act of 2002.

 

“SEC” means the United States Securities and Exchange Commission.

 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Software” means software, whether in source code or object code form, and whether firmware or otherwise and any programming and user documentation related thereto.

 

A-11

 

 

“Source Code” means, collectively, any Software source code or database specifications or designs, or any material proprietary information or algorithm contained in or relating to any Software source code or database specifications or designs.

 

“Straddle Tax Period” means any taxable period that begins on or before and ends after the Closing Date.

 

“Subsequent Transaction” means any Acquisition Transaction (with all references to 20% in the definition of Acquisition Transaction being treated as references to 50% for these purposes).

 

“Subsidiary” means, with respect to a Person, any other Person of which (a) such Person directly or indirectly owns or purports to own, beneficially or of record, (i) an amount of voting securities or other interests in such entity that is sufficient to enable such Person to elect at least a majority of the members of such Entity’s board of directors or other governing body, or (ii) at least 50% of the outstanding equity, voting, beneficial or financial interests in such Entity or (b) such Person or any of its Subsidiaries is a general partner or holds a majority of the voting interests of a partnership.

 

“Superior Offer” means, with respect to BLNE, an unsolicited bona fide written Acquisition Proposal (with all references to 20% in the definition of Acquisition Transaction being treated as references to greater than 50% for these purposes) that (a) was not obtained or made as a direct or indirect result of a material breach of (or in violation of) of Section 4.4 or Section 5.3(d) by BLNE, and (b) is on terms and conditions that the Special Committee determines in good faith, based on such matters that it deems relevant (including the likelihood of consummation thereof), and taking into account any written offer by the other Party to amend the terms of this Agreement, and following consultation with its outside legal counsel and outside financial advisors, if any, are more favorable, from a financial point of view, to BLNE’s stockholders than the terms of the Contemplated Transactions.

 

“Systems” means the Software, hardware, firmware, networks, platforms, servers, interfaces, applications, websites and related information technology systems used by the Company or BLNE, as applicable, in connection with the conduct of their respective businesses.

 

“Takeover Statute” means any “fair price,” “moratorium,” “control share acquisition” or other similar anti-takeover Law.

 

“Tax” means (a) any federal, state, local, foreign or other tax, including any income, capital gain, gross receipts, capital stock, profits, transfer, estimated, registration, stamp, premium, escheat, unclaimed property, customs duty, ad valorem, occupancy, occupation, alternative, add-on, windfall profits, value added, severance, property, business, production, sales, use, license, excise, franchise, employment, payroll, social security, disability, unemployment, workers’ compensation, national health insurance, withholding or other taxes, duties, fees, assessments or governmental charges, surtaxes or deficiencies thereof of any kind whatsoever, however denominated, and including any fine, penalty, addition to tax or interest imposed by a Governmental Body with respect thereto, whether disputed or not, and (b) any liability for any amount described in the immediately preceding clause (a) of any other Person as a result of being a transferee or successor, an indemnitor, by Contract, assumption or otherwise, or as a result of being or having been a member of an affiliated, consolidated, combined, unitary, aggregate or similar group for Tax purposes, including under Treasury Regulations Section 1.1502-6 or similar state, local or foreign Law, or pursuant to a tax indemnity, tax sharing or other Contract, agreement, arrangement or understanding.

 

“Tax Return” means any return (including any information return), report, statement, declaration, estimate, schedule, notice, notification, form, election, certificate or other document, and any amendment or supplement to any of the foregoing, filed with or submitted to, or required to be filed with or submitted to, any Governmental Body in connection with the determination, assessment, collection or payment of any Tax or in connection with the administration, implementation or enforcement of or compliance with any Law relating to any Tax.

 

“Treasury Regulations” means the United States Treasury regulations promulgated under the Code.

 

“VWAP” means the volume weighted average sale price of a share of BLNE Common Stock as reported on Nasdaq for the period of ten consecutive trading days ending on the date of determination as to the final amount of Losses for each such indemnification claim (adjusted as appropriate to reflect any stock split, split-up, reverse stock split, stock dividend or distribution of securities convertible into BLNE Common Stock, reorganization, recapitalization, reclassification or other like change with respect to the BLNE Common Stock occurring after the Effective Time but prior to the measurement date).

 

A-12

 

 

2. Each of the following terms is defined in the Section set forth opposite such term:

 

Term   Section
Action   5.10(g)
Agreement   Preamble
Allocation Certificate   5.13(a)
Anti-Bribery Laws   2.23
Assumed Option   1.6(a)
Basket   10.4(a)
BLNE   Preamble
BLNE Allocation Percentage   1.5(a)(i)(B)
BLNE Disclosure Schedule   3
BLNE Financial Advisor   3.21
BLNE Indemnitees   10.2
BLNE Material Contracts   3.13(a)
BLNE Notice Period   5.3(d)
BLNE Outstanding Shares   1.5(a)(i)(C)
BLNE Outstanding Shares Certificate   5.13(b)
BLNE Privacy and Data Security Requirements   3.12(a)
BLNE Real Estate Leases   3.10
BLNE SEC Documents   3.7(a)
BLNE Stockholders’ Meeting   5.3(a)
BLNE Stockholder Support Agreement   Recitals
Book-Entry Shares   1.7(c)
Cap   10.4(a)
Capitalization Date   3.6(a)
Certificate of Merger   1.3
Certifications   3.7(a)
Closing   1.3
Closing Date   1.3
Company   Preamble
Company 2026 Financial Statements   5.14
Company Allocation Percentage   1.5(a)(i)(E)
Company Disclosure Schedule   Section 2
Company Equity Plan   1.6(a)
Company Financials   2.7(a)
Company Interim Financial Statements   5.14
Company Material Contracts   2.14(a)
Company Merger Shares   1.5(a)(i)(F)
Company Option   1.6(a)
Company Outstanding Shares   1.5(a)(i)(G)
Company Privacy and Data Security Requirements   2.13(a)
Company Stockholder Written Consent   5.2(a)
Company Unaudited Balance Sheet   2.7(a)
Contemplated Transactions   Recitals
D&O Indemnified Parties   5.5(a)
Direct Claim   10.5(c)
Dissenting Shares   1.8(a)
Effective Time   1.3
End Date   9.1(b)
Exchange Agent   1.7(a)
Exchange Fund   1.7(a)
Exchange Ratio   1.5(a)(i)
Excluded Shares   1.5(a)(iii)
FIRPTA Certificate   5.10(d)
Fractional Real Property Interests   2.11
Fractional Share Cash Amount   1.7(d)
Holders’ Representative   Preamble
Indemnified Party   10.5(a)
Indemnifying Party   10.5(a)
Intended Tax Treatment   Recitals
Liability   2.9
Lock-Up Agreement   Recitals
Merger   Recitals
Merger Consideration   1.5(a)(i)
Merger Sub   Preamble
Mr. Liuzza   Preamble
Post-Closing BLNE Shares   1.5(a)(i)(I)
Pre-Closing Period   4.1(a)
Qualifying Financing   5.19
Required BLNE Stockholder Matters   5.3(a)
Required BLNE Stockholder Vote   3.4
Required Company Stockholder Vote   2.4
SEC Documents   5.9
Side Letter   Recitals
Special Committee Recommendation   3.3(c)
Stockholder Indemnitee   10.3
Stockholder Notice   5.2(b)
Stock Issuance   5.1(a)
Surviving Corporation   1.1
Third-Party Claim   10.5(b)
Token Warrants   2.6(b)

 

A-13

 

 

EXHIBIT B

 

Form of BLNE Stockholder Support Agreement

 

 B-1 

 

 

EXHIBIT C

 

Form of Lock-Up Agreement

 

 C-1 

 

 

EXHIBIT D

 

Illustrative Calculation of Exchange Ratio

 

BLNE Allocation Percentage   60.0%
BLNE Outstanding Shares   43,737,141
Company Allocation Percentage   40.0%
Company Merger Shares   72,895,234 multiplied by 40% = 29,158,094
Company Outstanding Shares   11,200,000
Post-Closing BLNE Shares   43,737,141 divided by 60% = 72,895,234
Exchange Ratio   29,158,094 divided by 11,200,000 = 2.6034

 

 D-1 

 

 

EXHIBIT E

 

Form of Letter of Transmittal

 

 E-1 

 

 

EXHIBIT F

 

Form of Side Letter

 

 F-1